id	sid	tid	token	lemma	pos
cord-352796-6einbent	1	1	key	key	JJ
cord-352796-6einbent	1	2	:	:	:
cord-352796-6einbent	1	3	cord-352796	cord-352796	NNP
cord-352796-6einbent	1	4	-	-	HYPH
cord-352796-6einbent	1	5	6einbent	6einbent	CD
cord-352796-6einbent	1	6	authors	author	NNS
cord-352796-6einbent	1	7	:	:	:
cord-352796-6einbent	2	1	Theodore	Theodore	NNP
cord-352796-6einbent	2	2	Coroneo	Coroneo	NNP
cord-352796-6einbent	2	3	,	,	,
cord-352796-6einbent	2	4	Minas	Minas	NNP
cord-352796-6einbent	2	5	title	title	NN
cord-352796-6einbent	2	6	:	:	:
cord-352796-6einbent	2	7	The	the	DT
cord-352796-6einbent	2	8	eye	eye	NN
cord-352796-6einbent	2	9	as	as	IN
cord-352796-6einbent	2	10	the	the	DT
cord-352796-6einbent	2	11	discrete	discrete	JJ
cord-352796-6einbent	2	12	but	but	CC
cord-352796-6einbent	2	13	defensible	defensible	JJ
cord-352796-6einbent	2	14	portal	portal	NN
cord-352796-6einbent	2	15	of	of	IN
cord-352796-6einbent	2	16	coronavirus	coronavirus	NN
cord-352796-6einbent	2	17	infection	infection	NN
cord-352796-6einbent	2	18	date	date	NN
cord-352796-6einbent	2	19	:	:	:
cord-352796-6einbent	2	20	2020	2020	CD
cord-352796-6einbent	2	21	-	-	HYPH
cord-352796-6einbent	2	22	05	05	CD
cord-352796-6einbent	2	23	-	-	SYM
cord-352796-6einbent	2	24	21	21	CD
cord-352796-6einbent	2	25	journal	journal	NN
cord-352796-6einbent	2	26	:	:	:
cord-352796-6einbent	2	27	Ocul	Ocul	NNP
cord-352796-6einbent	2	28	Surf	Surf	NNP
cord-352796-6einbent	2	29	DOI	DOI	NNP
cord-352796-6einbent	2	30	:	:	:
cord-352796-6einbent	2	31	10.1016	10.1016	CD
cord-352796-6einbent	2	32	/	/	SYM
cord-352796-6einbent	2	33	j.jtos.2020.05.011	j.jtos.2020.05.011	CD
cord-352796-6einbent	2	34	sha	sha	NNP
cord-352796-6einbent	2	35	:	:	:
cord-352796-6einbent	2	36	b818cfa6c8e17745679095305899f5e67cfd4323	b818cfa6c8e17745679095305899f5e67cfd4323	NNP
cord-352796-6einbent	2	37	doc_id	doc_id	CD
cord-352796-6einbent	2	38	:	:	:
cord-352796-6einbent	2	39	352796	352796	CD
cord-352796-6einbent	2	40	cord_uid	cord_uid	NNS
cord-352796-6einbent	2	41	:	:	:
cord-352796-6einbent	2	42	6einbent	6einbent	CD
cord-352796-6einbent	2	43	Oculo	Oculo	NNP
cord-352796-6einbent	2	44	-	-	HYPH
cord-352796-6einbent	2	45	centric	centric	NN
cord-352796-6einbent	2	46	factors	factor	NNS
cord-352796-6einbent	2	47	may	may	MD
cord-352796-6einbent	2	48	provide	provide	VB
cord-352796-6einbent	2	49	a	a	DT
cord-352796-6einbent	2	50	key	key	NN
cord-352796-6einbent	2	51	to	to	IN
cord-352796-6einbent	2	52	understanding	understand	VBG
cord-352796-6einbent	2	53	invasion	invasion	NN
cord-352796-6einbent	2	54	success	success	NN
cord-352796-6einbent	2	55	by	by	IN
cord-352796-6einbent	2	56	SARS	SARS	NNP
cord-352796-6einbent	2	57	-	-	HYPH
cord-352796-6einbent	2	58	CoV-2	CoV-2	NNP
cord-352796-6einbent	2	59	,	,	,
cord-352796-6einbent	2	60	a	a	DT
cord-352796-6einbent	2	61	highly	highly	RB
cord-352796-6einbent	2	62	contagious	contagious	JJ
cord-352796-6einbent	2	63	,	,	,
cord-352796-6einbent	2	64	potentially	potentially	RB
cord-352796-6einbent	2	65	lethal	lethal	JJ
cord-352796-6einbent	2	66	,	,	,
cord-352796-6einbent	2	67	virus	virus	NN
cord-352796-6einbent	2	68	with	with	IN
cord-352796-6einbent	2	69	ocular	ocular	JJ
cord-352796-6einbent	2	70	tropism	tropism	NN
cord-352796-6einbent	2	71	.	.	.
cord-352796-6einbent	3	1	Respiratory	respiratory	JJ
cord-352796-6einbent	3	2	infection	infection	NN
cord-352796-6einbent	3	3	transmission	transmission	NN
cord-352796-6einbent	3	4	via	via	IN
cord-352796-6einbent	3	5	the	the	DT
cord-352796-6einbent	3	6	eye	eye	NN
cord-352796-6einbent	3	7	and	and	CC
cord-352796-6einbent	3	8	lacrimal	lacrimal	NN
cord-352796-6einbent	3	9	-	-	HYPH
cord-352796-6einbent	3	10	nasal	nasal	NN
cord-352796-6einbent	3	11	pathway	pathway	NN
cord-352796-6einbent	3	12	elucidated	elucidate	VBN
cord-352796-6einbent	3	13	during	during	IN
cord-352796-6einbent	3	14	the	the	DT
cord-352796-6einbent	3	15	1918	1918	CD
cord-352796-6einbent	3	16	influenza	influenza	NN
cord-352796-6einbent	3	17	pandemic	pandemic	NN
cord-352796-6einbent	3	18	,	,	,
cord-352796-6einbent	3	19	remains	remain	VBZ
cord-352796-6einbent	3	20	to	to	TO
cord-352796-6einbent	3	21	be	be	VB
cord-352796-6einbent	3	22	explored	explore	VBN
cord-352796-6einbent	3	23	in	in	IN
cord-352796-6einbent	3	24	this	this	DT
cord-352796-6einbent	3	25	crisis	crisis	NN
cord-352796-6einbent	3	26	.	.	.
cord-352796-6einbent	4	1	The	the	DT
cord-352796-6einbent	4	2	eye	eye	NN
cord-352796-6einbent	4	3	and	and	CC
cord-352796-6einbent	4	4	its	-PRON-	PRP$
cord-352796-6einbent	4	5	adnexae	adnexae	NN
cord-352796-6einbent	4	6	represent	represent	VBP
cord-352796-6einbent	4	7	a	a	DT
cord-352796-6einbent	4	8	large	large	JJ
cord-352796-6einbent	4	9	surface	surface	NN
cord-352796-6einbent	4	10	area	area	NN
cord-352796-6einbent	4	11	directly	directly	RB
cord-352796-6einbent	4	12	exposed	expose	VBN
cord-352796-6einbent	4	13	to	to	IN
cord-352796-6einbent	4	14	airborne	airborne	JJ
cord-352796-6einbent	4	15	viral	viral	JJ
cord-352796-6einbent	4	16	particles	particle	NNS
cord-352796-6einbent	4	17	and	and	CC
cord-352796-6einbent	4	18	hand	hand	NN
cord-352796-6einbent	4	19	contact	contact	NN
cord-352796-6einbent	4	20	.	.	.
cord-352796-6einbent	5	1	The	the	DT
cord-352796-6einbent	5	2	virus	virus	NN
cord-352796-6einbent	5	3	may	may	MD
cord-352796-6einbent	5	4	bind	bind	VB
cord-352796-6einbent	5	5	to	to	IN
cord-352796-6einbent	5	6	corneal	corneal	JJ
cord-352796-6einbent	5	7	and	and	CC
cord-352796-6einbent	5	8	conjunctival	conjunctival	JJ
cord-352796-6einbent	5	9	angiotensin	angiotensin	NN
cord-352796-6einbent	5	10	converting	convert	VBG
cord-352796-6einbent	5	11	enzyme	enzyme	NN
cord-352796-6einbent	5	12	2	2	CD
cord-352796-6einbent	6	1	(	(	-LRB-
cord-352796-6einbent	6	2	ACE2	ACE2	NNP
cord-352796-6einbent	6	3	)	)	-RRB-
cord-352796-6einbent	6	4	receptors	receptor	NNS
cord-352796-6einbent	6	5	and	and	CC
cord-352796-6einbent	6	6	potentially	potentially	RB
cord-352796-6einbent	6	7	to	to	IN
cord-352796-6einbent	6	8	the	the	DT
cord-352796-6einbent	6	9	lipophilic	lipophilic	JJ
cord-352796-6einbent	6	10	periocular	periocular	NN
cord-352796-6einbent	6	11	skin	skin	NN
cord-352796-6einbent	6	12	and	and	CC
cord-352796-6einbent	6	13	superficial	superficial	JJ
cord-352796-6einbent	6	14	tear	tear	JJ
cord-352796-6einbent	6	15	film	film	NN
cord-352796-6einbent	6	16	with	with	IN
cord-352796-6einbent	6	17	downstream	downstream	JJ
cord-352796-6einbent	6	18	carriage	carriage	NN
cord-352796-6einbent	6	19	into	into	IN
cord-352796-6einbent	6	20	the	the	DT
cord-352796-6einbent	6	21	nasopharynx	nasopharynx	NN
cord-352796-6einbent	6	22	and	and	CC
cord-352796-6einbent	6	23	subsequent	subsequent	JJ
cord-352796-6einbent	6	24	access	access	NN
cord-352796-6einbent	6	25	to	to	IN
cord-352796-6einbent	6	26	the	the	DT
cord-352796-6einbent	6	27	lungs	lung	NNS
cord-352796-6einbent	6	28	and	and	CC
cord-352796-6einbent	6	29	gut	gut	NN
cord-352796-6einbent	6	30	.	.	.
cord-352796-6einbent	7	1	Adenoviruses	adenovirus	NNS
cord-352796-6einbent	7	2	and	and	CC
cord-352796-6einbent	7	3	influenza	influenza	NN
cord-352796-6einbent	7	4	viruses	virus	NNS
cord-352796-6einbent	7	5	share	share	VBP
cord-352796-6einbent	7	6	this	this	DT
cord-352796-6einbent	7	7	ocular	ocular	JJ
cord-352796-6einbent	7	8	tropism	tropism	NN
cord-352796-6einbent	7	9	and	and	CC
cord-352796-6einbent	7	10	despite	despite	IN
cord-352796-6einbent	7	11	differing	differ	VBG
cord-352796-6einbent	7	12	ocular	ocular	JJ
cord-352796-6einbent	7	13	and	and	CC
cord-352796-6einbent	7	14	systemic	systemic	JJ
cord-352796-6einbent	7	15	manifestations	manifestation	NNS
cord-352796-6einbent	7	16	and	and	CC
cord-352796-6einbent	7	17	disease	disease	NN
cord-352796-6einbent	7	18	patterns	pattern	NNS
cord-352796-6einbent	7	19	,	,	,
cord-352796-6einbent	7	20	common	common	JJ
cord-352796-6einbent	7	21	lessons	lesson	NNS
cord-352796-6einbent	7	22	,	,	,
cord-352796-6einbent	7	23	particularly	particularly	RB
cord-352796-6einbent	7	24	in	in	IN
cord-352796-6einbent	7	25	management	management	NN
cord-352796-6einbent	7	26	,	,	,
cord-352796-6einbent	7	27	emerge	emerge	VB
cord-352796-6einbent	7	28	.	.	.
cord-352796-6einbent	8	1	Slit	slit	JJ
cord-352796-6einbent	8	2	lamp	lamp	NN
cord-352796-6einbent	8	3	usage	usage	NN
cord-352796-6einbent	8	4	places	place	NNS
cord-352796-6einbent	8	5	ophthalmologists	ophthalmologist	NNS
cord-352796-6einbent	8	6	at	at	IN
cord-352796-6einbent	8	7	particular	particular	JJ
cord-352796-6einbent	8	8	risk	risk	NN
cord-352796-6einbent	8	9	of	of	IN
cord-352796-6einbent	8	10	exposure	exposure	NN
cord-352796-6einbent	8	11	to	to	IN
cord-352796-6einbent	8	12	high	high	JJ
cord-352796-6einbent	8	13	viral	viral	JJ
cord-352796-6einbent	8	14	loads	load	NNS
cord-352796-6einbent	8	15	(	(	-LRB-
cord-352796-6einbent	8	16	and	and	CC
cord-352796-6einbent	8	17	poor	poor	JJ
cord-352796-6einbent	8	18	prognosis	prognosis	NN
cord-352796-6einbent	8	19	)	)	-RRB-
cord-352796-6einbent	8	20	and	and	CC
cord-352796-6einbent	8	21	as	as	IN
cord-352796-6einbent	8	22	for	for	IN
cord-352796-6einbent	8	23	adenoviral	adenoviral	NNP
cord-352796-6einbent	8	24	epidemics	epidemic	NNS
cord-352796-6einbent	8	25	,	,	,
cord-352796-6einbent	8	26	this	this	DT
cord-352796-6einbent	8	27	may	may	MD
cord-352796-6einbent	8	28	be	be	VB
cord-352796-6einbent	8	29	a	a	DT
cord-352796-6einbent	8	30	setting	setting	NN
cord-352796-6einbent	8	31	for	for	IN
cord-352796-6einbent	8	32	disease	disease	NN
cord-352796-6einbent	8	33	transmission	transmission	NN
cord-352796-6einbent	8	34	.	.	.
cord-352796-6einbent	9	1	Local	local	JJ
cord-352796-6einbent	9	2	,	,	,
cord-352796-6einbent	9	3	rather	rather	RB
cord-352796-6einbent	9	4	than	than	IN
cord-352796-6einbent	9	5	systemic	systemic	JJ
cord-352796-6einbent	9	6	treatments	treatment	NNS
cord-352796-6einbent	9	7	blocking	block	VBG
cord-352796-6einbent	9	8	virus	virus	NN
cord-352796-6einbent	9	9	binding	bind	VBG
cord-352796-6einbent	9	10	in	in	IN
cord-352796-6einbent	9	11	this	this	DT
cord-352796-6einbent	9	12	pathway	pathway	NN
cord-352796-6einbent	9	13	(	(	-LRB-
cord-352796-6einbent	9	14	advocated	advocate	VBN
cord-352796-6einbent	9	15	for	for	IN
cord-352796-6einbent	9	16	adenovirus	adenovirus	NN
cord-352796-6einbent	9	17	)	)	-RRB-
cord-352796-6einbent	9	18	are	be	VBP
cord-352796-6einbent	9	19	worth	worth	JJ
cord-352796-6einbent	9	20	considering	consider	VBG
cord-352796-6einbent	9	21	.	.	.
cord-352796-6einbent	10	1	This	this	DT
cord-352796-6einbent	10	2	pathway	pathway	NN
cord-352796-6einbent	10	3	is	be	VBZ
cord-352796-6einbent	10	4	accessible	accessible	JJ
cord-352796-6einbent	10	5	with	with	IN
cord-352796-6einbent	10	6	eye	eye	NN
cord-352796-6einbent	10	7	drops	drop	NNS
cord-352796-6einbent	10	8	or	or	CC
cord-352796-6einbent	10	9	aerosols	aerosol	NNS
cord-352796-6einbent	10	10	containing	contain	VBG
cord-352796-6einbent	10	11	drugs	drug	NNS
cord-352796-6einbent	10	12	which	which	WDT
cord-352796-6einbent	10	13	appear	appear	VBP
cord-352796-6einbent	10	14	efficacious	efficacious	JJ
cord-352796-6einbent	10	15	via	via	IN
cord-352796-6einbent	10	16	systemic	systemic	JJ
cord-352796-6einbent	10	17	administration	administration	NN
cord-352796-6einbent	10	18	.	.	.
cord-352796-6einbent	11	1	A	a	DT
cord-352796-6einbent	11	2	combination	combination	NN
cord-352796-6einbent	11	3	such	such	JJ
cord-352796-6einbent	11	4	as	as	IN
cord-352796-6einbent	11	5	hydroxychloroquine	hydroxychloroquine	NNP
cord-352796-6einbent	11	6	,	,	,
cord-352796-6einbent	11	7	azithromycin	azithromycin	NN
cord-352796-6einbent	11	8	and	and	CC
cord-352796-6einbent	11	9	zinc	zinc	NN
cord-352796-6einbent	11	10	,	,	,
cord-352796-6einbent	11	11	all	all	DT
cord-352796-6einbent	11	12	of	of	IN
cord-352796-6einbent	11	13	which	which	WDT
cord-352796-6einbent	11	14	have	have	VBP
cord-352796-6einbent	11	15	previously	previously	RB
cord-352796-6einbent	11	16	been	be	VBN
cord-352796-6einbent	11	17	used	use	VBN
cord-352796-6einbent	11	18	topically	topically	RB
cord-352796-6einbent	11	19	in	in	IN
cord-352796-6einbent	11	20	the	the	DT
cord-352796-6einbent	11	21	eye	eye	NN
cord-352796-6einbent	11	22	and	and	CC
cord-352796-6einbent	11	23	which	which	WDT
cord-352796-6einbent	11	24	work	work	VBP
cord-352796-6einbent	11	25	at	at	IN
cord-352796-6einbent	11	26	least	least	JJS
cord-352796-6einbent	11	27	in	in	IN
cord-352796-6einbent	11	28	part	part	NN
cord-352796-6einbent	11	29	by	by	IN
cord-352796-6einbent	11	30	blocking	block	VBG
cord-352796-6einbent	11	31	ACE2	ACE2	NNP
cord-352796-6einbent	11	32	receptors	receptor	NNS
cord-352796-6einbent	11	33	,	,	,
cord-352796-6einbent	11	34	may	may	MD
cord-352796-6einbent	11	35	offer	offer	VB
cord-352796-6einbent	11	36	a	a	DT
cord-352796-6einbent	11	37	safe	safe	JJ
cord-352796-6einbent	11	38	,	,	,
cord-352796-6einbent	11	39	cost	cost	NN
cord-352796-6einbent	11	40	-	-	HYPH
cord-352796-6einbent	11	41	effective	effective	JJ
cord-352796-6einbent	11	42	and	and	CC
cord-352796-6einbent	11	43	resource	resource	NN
cord-352796-6einbent	11	44	-	-	HYPH
cord-352796-6einbent	11	45	sparing	spare	VBG
cord-352796-6einbent	11	46	intervention	intervention	NN
cord-352796-6einbent	11	47	.	.	.
cord-352796-6einbent	12	1	Unexpectedly	unexpectedly	RB
cord-352796-6einbent	12	2	,	,	,
cord-352796-6einbent	12	3	ophthalmology	ophthalmology	NN
cord-352796-6einbent	12	4	may	may	MD
cord-352796-6einbent	12	5	be	be	VB
cord-352796-6einbent	12	6	playing	play	VBG
cord-352796-6einbent	12	7	a	a	DT
cord-352796-6einbent	12	8	central	central	JJ
cord-352796-6einbent	12	9	role	role	NN
cord-352796-6einbent	12	10	in	in	IN
cord-352796-6einbent	12	11	the	the	DT
cord-352796-6einbent	12	12	current	current	JJ
cord-352796-6einbent	12	13	Coronavirus	Coronavirus	NNP
cord-352796-6einbent	12	14	Disease	Disease	NNP
cord-352796-6einbent	12	15	2019	2019	CD
cord-352796-6einbent	12	16	(	(	-LRB-
cord-352796-6einbent	12	17	COVID-	covid-	NN
cord-352796-6einbent	12	18	19	19	CD
cord-352796-6einbent	12	19	)	)	-RRB-
cord-352796-6einbent	12	20	epidemic	epidemic	NN
cord-352796-6einbent	12	21	.	.	.
cord-352796-6einbent	13	1	The	the	DT
cord-352796-6einbent	13	2	harbinger	harbinger	NN
cord-352796-6einbent	13	3	of	of	IN
cord-352796-6einbent	13	4	the	the	DT
cord-352796-6einbent	13	5	third	third	JJ
cord-352796-6einbent	13	6	zoonotic	zoonotic	JJ
cord-352796-6einbent	13	7	coronavirus	coronavirus	NN
cord-352796-6einbent	13	8	epidemic	epidemic	NN
cord-352796-6einbent	13	9	in	in	IN
cord-352796-6einbent	13	10	as	as	RB
cord-352796-6einbent	13	11	many	many	JJ
cord-352796-6einbent	13	12	decades	decade	NNS
cord-352796-6einbent	13	13	(	(	-LRB-
cord-352796-6einbent	13	14	1	1	CD
cord-352796-6einbent	13	15	)	)	-RRB-
cord-352796-6einbent	13	16	,	,	,
cord-352796-6einbent	13	17	was	be	VBD
cord-352796-6einbent	13	18	Dr	Dr	NNP
cord-352796-6einbent	13	19	Li	Li	NNP
cord-352796-6einbent	13	20	Wenliang	Wenliang	NNP
cord-352796-6einbent	13	21	,	,	,
cord-352796-6einbent	13	22	an	an	DT
cord-352796-6einbent	13	23	ophthalmologist	ophthalmologist	NN
cord-352796-6einbent	13	24	,	,	,
cord-352796-6einbent	13	25	who	who	WP
cord-352796-6einbent	13	26	died	die	VBD
cord-352796-6einbent	13	27	following	follow	VBG
cord-352796-6einbent	13	28	infection	infection	NN
cord-352796-6einbent	13	29	with	with	IN
cord-352796-6einbent	13	30	COVID-19	COVID-19	NNP
cord-352796-6einbent	13	31	(	(	-LRB-
cord-352796-6einbent	13	32	2	2	CD
cord-352796-6einbent	13	33	,	,	,
cord-352796-6einbent	13	34	3	3	CD
cord-352796-6einbent	13	35	)	)	-RRB-
cord-352796-6einbent	13	36	.	.	.
cord-352796-6einbent	14	1	It	-PRON-	PRP
cord-352796-6einbent	14	2	was	be	VBD
cord-352796-6einbent	14	3	thought	think	VBN
cord-352796-6einbent	14	4	he	-PRON-	PRP
cord-352796-6einbent	14	5	was	be	VBD
cord-352796-6einbent	14	6	infected	infect	VBN
cord-352796-6einbent	14	7	during	during	IN
cord-352796-6einbent	14	8	examination	examination	NN
cord-352796-6einbent	14	9	of	of	IN
cord-352796-6einbent	14	10	a	a	DT
cord-352796-6einbent	14	11	patient	patient	NN
cord-352796-6einbent	14	12	with	with	IN
cord-352796-6einbent	14	13	angle	angle	NN
cord-352796-6einbent	14	14	closure	closure	NN
cord-352796-6einbent	14	15	glaucoma	glaucoma	NN
cord-352796-6einbent	14	16	in	in	IN
cord-352796-6einbent	14	17	the	the	DT
cord-352796-6einbent	14	18	second	second	JJ
cord-352796-6einbent	14	19	week	week	NN
cord-352796-6einbent	14	20	of	of	IN
cord-352796-6einbent	14	21	January	January	NNP
cord-352796-6einbent	14	22	2020	2020	CD
cord-352796-6einbent	14	23	.	.	.
cord-352796-6einbent	15	1	He	-PRON-	PRP
cord-352796-6einbent	15	2	suspected	suspect	VBD
cord-352796-6einbent	15	3	an	an	DT
cord-352796-6einbent	15	4	outbreak	outbreak	NN
cord-352796-6einbent	15	5	after	after	IN
cord-352796-6einbent	15	6	seeing	see	VBG
cord-352796-6einbent	15	7	patients	patient	NNS
cord-352796-6einbent	15	8	with	with	IN
cord-352796-6einbent	15	9	SARS	SARS	NNP
cord-352796-6einbent	15	10	-	-	HYPH
cord-352796-6einbent	15	11	like	like	JJ
cord-352796-6einbent	15	12	symptoms	symptom	NNS
cord-352796-6einbent	15	13	and	and	CC
cord-352796-6einbent	15	14	the	the	DT
cord-352796-6einbent	15	15	system	system	NN
cord-352796-6einbent	15	16	failure	failure	NN
cord-352796-6einbent	15	17	to	to	TO
cord-352796-6einbent	15	18	heed	heed	VB
cord-352796-6einbent	15	19	his	-PRON-	PRP$
cord-352796-6einbent	15	20	warning	warning	NN
cord-352796-6einbent	15	21	may	may	MD
cord-352796-6einbent	15	22	well	well	RB
cord-352796-6einbent	15	23	have	have	VB
cord-352796-6einbent	15	24	changed	change	VBN
cord-352796-6einbent	15	25	the	the	DT
cord-352796-6einbent	15	26	course	course	NN
cord-352796-6einbent	15	27	of	of	IN
cord-352796-6einbent	15	28	world	world	NN
cord-352796-6einbent	15	29	history	history	NN
cord-352796-6einbent	15	30	.	.	.
cord-352796-6einbent	16	1	The	the	DT
cord-352796-6einbent	16	2	second	second	JJ
cord-352796-6einbent	16	3	instructive	instructive	JJ
cord-352796-6einbent	16	4	case	case	NN
cord-352796-6einbent	16	5	is	be	VBZ
cord-352796-6einbent	16	6	that	that	DT
cord-352796-6einbent	16	7	of	of	IN
cord-352796-6einbent	16	8	the	the	DT
cord-352796-6einbent	16	9	respiratory	respiratory	JJ
cord-352796-6einbent	16	10	physician	physician	NN
cord-352796-6einbent	16	11	Guangfa	Guangfa	NNP
cord-352796-6einbent	16	12	Wang	Wang	NNP
cord-352796-6einbent	16	13	(	(	-LRB-
cord-352796-6einbent	16	14	4	4	CD
cord-352796-6einbent	16	15	)	)	-RRB-
cord-352796-6einbent	16	16	.	.	.
cord-352796-6einbent	17	1	Days	day	NNS
cord-352796-6einbent	17	2	before	before	IN
cord-352796-6einbent	17	3	pneumonia	pneumonia	NN
cord-352796-6einbent	17	4	onset	onset	NN
cord-352796-6einbent	17	5	,	,	,
cord-352796-6einbent	17	6	his	-PRON-	PRP$
cord-352796-6einbent	17	7	earliest	early	JJS
cord-352796-6einbent	17	8	symptoms	symptom	NNS
cord-352796-6einbent	17	9	related	relate	VBN
cord-352796-6einbent	17	10	to	to	IN
cord-352796-6einbent	17	11	left	left	JJ
cord-352796-6einbent	17	12	conjunctivitis	conjunctivitis	NN
cord-352796-6einbent	17	13	,	,	,
cord-352796-6einbent	17	14	then	then	RB
cord-352796-6einbent	17	15	catarrhal	catarrhal	VBZ
cord-352796-6einbent	17	16	symptoms	symptom	NNS
cord-352796-6einbent	17	17	and	and	CC
cord-352796-6einbent	17	18	fever	fever	NN
cord-352796-6einbent	17	19	which	which	WDT
cord-352796-6einbent	17	20	developed	develop	VBD
cord-352796-6einbent	17	21	after	after	IN
cord-352796-6einbent	17	22	2	2	CD
cord-352796-6einbent	17	23	-	-	SYM
cord-352796-6einbent	17	24	3	3	CD
cord-352796-6einbent	17	25	hours	hour	NNS
cord-352796-6einbent	17	26	,	,	,
cord-352796-6einbent	17	27	slower	slow	JJR
cord-352796-6einbent	17	28	than	than	IN
cord-352796-6einbent	17	29	might	may	MD
cord-352796-6einbent	17	30	be	be	VB
cord-352796-6einbent	17	31	expected	expect	VBN
cord-352796-6einbent	17	32	from	from	IN
cord-352796-6einbent	17	33	older	old	JJR
cord-352796-6einbent	17	34	studies	study	NNS
cord-352796-6einbent	17	35	tracing	trace	VBG
cord-352796-6einbent	17	36	the	the	DT
cord-352796-6einbent	17	37	passage	passage	NN
cord-352796-6einbent	17	38	of	of	IN
cord-352796-6einbent	17	39	bacteria	bacteria	NNS
cord-352796-6einbent	17	40	through	through	IN
cord-352796-6einbent	17	41	the	the	DT
cord-352796-6einbent	17	42	lacrimal	lacrimal	JJ
cord-352796-6einbent	17	43	drainage	drainage	NN
cord-352796-6einbent	17	44	system	system	NN
cord-352796-6einbent	17	45	(	(	-LRB-
cord-352796-6einbent	17	46	5	5	CD
cord-352796-6einbent	17	47	)	)	-RRB-
cord-352796-6einbent	17	48	.	.	.
cord-352796-6einbent	18	1	While	while	IN
cord-352796-6einbent	18	2	an	an	DT
cord-352796-6einbent	18	3	N95	N95	NNP
cord-352796-6einbent	18	4	respirator	respirator	NN
cord-352796-6einbent	18	5	was	be	VBD
cord-352796-6einbent	18	6	worn	wear	VBN
cord-352796-6einbent	18	7	,	,	,
cord-352796-6einbent	18	8	offering	offer	VBG
cord-352796-6einbent	18	9	protection	protection	NN
cord-352796-6einbent	18	10	from	from	IN
cord-352796-6einbent	18	11	infection	infection	NN
cord-352796-6einbent	18	12	via	via	IN
cord-352796-6einbent	18	13	oro	oro	NNP
cord-352796-6einbent	18	14	-	-	HYPH
cord-352796-6einbent	18	15	nasal	nasal	NN
cord-352796-6einbent	18	16	pathways	pathway	NNS
cord-352796-6einbent	18	17	,	,	,
cord-352796-6einbent	18	18	eye	eye	NN
cord-352796-6einbent	18	19	protection	protection	NN
cord-352796-6einbent	18	20	was	be	VBD
cord-352796-6einbent	18	21	not	not	RB
cord-352796-6einbent	18	22	.	.	.
cord-352796-6einbent	19	1	Evidence	evidence	NN
cord-352796-6einbent	19	2	that	that	IN
cord-352796-6einbent	19	3	ocular	ocular	JJ
cord-352796-6einbent	19	4	and	and	CC
cord-352796-6einbent	19	5	periocular	periocular	JJ
cord-352796-6einbent	19	6	tissue	tissue	NN
cord-352796-6einbent	19	7	may	may	MD
cord-352796-6einbent	19	8	be	be	VB
cord-352796-6einbent	19	9	uniquely	uniquely	RB
cord-352796-6einbent	19	10	placed	place	VBN
cord-352796-6einbent	19	11	as	as	IN
cord-352796-6einbent	19	12	an	an	DT
cord-352796-6einbent	19	13	entry	entry	NN
cord-352796-6einbent	19	14	point	point	NN
cord-352796-6einbent	19	15	for	for	IN
cord-352796-6einbent	19	16	viral	viral	JJ
cord-352796-6einbent	19	17	invasion	invasion	NN
cord-352796-6einbent	19	18	will	will	MD
cord-352796-6einbent	19	19	be	be	VB
cord-352796-6einbent	19	20	reviewed	review	VBN
cord-352796-6einbent	19	21	.	.	.
cord-352796-6einbent	20	1	At	at	IN
cord-352796-6einbent	20	2	the	the	DT
cord-352796-6einbent	20	3	height	height	NN
cord-352796-6einbent	20	4	of	of	IN
cord-352796-6einbent	20	5	the	the	DT
cord-352796-6einbent	20	6	1918	1918	CD
cord-352796-6einbent	20	7	world	world	NN
cord-352796-6einbent	20	8	influenza	influenza	NN
cord-352796-6einbent	20	9	epidemic	epidemic	NN
cord-352796-6einbent	20	10	,	,	,
cord-352796-6einbent	20	11	a	a	DT
cord-352796-6einbent	20	12	landmark	landmark	NN
cord-352796-6einbent	20	13	paper	paper	NN
cord-352796-6einbent	20	14	appeared	appear	VBD
cord-352796-6einbent	20	15	,	,	,
cord-352796-6einbent	20	16	proposing	propose	VBG
cord-352796-6einbent	20	17	transmission	transmission	NN
cord-352796-6einbent	20	18	of	of	IN
cord-352796-6einbent	20	19	acute	acute	JJ
cord-352796-6einbent	20	20	respiratory	respiratory	JJ
cord-352796-6einbent	20	21	infections	infection	NNS
cord-352796-6einbent	20	22	via	via	IN
cord-352796-6einbent	20	23	the	the	DT
cord-352796-6einbent	20	24	eye	eye	NN
cord-352796-6einbent	20	25	and	and	CC
cord-352796-6einbent	20	26	lacrimal	lacrimal	NN
cord-352796-6einbent	20	27	-	-	HYPH
cord-352796-6einbent	20	28	nasal	nasal	NN
cord-352796-6einbent	20	29	pathway	pathway	NN
cord-352796-6einbent	20	30	(	(	-LRB-
cord-352796-6einbent	20	31	5	5	CD
cord-352796-6einbent	20	32	)	)	-RRB-
cord-352796-6einbent	21	1	(	(	-LRB-
cord-352796-6einbent	21	2	Figure	figure	NN
cord-352796-6einbent	21	3	1	1	CD
cord-352796-6einbent	21	4	)	)	-RRB-
cord-352796-6einbent	21	5	.	.	.
cord-352796-6einbent	22	1	It	-PRON-	PRP
cord-352796-6einbent	22	2	was	be	VBD
cord-352796-6einbent	22	3	noted	note	VBN
cord-352796-6einbent	22	4	that	that	IN
cord-352796-6einbent	22	5	this	this	DT
cord-352796-6einbent	22	6	pathway	pathway	NN
cord-352796-6einbent	22	7	had	have	VBD
cord-352796-6einbent	22	8	been	be	VBN
cord-352796-6einbent	22	9	"	"	``
cord-352796-6einbent	22	10	disregarded	disregard	VBN
cord-352796-6einbent	22	11	in	in	IN
cord-352796-6einbent	22	12	planning	plan	VBG
cord-352796-6einbent	22	13	measures	measure	NNS
cord-352796-6einbent	22	14	for	for	IN
cord-352796-6einbent	22	15	the	the	DT
cord-352796-6einbent	22	16	prevention	prevention	NN
cord-352796-6einbent	22	17	of	of	IN
cord-352796-6einbent	22	18	the	the	DT
cord-352796-6einbent	22	19	spread	spread	NN
cord-352796-6einbent	22	20	of	of	IN
cord-352796-6einbent	22	21	contagious	contagious	JJ
cord-352796-6einbent	22	22	diseases	disease	NNS
cord-352796-6einbent	22	23	"	"	''
cord-352796-6einbent	22	24	and	and	CC
cord-352796-6einbent	22	25	it	-PRON-	PRP
cord-352796-6einbent	22	26	would	would	MD
cord-352796-6einbent	22	27	appear	appear	VB
cord-352796-6einbent	22	28	that	that	DT
cord-352796-6einbent	22	29	little	little	JJ
cord-352796-6einbent	22	30	has	have	VBZ
cord-352796-6einbent	22	31	changed	change	VBN
cord-352796-6einbent	22	32	.	.	.
cord-352796-6einbent	23	1	Figure	figure	NN
cord-352796-6einbent	23	2	1	1	CD
cord-352796-6einbent	23	3	.	.	.
cord-352796-6einbent	24	1	The	the	DT
cord-352796-6einbent	24	2	lacrimatory	lacrimatory	NN
cord-352796-6einbent	24	3	-	-	HYPH
cord-352796-6einbent	24	4	nasal	nasal	NN
cord-352796-6einbent	24	5	mechanism	mechanism	NN
cord-352796-6einbent	24	6	for	for	IN
cord-352796-6einbent	24	7	the	the	DT
cord-352796-6einbent	24	8	mechanical	mechanical	JJ
cord-352796-6einbent	24	9	disposition	disposition	NN
cord-352796-6einbent	24	10	of	of	IN
cord-352796-6einbent	24	11	organisms	organism	NNS
cord-352796-6einbent	24	12	entering	enter	VBG
cord-352796-6einbent	24	13	the	the	DT
cord-352796-6einbent	24	14	upper	upper	JJ
cord-352796-6einbent	24	15	respiratory	respiratory	JJ
cord-352796-6einbent	24	16	tract	tract	NN
cord-352796-6einbent	24	17	(	(	-LRB-
cord-352796-6einbent	24	18	5	5	CD
cord-352796-6einbent	24	19	)	)	-RRB-
cord-352796-6einbent	24	20	.	.	.
cord-352796-6einbent	25	1	A	a	DT
cord-352796-6einbent	25	2	third	third	JJ
cord-352796-6einbent	25	3	factor	factor	NN
cord-352796-6einbent	25	4	in	in	IN
cord-352796-6einbent	25	5	this	this	DT
cord-352796-6einbent	25	6	perfect	perfect	JJ
cord-352796-6einbent	25	7	storm	storm	NN
cord-352796-6einbent	25	8	is	be	VBZ
cord-352796-6einbent	25	9	the	the	DT
cord-352796-6einbent	25	10	well	well	RB
cord-352796-6einbent	25	11	-	-	HYPH
cord-352796-6einbent	25	12	established	establish	VBN
cord-352796-6einbent	25	13	but	but	CC
cord-352796-6einbent	25	14	not	not	RB
cord-352796-6einbent	25	15	well	well	RB
cord-352796-6einbent	25	16	recognized	recognize	VBN
cord-352796-6einbent	25	17	coronavirus	coronavirus	NN
cord-352796-6einbent	25	18	ocular	ocular	JJ
cord-352796-6einbent	25	19	tropism	tropism	NN
cord-352796-6einbent	25	20	(	(	-LRB-
cord-352796-6einbent	25	21	6	6	CD
cord-352796-6einbent	25	22	)	)	-RRB-
cord-352796-6einbent	25	23	.	.	.
cord-352796-6einbent	26	1	The	the	DT
cord-352796-6einbent	26	2	study	study	NN
cord-352796-6einbent	26	3	of	of	IN
cord-352796-6einbent	26	4	oculotropic	oculotropic	NNP
cord-352796-6einbent	26	5	influenza	influenza	NN
cord-352796-6einbent	26	6	and	and	CC
cord-352796-6einbent	26	7	adenoviruses	adenovirus	NNS
cord-352796-6einbent	26	8	(	(	-LRB-
cord-352796-6einbent	26	9	7	7	CD
cord-352796-6einbent	26	10	-	-	SYM
cord-352796-6einbent	26	11	9	9	CD
cord-352796-6einbent	26	12	)	)	-RRB-
cord-352796-6einbent	26	13	sets	set	VBZ
cord-352796-6einbent	26	14	precedents	precedent	NNS
cord-352796-6einbent	26	15	for	for	IN
cord-352796-6einbent	26	16	disease	disease	NN
cord-352796-6einbent	26	17	patterns	pattern	NNS
cord-352796-6einbent	26	18	,	,	,
cord-352796-6einbent	26	19	bought	buy	VBN
cord-352796-6einbent	26	20	into	into	IN
cord-352796-6einbent	26	21	focus	focus	NN
cord-352796-6einbent	26	22	by	by	IN
cord-352796-6einbent	26	23	coronaviruses	coronaviruse	NNS
cord-352796-6einbent	26	24	.	.	.
cord-352796-6einbent	27	1	Whereas	whereas	IN
cord-352796-6einbent	27	2	influenza	influenza	NN
cord-352796-6einbent	27	3	viruses	virus	NNS
cord-352796-6einbent	27	4	generally	generally	RB
cord-352796-6einbent	27	5	represent	represent	VBP
cord-352796-6einbent	27	6	a	a	DT
cord-352796-6einbent	27	7	respiratory	respiratory	JJ
cord-352796-6einbent	27	8	pathogen	pathogen	NN
cord-352796-6einbent	27	9	and	and	CC
cord-352796-6einbent	27	10	only	only	RB
cord-352796-6einbent	27	11	occasionally	occasionally	RB
cord-352796-6einbent	27	12	cause	cause	VBP
cord-352796-6einbent	27	13	ocular	ocular	JJ
cord-352796-6einbent	27	14	complications	complication	NNS
cord-352796-6einbent	27	15	,	,	,
cord-352796-6einbent	27	16	adenoviruses	adenovirus	NNS
cord-352796-6einbent	27	17	mirror	mirror	VBP
cord-352796-6einbent	27	18	image	image	NN
cord-352796-6einbent	27	19	this	this	DT
cord-352796-6einbent	27	20	disease	disease	NN
cord-352796-6einbent	27	21	pattern	pattern	NN
cord-352796-6einbent	27	22	,	,	,
cord-352796-6einbent	27	23	causing	cause	VBG
cord-352796-6einbent	27	24	severe	severe	JJ
cord-352796-6einbent	27	25	ocular	ocular	JJ
cord-352796-6einbent	27	26	surface	surface	NN
cord-352796-6einbent	27	27	disease	disease	NN
cord-352796-6einbent	27	28	,	,	,
cord-352796-6einbent	27	29	and	and	CC
cord-352796-6einbent	27	30	are	be	VBP
cord-352796-6einbent	27	31	often	often	RB
cord-352796-6einbent	27	32	highly	highly	RB
cord-352796-6einbent	27	33	contagious	contagious	JJ
cord-352796-6einbent	27	34	(	(	-LRB-
cord-352796-6einbent	27	35	known	know	VBN
cord-352796-6einbent	27	36	as	as	IN
cord-352796-6einbent	27	37	"	"	``
cord-352796-6einbent	27	38	eye	eye	NN
cord-352796-6einbent	27	39	hospital	hospital	NN
cord-352796-6einbent	27	40	eye"(10	eye"(10	NNP
cord-352796-6einbent	27	41	)	)	-RRB-
cord-352796-6einbent	27	42	)	)	-RRB-
cord-352796-6einbent	27	43	with	with	IN
cord-352796-6einbent	27	44	fewer	few	JJR
cord-352796-6einbent	27	45	,	,	,
cord-352796-6einbent	27	46	seldom	seldom	RB
cord-352796-6einbent	27	47	lethal	lethal	JJ
cord-352796-6einbent	27	48	,	,	,
cord-352796-6einbent	27	49	systemic	systemic	JJ
cord-352796-6einbent	27	50	manifestations	manifestation	NNS
cord-352796-6einbent	27	51	.	.	.
cord-352796-6einbent	28	1	Thus	thus	RB
cord-352796-6einbent	28	2	,	,	,
cord-352796-6einbent	28	3	all	all	DT
cord-352796-6einbent	28	4	three	three	CD
cord-352796-6einbent	28	5	virus	virus	NN
cord-352796-6einbent	28	6	types	type	NNS
cord-352796-6einbent	28	7	share	share	VBP
cord-352796-6einbent	28	8	a	a	DT
cord-352796-6einbent	28	9	common	common	JJ
cord-352796-6einbent	28	10	ocular	ocular	JJ
cord-352796-6einbent	28	11	entrée	entrée	NN
cord-352796-6einbent	28	12	but	but	CC
cord-352796-6einbent	28	13	vary	vary	VBP
cord-352796-6einbent	28	14	in	in	IN
cord-352796-6einbent	28	15	their	-PRON-	PRP$
cord-352796-6einbent	28	16	degree	degree	NN
cord-352796-6einbent	28	17	of	of	IN
cord-352796-6einbent	28	18	contagion	contagion	NN
cord-352796-6einbent	28	19	,	,	,
cord-352796-6einbent	28	20	ocular	ocular	JJ
cord-352796-6einbent	28	21	versus	versus	IN
cord-352796-6einbent	28	22	respiratory	respiratory	JJ
cord-352796-6einbent	28	23	/	/	SYM
cord-352796-6einbent	28	24	system	system	NN
cord-352796-6einbent	28	25	impact	impact	NN
cord-352796-6einbent	28	26	and	and	CC
cord-352796-6einbent	28	27	lethality	lethality	NN
cord-352796-6einbent	28	28	.	.	.
cord-352796-6einbent	29	1	Taken	take	VBN
cord-352796-6einbent	29	2	as	as	IN
cord-352796-6einbent	29	3	a	a	DT
cord-352796-6einbent	29	4	whole	whole	NN
cord-352796-6einbent	29	5	,	,	,
cord-352796-6einbent	29	6	these	these	DT
cord-352796-6einbent	29	7	disease	disease	NN
cord-352796-6einbent	29	8	patterns	pattern	NNS
cord-352796-6einbent	29	9	have	have	VBP
cord-352796-6einbent	29	10	implications	implication	NNS
cord-352796-6einbent	29	11	for	for	IN
cord-352796-6einbent	29	12	more	more	JJR
cord-352796-6einbent	29	13	effective	effective	JJ
cord-352796-6einbent	29	14	management	management	NN
cord-352796-6einbent	29	15	strategies	strategy	NNS
cord-352796-6einbent	29	16	.	.	.
cord-352796-6einbent	30	1	Dr	Dr	NNP
cord-352796-6einbent	30	2	Li	Li	NNP
cord-352796-6einbent	30	3	Wenliang	Wenliang	NNP
cord-352796-6einbent	30	4	's	's	POS
cord-352796-6einbent	30	5	death	death	NN
cord-352796-6einbent	30	6	and	and	CC
cord-352796-6einbent	30	7	the	the	DT
cord-352796-6einbent	30	8	apparent	apparent	JJ
cord-352796-6einbent	30	9	high	high	JJ
cord-352796-6einbent	30	10	infection	infection	NN
cord-352796-6einbent	30	11	rate	rate	NN
cord-352796-6einbent	30	12	in	in	IN
cord-352796-6einbent	30	13	ophthalmologists	ophthalmologist	NNS
cord-352796-6einbent	30	14	(	(	-LRB-
cord-352796-6einbent	30	15	and	and	CC
cord-352796-6einbent	30	16	ENT	ENT	NNP
cord-352796-6einbent	30	17	surgeons	surgeon	NNS
cord-352796-6einbent	30	18	)	)	-RRB-
cord-352796-6einbent	30	19	(	(	-LRB-
cord-352796-6einbent	30	20	11	11	CD
cord-352796-6einbent	30	21	)	)	-RRB-
cord-352796-6einbent	30	22	,	,	,
cord-352796-6einbent	30	23	attributed	attribute	VBN
cord-352796-6einbent	30	24	to	to	IN
cord-352796-6einbent	30	25	the	the	DT
cord-352796-6einbent	30	26	high	high	JJ
cord-352796-6einbent	30	27	viral	viral	JJ
cord-352796-6einbent	30	28	shedding	shed	VBG
cord-352796-6einbent	30	29	from	from	IN
cord-352796-6einbent	30	30	the	the	DT
cord-352796-6einbent	30	31	nasal	nasal	NN
cord-352796-6einbent	30	32	cavity	cavity	NN
cord-352796-6einbent	30	33	,	,	,
cord-352796-6einbent	30	34	should	should	MD
cord-352796-6einbent	30	35	not	not	RB
cord-352796-6einbent	30	36	be	be	VB
cord-352796-6einbent	30	37	unexpected	unexpected	JJ
cord-352796-6einbent	30	38	.	.	.
cord-352796-6einbent	31	1	A	a	DT
cord-352796-6einbent	31	2	high	high	JJ
cord-352796-6einbent	31	3	initial	initial	JJ
cord-352796-6einbent	31	4	viral	viral	JJ
cord-352796-6einbent	31	5	load	load	NN
cord-352796-6einbent	31	6	is	be	VBZ
cord-352796-6einbent	31	7	associated	associate	VBN
cord-352796-6einbent	31	8	with	with	IN
cord-352796-6einbent	31	9	poor	poor	JJ
cord-352796-6einbent	31	10	prognosis	prognosis	NN
cord-352796-6einbent	31	11	(	(	-LRB-
cord-352796-6einbent	31	12	12	12	CD
cord-352796-6einbent	31	13	)	)	-RRB-
cord-352796-6einbent	31	14	and	and	CC
cord-352796-6einbent	31	15	ophthalmologists	ophthalmologist	NNS
cord-352796-6einbent	31	16	are	be	VBP
cord-352796-6einbent	31	17	particularly	particularly	RB
cord-352796-6einbent	31	18	at	at	IN
cord-352796-6einbent	31	19	risk	risk	NN
cord-352796-6einbent	31	20	,	,	,
cord-352796-6einbent	31	21	since	since	IN
cord-352796-6einbent	31	22	ophthalmic	ophthalmic	JJ
cord-352796-6einbent	31	23	practice	practice	NN
cord-352796-6einbent	31	24	involves	involve	VBZ
cord-352796-6einbent	31	25	very	very	RB
cord-352796-6einbent	31	26	close	close	JJ
cord-352796-6einbent	31	27	ophthalmologist	ophthalmologist	NN
cord-352796-6einbent	31	28	-	-	HYPH
cord-352796-6einbent	31	29	patient	patient	NN
cord-352796-6einbent	31	30	physical	physical	JJ
cord-352796-6einbent	31	31	proximity	proximity	NN
cord-352796-6einbent	31	32	.	.	.
cord-352796-6einbent	32	1	This	this	DT
cord-352796-6einbent	32	2	is	be	VBZ
cord-352796-6einbent	32	3	necessitated	necessitate	VBN
cord-352796-6einbent	32	4	by	by	IN
cord-352796-6einbent	32	5	optical	optical	JJ
cord-352796-6einbent	32	6	imperatives	imperative	NNS
cord-352796-6einbent	32	7	to	to	TO
cord-352796-6einbent	32	8	optimise	optimise	VB
cord-352796-6einbent	32	9	image	image	NN
cord-352796-6einbent	32	10	quality	quality	NN
cord-352796-6einbent	32	11	by	by	IN
cord-352796-6einbent	32	12	close	close	JJ
cord-352796-6einbent	32	13	alignment	alignment	NN
cord-352796-6einbent	32	14	of	of	IN
cord-352796-6einbent	32	15	imaging	image	VBG
cord-352796-6einbent	32	16	devices	device	NNS
cord-352796-6einbent	32	17	to	to	IN
cord-352796-6einbent	32	18	the	the	DT
cord-352796-6einbent	32	19	eye	eye	NN
cord-352796-6einbent	32	20	.	.	.
cord-352796-6einbent	33	1	Slit	slit	JJ
cord-352796-6einbent	33	2	lamp	lamp	NN
cord-352796-6einbent	33	3	biomicroscopy	biomicroscopy	NN
cord-352796-6einbent	33	4	is	be	VBZ
cord-352796-6einbent	33	5	the	the	DT
cord-352796-6einbent	33	6	cornerstone	cornerstone	NN
cord-352796-6einbent	33	7	of	of	IN
cord-352796-6einbent	33	8	ophthalmic	ophthalmic	JJ
cord-352796-6einbent	33	9	practice	practice	NN
cord-352796-6einbent	33	10	and	and	CC
cord-352796-6einbent	33	11	the	the	DT
cord-352796-6einbent	33	12	slit	slit	JJ
cord-352796-6einbent	33	13	lamp	lamp	NN
cord-352796-6einbent	33	14	is	be	VBZ
cord-352796-6einbent	33	15	also	also	RB
cord-352796-6einbent	33	16	used	use	VBN
cord-352796-6einbent	33	17	to	to	TO
cord-352796-6einbent	33	18	carry	carry	VB
cord-352796-6einbent	33	19	out	out	RP
cord-352796-6einbent	33	20	surgical	surgical	JJ
cord-352796-6einbent	33	21	procedures	procedure	NNS
cord-352796-6einbent	33	22	.	.	.
cord-352796-6einbent	34	1	The	the	DT
cord-352796-6einbent	34	2	back	back	JJ
cord-352796-6einbent	34	3	focal	focal	JJ
cord-352796-6einbent	34	4	distance	distance	NN
cord-352796-6einbent	34	5	(	(	-LRB-
cord-352796-6einbent	34	6	the	the	DT
cord-352796-6einbent	34	7	distance	distance	NN
cord-352796-6einbent	34	8	of	of	IN
cord-352796-6einbent	34	9	the	the	DT
cord-352796-6einbent	34	10	subject	subject	NN
cord-352796-6einbent	34	11	from	from	IN
cord-352796-6einbent	34	12	the	the	DT
cord-352796-6einbent	34	13	front	front	JJ
cord-352796-6einbent	34	14	lens	lens	NN
cord-352796-6einbent	34	15	surface	surface	NN
cord-352796-6einbent	34	16	of	of	IN
cord-352796-6einbent	34	17	the	the	DT
cord-352796-6einbent	34	18	microscope	microscope	NN
cord-352796-6einbent	34	19	)	)	-RRB-
cord-352796-6einbent	34	20	,	,	,
cord-352796-6einbent	34	21	is	be	VBZ
cord-352796-6einbent	34	22	set	set	VBN
cord-352796-6einbent	34	23	to	to	TO
cord-352796-6einbent	34	24	give	give	VB
cord-352796-6einbent	34	25	the	the	DT
cord-352796-6einbent	34	26	surgeon	surgeon	NN
cord-352796-6einbent	34	27	sufficient	sufficient	JJ
cord-352796-6einbent	34	28	space	space	NN
cord-352796-6einbent	34	29	for	for	IN
cord-352796-6einbent	34	30	manipulation	manipulation	NN
cord-352796-6einbent	34	31	~	~	NFP
cord-352796-6einbent	34	32	11	11	CD
cord-352796-6einbent	34	33	cm	cm	NNS
cord-352796-6einbent	34	34	(	(	-LRB-
cord-352796-6einbent	34	35	Figure	figure	NN
cord-352796-6einbent	34	36	2A	2a	CD
cord-352796-6einbent	34	37	)	)	-RRB-
cord-352796-6einbent	34	38	.	.	.
cord-352796-6einbent	35	1	With	with	IN
cord-352796-6einbent	35	2	the	the	DT
cord-352796-6einbent	35	3	instrument	instrument	NN
cord-352796-6einbent	35	4	body	body	NN
cord-352796-6einbent	35	5	length	length	NN
cord-352796-6einbent	35	6	added	add	VBN
cord-352796-6einbent	35	7	,	,	,
cord-352796-6einbent	35	8	the	the	DT
cord-352796-6einbent	35	9	distance	distance	NN
cord-352796-6einbent	35	10	from	from	IN
cord-352796-6einbent	35	11	patient	patient	NN
cord-352796-6einbent	35	12	to	to	IN
cord-352796-6einbent	35	13	the	the	DT
cord-352796-6einbent	35	14	surgeon	surgeon	NN
cord-352796-6einbent	35	15	's	's	POS
cord-352796-6einbent	35	16	eye	eye	NN
cord-352796-6einbent	35	17	is	be	VBZ
cord-352796-6einbent	35	18	at	at	IN
cord-352796-6einbent	35	19	a	a	DT
cord-352796-6einbent	35	20	convenient	convenient	JJ
cord-352796-6einbent	35	21	working	working	NN
cord-352796-6einbent	35	22	distance	distance	NN
cord-352796-6einbent	35	23	of	of	IN
cord-352796-6einbent	35	24	~	~	CD
cord-352796-6einbent	35	25	28	28	CD
cord-352796-6einbent	35	26	-	-	SYM
cord-352796-6einbent	35	27	30	30	CD
cord-352796-6einbent	35	28	cm	cm	NN
cord-352796-6einbent	35	29	.	.	.
cord-352796-6einbent	36	1	This	this	DT
cord-352796-6einbent	36	2	proximity	proximity	NN
cord-352796-6einbent	36	3	and	and	CC
cord-352796-6einbent	36	4	the	the	DT
cord-352796-6einbent	36	5	possibility	possibility	NN
cord-352796-6einbent	36	6	of	of	IN
cord-352796-6einbent	36	7	cross	cross	NN
cord-352796-6einbent	36	8	infection	infection	NN
cord-352796-6einbent	36	9	between	between	IN
cord-352796-6einbent	36	10	examiner	examiner	NN
cord-352796-6einbent	36	11	and	and	CC
cord-352796-6einbent	36	12	examinee	examinee	NN
cord-352796-6einbent	36	13	has	have	VBZ
cord-352796-6einbent	36	14	long	long	RB
cord-352796-6einbent	36	15	been	be	VBN
cord-352796-6einbent	36	16	recognized	recognize	VBN
cord-352796-6einbent	36	17	and	and	CC
cord-352796-6einbent	36	18	a	a	DT
cord-352796-6einbent	36	19	protective	protective	JJ
cord-352796-6einbent	36	20	,	,	,
cord-352796-6einbent	36	21	transparent	transparent	JJ
cord-352796-6einbent	36	22	,	,	,
cord-352796-6einbent	36	23	typically	typically	RB
cord-352796-6einbent	36	24	Perspex	Perspex	NNP
cord-352796-6einbent	36	25	®	®	.
cord-352796-6einbent	36	26	"	"	``
cord-352796-6einbent	36	27	breath	breath	NN
cord-352796-6einbent	36	28	shield	shield	NN
cord-352796-6einbent	36	29	"	"	''
cord-352796-6einbent	36	30	was	be	VBD
cord-352796-6einbent	36	31	added	add	VBN
cord-352796-6einbent	36	32	to	to	IN
cord-352796-6einbent	36	33	slit	slit	NN
cord-352796-6einbent	36	34	lamps	lamp	NNS
cord-352796-6einbent	36	35	.	.	.
cord-352796-6einbent	37	1	It	-PRON-	PRP
cord-352796-6einbent	37	2	is	be	VBZ
cord-352796-6einbent	37	3	evident	evident	JJ
cord-352796-6einbent	37	4	in	in	IN
cord-352796-6einbent	37	5	slit	slit	JJ
cord-352796-6einbent	37	6	lamps	lamp	NNS
cord-352796-6einbent	37	7	from	from	IN
cord-352796-6einbent	37	8	as	as	RB
cord-352796-6einbent	37	9	early	early	RB
cord-352796-6einbent	37	10	as	as	IN
cord-352796-6einbent	37	11	1919	1919	CD
cord-352796-6einbent	37	12	(	(	-LRB-
cord-352796-6einbent	37	13	13	13	CD
cord-352796-6einbent	37	14	)	)	-RRB-
cord-352796-6einbent	37	15	and	and	CC
cord-352796-6einbent	37	16	may	may	MD
cord-352796-6einbent	37	17	well	well	RB
cord-352796-6einbent	37	18	have	have	VB
cord-352796-6einbent	37	19	gained	gain	VBN
cord-352796-6einbent	37	20	popularity	popularity	NN
cord-352796-6einbent	37	21	during	during	IN
cord-352796-6einbent	37	22	the	the	DT
cord-352796-6einbent	37	23	era	era	NN
cord-352796-6einbent	37	24	of	of	IN
cord-352796-6einbent	37	25	the	the	DT
cord-352796-6einbent	37	26	1918	1918	CD
cord-352796-6einbent	37	27	influenza	influenza	NN
cord-352796-6einbent	37	28	pandemic	pandemic	NN
cord-352796-6einbent	37	29	.	.	.
cord-352796-6einbent	38	1	The	the	DT
cord-352796-6einbent	38	2	necessity	necessity	NN
cord-352796-6einbent	38	3	for	for	IN
cord-352796-6einbent	38	4	such	such	JJ
cord-352796-6einbent	38	5	shields	shield	NNS
cord-352796-6einbent	38	6	is	be	VBZ
cord-352796-6einbent	38	7	readily	readily	RB
cord-352796-6einbent	38	8	apparent	apparent	JJ
cord-352796-6einbent	38	9	from	from	IN
cord-352796-6einbent	38	10	studies	study	NNS
cord-352796-6einbent	38	11	in	in	IN
cord-352796-6einbent	38	12	which	which	WDT
cord-352796-6einbent	38	13	exposure	exposure	NN
cord-352796-6einbent	38	14	between	between	IN
cord-352796-6einbent	38	15	two	two	CD
cord-352796-6einbent	38	16	face	face	NN
cord-352796-6einbent	38	17	-	-	HYPH
cord-352796-6einbent	38	18	to	to	IN
cord-352796-6einbent	38	19	-	-	HYPH
cord-352796-6einbent	38	20	face	face	NN
cord-352796-6einbent	38	21	breathing	breathing	NN
cord-352796-6einbent	38	22	manikins	manikin	NNS
cord-352796-6einbent	38	23	is	be	VBZ
cord-352796-6einbent	38	24	measured	measure	VBN
cord-352796-6einbent	38	25	This	this	DT
cord-352796-6einbent	38	26	study	study	NN
cord-352796-6einbent	38	27	concluded	conclude	VBD
cord-352796-6einbent	38	28	that	that	IN
cord-352796-6einbent	38	29	air	air	NN
cord-352796-6einbent	38	30	exhaled	exhale	VBD
cord-352796-6einbent	38	31	from	from	IN
cord-352796-6einbent	38	32	human	human	JJ
cord-352796-6einbent	38	33	respiration	respiration	NN
cord-352796-6einbent	38	34	contains	contain	VBZ
cord-352796-6einbent	38	35	contaminants	contaminant	NNS
cord-352796-6einbent	38	36	and	and	CC
cord-352796-6einbent	38	37	is	be	VBZ
cord-352796-6einbent	38	38	able	able	JJ
cord-352796-6einbent	38	39	to	to	TO
cord-352796-6einbent	38	40	penetrate	penetrate	VB
cord-352796-6einbent	38	41	the	the	DT
cord-352796-6einbent	38	42	breathing	breathing	NN
cord-352796-6einbent	38	43	zone	zone	NN
cord-352796-6einbent	38	44	of	of	IN
cord-352796-6einbent	38	45	other	other	JJ
cord-352796-6einbent	38	46	nearby	nearby	JJ
cord-352796-6einbent	38	47	persons	person	NNS
cord-352796-6einbent	38	48	.	.	.
cord-352796-6einbent	39	1	Of	of	IN
cord-352796-6einbent	39	2	interest	interest	NN
cord-352796-6einbent	39	3	is	be	VBZ
cord-352796-6einbent	39	4	that	that	DT
cord-352796-6einbent	39	5	exhalation	exhalation	NN
cord-352796-6einbent	39	6	flow	flow	NN
cord-352796-6einbent	39	7	may	may	MD
cord-352796-6einbent	39	8	stratify	stratify	VB
cord-352796-6einbent	39	9	in	in	IN
cord-352796-6einbent	39	10	a	a	DT
cord-352796-6einbent	39	11	horizontal	horizontal	JJ
cord-352796-6einbent	39	12	layer	layer	NN
cord-352796-6einbent	39	13	at	at	IN
cord-352796-6einbent	39	14	breathing	breathing	NN
cord-352796-6einbent	39	15	zone	zone	NN
cord-352796-6einbent	39	16	height	height	NN
cord-352796-6einbent	39	17	under	under	IN
cord-352796-6einbent	39	18	certain	certain	JJ
cord-352796-6einbent	39	19	conditions	condition	NNS
cord-352796-6einbent	39	20	.	.	.
cord-352796-6einbent	40	1	Thus	thus	RB
cord-352796-6einbent	40	2	,	,	,
cord-352796-6einbent	40	3	with	with	IN
cord-352796-6einbent	40	4	slit	slit	JJ
cord-352796-6einbent	40	5	lamp	lamp	NN
cord-352796-6einbent	40	6	examination	examination	NN
cord-352796-6einbent	40	7	,	,	,
cord-352796-6einbent	40	8	the	the	DT
cord-352796-6einbent	40	9	layer	layer	NN
cord-352796-6einbent	40	10	of	of	IN
cord-352796-6einbent	40	11	air	air	NN
cord-352796-6einbent	40	12	between	between	IN
cord-352796-6einbent	40	13	patient	patient	NN
cord-352796-6einbent	40	14	and	and	CC
cord-352796-6einbent	40	15	ophthalmologist	ophthalmologist	NN
cord-352796-6einbent	40	16	may	may	MD
cord-352796-6einbent	40	17	remain	remain	VB
cord-352796-6einbent	40	18	stable	stable	JJ
cord-352796-6einbent	40	19	,	,	,
cord-352796-6einbent	40	20	exposing	expose	VBG
cord-352796-6einbent	40	21	both	both	DT
cord-352796-6einbent	40	22	individuals	individual	NNS
cord-352796-6einbent	40	23	for	for	IN
cord-352796-6einbent	40	24	the	the	DT
cord-352796-6einbent	40	25	entire	entire	JJ
cord-352796-6einbent	40	26	time	time	NN
cord-352796-6einbent	40	27	of	of	IN
cord-352796-6einbent	40	28	the	the	DT
cord-352796-6einbent	40	29	examination	examination	NN
cord-352796-6einbent	40	30	.	.	.
cord-352796-6einbent	41	1	Breath	Breath	NNP
cord-352796-6einbent	41	2	shields	shield	NNS
cord-352796-6einbent	41	3	6	6	CD
cord-352796-6einbent	41	4	are	be	VBP
cord-352796-6einbent	41	5	often	often	RB
cord-352796-6einbent	41	6	missing	miss	VBG
cord-352796-6einbent	41	7	from	from	IN
cord-352796-6einbent	41	8	slit	slit	NN
cord-352796-6einbent	41	9	lamps	lamp	NNS
cord-352796-6einbent	41	10	either	either	RB
cord-352796-6einbent	41	11	because	because	IN
cord-352796-6einbent	41	12	they	-PRON-	PRP
cord-352796-6einbent	41	13	are	be	VBP
cord-352796-6einbent	41	14	not	not	RB
cord-352796-6einbent	41	15	fitted	fit	VBN
cord-352796-6einbent	41	16	or	or	CC
cord-352796-6einbent	41	17	because	because	IN
cord-352796-6einbent	41	18	,	,	,
cord-352796-6einbent	41	19	as	as	IN
cord-352796-6einbent	41	20	they	-PRON-	PRP
cord-352796-6einbent	41	21	get	get	VBP
cord-352796-6einbent	41	22	in	in	IN
cord-352796-6einbent	41	23	the	the	DT
cord-352796-6einbent	41	24	way	way	NN
cord-352796-6einbent	41	25	,	,	,
cord-352796-6einbent	41	26	are	be	VBP
cord-352796-6einbent	41	27	removed	remove	VBN
cord-352796-6einbent	41	28	.	.	.
cord-352796-6einbent	42	1	nares	nares	NNP
cord-352796-6einbent	42	2	:	:	:
cord-352796-6einbent	42	3	(	(	-LRB-
cord-352796-6einbent	42	4	a	a	LS
cord-352796-6einbent	42	5	)	)	-RRB-
cord-352796-6einbent	42	6	,	,	,
cord-352796-6einbent	42	7	average	average	JJ
cord-352796-6einbent	42	8	total	total	JJ
cord-352796-6einbent	42	9	eye	eye	NN
cord-352796-6einbent	42	10	surface	surface	NN
cord-352796-6einbent	42	11	exposed	expose	VBN
cord-352796-6einbent	43	1	;	;	:
cord-352796-6einbent	43	2	shaded	shaded	JJ
cord-352796-6einbent	43	3	area	area	NN
cord-352796-6einbent	43	4	represents	represent	VBZ
cord-352796-6einbent	43	5	proportion	proportion	NN
cord-352796-6einbent	43	6	of	of	IN
cord-352796-6einbent	43	7	time	time	NN
cord-352796-6einbent	43	8	not	not	RB
cord-352796-6einbent	43	9	exposed	expose	VBN
cord-352796-6einbent	43	10	,	,	,
cord-352796-6einbent	43	11	due	due	IN
cord-352796-6einbent	43	12	to	to	IN
cord-352796-6einbent	43	13	winking	winking	NN
cord-352796-6einbent	43	14	;	;	:
cord-352796-6einbent	43	15	(	(	-LRB-
cord-352796-6einbent	43	16	b	b	NN
cord-352796-6einbent	43	17	)	)	-RRB-
cord-352796-6einbent	43	18	,	,	,
cord-352796-6einbent	43	19	average	average	JJ
cord-352796-6einbent	43	20	total	total	JJ
cord-352796-6einbent	43	21	mouth	mouth	NN
cord-352796-6einbent	43	22	area	area	NN
cord-352796-6einbent	43	23	exposed	expose	VBN
cord-352796-6einbent	43	24	in	in	IN
cord-352796-6einbent	43	25	talking	talk	VBG
cord-352796-6einbent	43	26	;	;	:
cord-352796-6einbent	43	27	shaded	shaded	JJ
cord-352796-6einbent	43	28	area	area	NN
cord-352796-6einbent	43	29	represents	represent	VBZ
cord-352796-6einbent	43	30	proportion	proportion	NN
cord-352796-6einbent	43	31	of	of	IN
cord-352796-6einbent	43	32	time	time	NN
cord-352796-6einbent	43	33	not	not	RB
cord-352796-6einbent	43	34	exposed	expose	VBN
cord-352796-6einbent	43	35	,	,	,
cord-352796-6einbent	43	36	due	due	IN
cord-352796-6einbent	43	37	to	to	IN
cord-352796-6einbent	43	38	closure	closure	NN
cord-352796-6einbent	43	39	;	;	:
cord-352796-6einbent	43	40	(	(	-LRB-
cord-352796-6einbent	43	41	c	c	NN
cord-352796-6einbent	43	42	)	)	-RRB-
cord-352796-6einbent	43	43	,	,	,
cord-352796-6einbent	43	44	average	average	JJ
cord-352796-6einbent	43	45	total	total	JJ
cord-352796-6einbent	43	46	area	area	NN
cord-352796-6einbent	43	47	of	of	IN
cord-352796-6einbent	43	48	crosssection	crosssection	NN
cord-352796-6einbent	43	49	of	of	IN
cord-352796-6einbent	43	50	nares	nares	NNP
cord-352796-6einbent	43	51	exposed	expose	VBN
cord-352796-6einbent	43	52	;	;	:
cord-352796-6einbent	43	53	shaded	shaded	JJ
cord-352796-6einbent	43	54	area	area	NN
cord-352796-6einbent	43	55	represents	represent	VBZ
cord-352796-6einbent	43	56	proportion	proportion	NN
cord-352796-6einbent	43	57	of	of	IN
cord-352796-6einbent	43	58	time	time	NN
cord-352796-6einbent	43	59	not	not	RB
cord-352796-6einbent	43	60	exposed	expose	VBN
cord-352796-6einbent	43	61	,	,	,
cord-352796-6einbent	43	62	owing	owe	VBG
cord-352796-6einbent	43	63	to	to	IN
cord-352796-6einbent	43	64	protected	protect	VBN
cord-352796-6einbent	43	65	position	position	NN
cord-352796-6einbent	43	66	and	and	CC
cord-352796-6einbent	43	67	expiration	expiration	NN
cord-352796-6einbent	43	68	(	(	-LRB-
cord-352796-6einbent	43	69	5	5	CD
cord-352796-6einbent	43	70	)	)	-RRB-
cord-352796-6einbent	43	71	.	.	.
cord-352796-6einbent	44	1	That	that	DT
cord-352796-6einbent	44	2	slit	slit	NN
cord-352796-6einbent	44	3	lamps	lamp	NNS
cord-352796-6einbent	44	4	and	and	CC
cord-352796-6einbent	44	5	their	-PRON-	PRP$
cord-352796-6einbent	44	6	accessory	accessory	NN
cord-352796-6einbent	44	7	lenses	lense	NNS
cord-352796-6einbent	44	8	are	be	VBP
cord-352796-6einbent	44	9	a	a	DT
cord-352796-6einbent	44	10	source	source	NN
cord-352796-6einbent	44	11	of	of	IN
cord-352796-6einbent	44	12	infection	infection	NN
cord-352796-6einbent	44	13	transmission	transmission	NN
cord-352796-6einbent	44	14	has	have	VBZ
cord-352796-6einbent	44	15	long	long	RB
cord-352796-6einbent	44	16	been	be	VBN
cord-352796-6einbent	44	17	known	know	VBN
cord-352796-6einbent	44	18	(	(	-LRB-
cord-352796-6einbent	44	19	15	15	CD
cord-352796-6einbent	44	20	)	)	-RRB-
cord-352796-6einbent	44	21	.	.	.
cord-352796-6einbent	45	1	In	in	IN
cord-352796-6einbent	45	2	epidemic	epidemic	JJ
cord-352796-6einbent	45	3	adenoviral	adenoviral	NNP
cord-352796-6einbent	45	4	keratoconjunctivitis	keratoconjunctivitis	NNP
cord-352796-6einbent	45	5	(	(	-LRB-
cord-352796-6einbent	45	6	(	(	-LRB-
cord-352796-6einbent	45	7	AKC	AKC	NNP
cord-352796-6einbent	45	8	)	)	-RRB-
cord-352796-6einbent	45	9	,	,	,
cord-352796-6einbent	45	10	shipyard	shipyard	NN
cord-352796-6einbent	45	11	/	/	SYM
cord-352796-6einbent	45	12	eye	eye	NN
cord-352796-6einbent	45	13	hospital	hospital	NN
cord-352796-6einbent	45	14	eye	eye	NN
cord-352796-6einbent	45	15	)	)	-RRB-
cord-352796-6einbent	45	16	(	(	-LRB-
cord-352796-6einbent	45	17	10	10	CD
cord-352796-6einbent	45	18	,	,	,
cord-352796-6einbent	45	19	16	16	CD
cord-352796-6einbent	45	20	)	)	-RRB-
cord-352796-6einbent	45	21	,	,	,
cord-352796-6einbent	45	22	ophthalmologists	ophthalmologist	NNS
cord-352796-6einbent	45	23	are	be	VBP
cord-352796-6einbent	45	24	not	not	RB
cord-352796-6einbent	45	25	infrequently	infrequently	RB
cord-352796-6einbent	45	26	infected	infect	VBN
cord-352796-6einbent	45	27	although	although	IN
cord-352796-6einbent	45	28	this	this	DT
cord-352796-6einbent	45	29	is	be	VBZ
cord-352796-6einbent	45	30	not	not	RB
cord-352796-6einbent	45	31	well	well	RB
cord-352796-6einbent	45	32	documented	document	VBN
cord-352796-6einbent	45	33	(	(	-LRB-
cord-352796-6einbent	45	34	17	17	CD
cord-352796-6einbent	45	35	,	,	,
cord-352796-6einbent	45	36	18	18	CD
cord-352796-6einbent	45	37	)	)	-RRB-
cord-352796-6einbent	45	38	.	.	.
cord-352796-6einbent	46	1	While	while	IN
cord-352796-6einbent	46	2	AKC	AKC	NNP
cord-352796-6einbent	46	3	can	can	MD
cord-352796-6einbent	46	4	cause	cause	VB
cord-352796-6einbent	46	5	considerable	considerable	JJ
cord-352796-6einbent	46	6	incapacity	incapacity	NN
cord-352796-6einbent	46	7	and	and	CC
cord-352796-6einbent	46	8	has	have	VBZ
cord-352796-6einbent	46	9	resulted	result	VBN
cord-352796-6einbent	46	10	in	in	IN
cord-352796-6einbent	46	11	some	some	DT
cord-352796-6einbent	46	12	riskminimization	riskminimization	NN
cord-352796-6einbent	46	13	measures	measure	NNS
cord-352796-6einbent	46	14	,	,	,
cord-352796-6einbent	46	15	unlike	unlike	IN
cord-352796-6einbent	46	16	coronavirus	coronavirus	NN
cord-352796-6einbent	46	17	it	-PRON-	PRP
cord-352796-6einbent	46	18	does	do	VBZ
cord-352796-6einbent	46	19	not	not	RB
cord-352796-6einbent	46	20	usually	usually	RB
cord-352796-6einbent	46	21	result	result	VB
cord-352796-6einbent	46	22	in	in	IN
cord-352796-6einbent	46	23	death	death	NN
cord-352796-6einbent	46	24	.	.	.
cord-352796-6einbent	47	1	The	the	DT
cord-352796-6einbent	47	2	earlier	early	RBR
cord-352796-6einbent	47	3	severe	severe	JJ
cord-352796-6einbent	47	4	acute	acute	JJ
cord-352796-6einbent	47	5	respiratory	respiratory	JJ
cord-352796-6einbent	47	6	syndrome	syndrome	NN
cord-352796-6einbent	47	7	(	(	-LRB-
cord-352796-6einbent	47	8	SARS	SARS	NNP
cord-352796-6einbent	47	9	)	)	-RRB-
cord-352796-6einbent	47	10	epidemic	epidemic	NN
cord-352796-6einbent	47	11	resulted	result	VBD
cord-352796-6einbent	47	12	in	in	IN
cord-352796-6einbent	47	13	recommendations	recommendation	NNS
cord-352796-6einbent	47	14	for	for	IN
cord-352796-6einbent	47	15	how	how	WRB
cord-352796-6einbent	47	16	to	to	TO
cord-352796-6einbent	47	17	manage	manage	VB
cord-352796-6einbent	47	18	eye	eye	NN
cord-352796-6einbent	47	19	facilities	facility	NNS
cord-352796-6einbent	47	20	and	and	CC
cord-352796-6einbent	47	21	include	include	VBP
cord-352796-6einbent	47	22	advice	advice	NN
cord-352796-6einbent	47	23	in	in	IN
cord-352796-6einbent	47	24	relation	relation	NN
cord-352796-6einbent	47	25	to	to	IN
cord-352796-6einbent	47	26	slit	slit	JJ
cord-352796-6einbent	47	27	lamp	lamp	NN
cord-352796-6einbent	47	28	cleaning	cleaning	NN
cord-352796-6einbent	47	29	and	and	CC
cord-352796-6einbent	47	30	eye	eye	NN
cord-352796-6einbent	47	31	protection	protection	NN
cord-352796-6einbent	47	32	for	for	IN
cord-352796-6einbent	47	33	staff	staff	NN
cord-352796-6einbent	47	34	(	(	-LRB-
cord-352796-6einbent	47	35	19	19	CD
cord-352796-6einbent	47	36	,	,	,
cord-352796-6einbent	47	37	20	20	CD
cord-352796-6einbent	47	38	)	)	-RRB-
cord-352796-6einbent	47	39	.	.	.
cord-352796-6einbent	48	1	Slit	slit	JJ
cord-352796-6einbent	48	2	lamp	lamp	NN
cord-352796-6einbent	48	3	biomicroscopy	biomicroscopy	NN
cord-352796-6einbent	48	4	is	be	VBZ
cord-352796-6einbent	48	5	an	an	DT
cord-352796-6einbent	48	6	almost	almost	RB
cord-352796-6einbent	48	7	optimal	optimal	JJ
cord-352796-6einbent	48	8	method	method	NN
cord-352796-6einbent	48	9	of	of	IN
cord-352796-6einbent	48	10	transferring	transfer	VBG
cord-352796-6einbent	48	11	material	material	NN
cord-352796-6einbent	48	12	in	in	IN
cord-352796-6einbent	48	13	breaths	breath	NNS
cord-352796-6einbent	48	14	between	between	IN
cord-352796-6einbent	48	15	two	two	CD
cord-352796-6einbent	48	16	individuals	individual	NNS
cord-352796-6einbent	48	17	,	,	,
cord-352796-6einbent	48	18	short	short	JJ
cord-352796-6einbent	48	19	of	of	IN
cord-352796-6einbent	48	20	actual	actual	JJ
cord-352796-6einbent	48	21	facial	facial	JJ
cord-352796-6einbent	48	22	contact	contact	NN
cord-352796-6einbent	48	23	.	.	.
cord-352796-6einbent	49	1	A	a	DT
cord-352796-6einbent	49	2	very	very	RB
cord-352796-6einbent	49	3	recent	recent	JJ
cord-352796-6einbent	49	4	study	study	NN
cord-352796-6einbent	49	5	provides	provide	VBZ
cord-352796-6einbent	49	6	evidence	evidence	NN
cord-352796-6einbent	49	7	for	for	IN
cord-352796-6einbent	49	8	human	human	NN
cord-352796-6einbent	49	9	-	-	HYPH
cord-352796-6einbent	49	10	to	to	IN
cord-352796-6einbent	49	11	-	-	HYPH
cord-352796-6einbent	49	12	human	human	JJ
cord-352796-6einbent	49	13	transmission	transmission	NN
cord-352796-6einbent	49	14	(	(	-LRB-
cord-352796-6einbent	49	15	21	21	CD
cord-352796-6einbent	49	16	)	)	-RRB-
cord-352796-6einbent	49	17	.	.	.
cord-352796-6einbent	50	1	Pathways	pathway	NNS
cord-352796-6einbent	50	2	include	include	VBP
cord-352796-6einbent	50	3	direct	direct	JJ
cord-352796-6einbent	50	4	transmission	transmission	NN
cord-352796-6einbent	50	5	,	,	,
cord-352796-6einbent	50	6	such	such	JJ
cord-352796-6einbent	50	7	as	as	IN
cord-352796-6einbent	50	8	cough	cough	NN
cord-352796-6einbent	50	9	,	,	,
cord-352796-6einbent	50	10	sneeze	sneeze	VB
cord-352796-6einbent	50	11	,	,	,
cord-352796-6einbent	50	12	droplet	droplet	NN
cord-352796-6einbent	50	13	inhalation	inhalation	NN
cord-352796-6einbent	50	14	transmission	transmission	NN
cord-352796-6einbent	50	15	as	as	RB
cord-352796-6einbent	50	16	well	well	RB
cord-352796-6einbent	50	17	as	as	IN
cord-352796-6einbent	50	18	contact	contact	NN
cord-352796-6einbent	50	19	transmission	transmission	NN
cord-352796-6einbent	50	20	including	include	VBG
cord-352796-6einbent	50	21	contact	contact	NN
cord-352796-6einbent	50	22	with	with	IN
cord-352796-6einbent	50	23	oral	oral	JJ
cord-352796-6einbent	50	24	,	,	,
cord-352796-6einbent	50	25	nasal	nasal	NN
cord-352796-6einbent	50	26	,	,	,
cord-352796-6einbent	50	27	and	and	CC
cord-352796-6einbent	50	28	eye	eye	NN
cord-352796-6einbent	50	29	mucous	mucous	JJ
cord-352796-6einbent	50	30	membranes	membrane	NNS
cord-352796-6einbent	50	31	(	(	-LRB-
cord-352796-6einbent	50	32	22	22	CD
cord-352796-6einbent	50	33	)	)	-RRB-
cord-352796-6einbent	50	34	.	.	.
cord-352796-6einbent	51	1	SARS	SARS	NNP
cord-352796-6einbent	51	2	-	-	HYPH
cord-352796-6einbent	51	3	CoV-2	CoV-2	NNP
cord-352796-6einbent	51	4	aerosol	aerosol	NN
cord-352796-6einbent	51	5	and	and	CC
cord-352796-6einbent	51	6	fomite	fomite	NN
cord-352796-6einbent	51	7	transmission	transmission	NN
cord-352796-6einbent	51	8	is	be	VBZ
cord-352796-6einbent	51	9	highly	highly	RB
cord-352796-6einbent	51	10	likely	likely	JJ
cord-352796-6einbent	51	11	,	,	,
cord-352796-6einbent	51	12	since	since	IN
cord-352796-6einbent	51	13	the	the	DT
cord-352796-6einbent	51	14	virus	virus	NN
cord-352796-6einbent	51	15	can	can	MD
cord-352796-6einbent	51	16	remain	remain	VB
cord-352796-6einbent	51	17	viable	viable	JJ
cord-352796-6einbent	51	18	and	and	CC
cord-352796-6einbent	51	19	infectious	infectious	JJ
cord-352796-6einbent	51	20	in	in	IN
cord-352796-6einbent	51	21	aerosols	aerosol	NNS
cord-352796-6einbent	51	22	for	for	IN
cord-352796-6einbent	51	23	hours	hour	NNS
cord-352796-6einbent	51	24	and	and	CC
cord-352796-6einbent	51	25	on	on	IN
cord-352796-6einbent	51	26	different	different	JJ
cord-352796-6einbent	51	27	surfaces	surface	NNS
cord-352796-6einbent	51	28	up	up	RP
cord-352796-6einbent	51	29	to	to	IN
cord-352796-6einbent	51	30	days	day	NNS
cord-352796-6einbent	51	31	(	(	-LRB-
cord-352796-6einbent	51	32	23	23	CD
cord-352796-6einbent	51	33	)	)	-RRB-
cord-352796-6einbent	51	34	.	.	.
cord-352796-6einbent	52	1	While	while	IN
cord-352796-6einbent	52	2	transmission	transmission	NN
cord-352796-6einbent	52	3	of	of	IN
cord-352796-6einbent	52	4	coronaviruses	coronaviruse	NNS
cord-352796-6einbent	52	5	occurs	occur	VBZ
cord-352796-6einbent	52	6	via	via	IN
cord-352796-6einbent	52	7	an	an	DT
cord-352796-6einbent	52	8	airborne	airborne	JJ
cord-352796-6einbent	52	9	route	route	NN
cord-352796-6einbent	52	10	(	(	-LRB-
cord-352796-6einbent	52	11	24	24	CD
cord-352796-6einbent	52	12	)	)	-RRB-
cord-352796-6einbent	52	13	,	,	,
cord-352796-6einbent	52	14	because	because	IN
cord-352796-6einbent	52	15	infected	infected	JJ
cord-352796-6einbent	52	16	,	,	,
cord-352796-6einbent	52	17	symptomatic	symptomatic	JJ
cord-352796-6einbent	52	18	patients	patient	NNS
cord-352796-6einbent	52	19	tend	tend	VBP
cord-352796-6einbent	52	20	to	to	TO
cord-352796-6einbent	52	21	develop	develop	VB
cord-352796-6einbent	52	22	severe	severe	JJ
cord-352796-6einbent	52	23	lower	low	JJR
cord-352796-6einbent	52	24	,	,	,
cord-352796-6einbent	52	25	as	as	IN
cord-352796-6einbent	52	26	opposed	oppose	VBN
cord-352796-6einbent	52	27	to	to	IN
cord-352796-6einbent	52	28	upper	upper	JJ
cord-352796-6einbent	52	29	respiratory	respiratory	JJ
cord-352796-6einbent	52	30	tract	tract	NN
cord-352796-6einbent	52	31	infections	infection	NNS
cord-352796-6einbent	52	32	,	,	,
cord-352796-6einbent	52	33	it	-PRON-	PRP
cord-352796-6einbent	52	34	has	have	VBZ
cord-352796-6einbent	52	35	been	be	VBN
cord-352796-6einbent	52	36	supposed	suppose	VBN
cord-352796-6einbent	52	37	that	that	IN
cord-352796-6einbent	52	38	airborne	airborne	JJ
cord-352796-6einbent	52	39	agent	agent	NN
cord-352796-6einbent	52	40	virus	virus	NN
cord-352796-6einbent	52	41	has	have	VBZ
cord-352796-6einbent	52	42	to	to	TO
cord-352796-6einbent	52	43	be	be	VB
cord-352796-6einbent	52	44	small	small	JJ
cord-352796-6einbent	52	45	enough	enough	RB
cord-352796-6einbent	52	46	to	to	TO
cord-352796-6einbent	52	47	penetrate	penetrate	VB
cord-352796-6einbent	52	48	directly	directly	RB
cord-352796-6einbent	52	49	into	into	IN
cord-352796-6einbent	52	50	the	the	DT
cord-352796-6einbent	52	51	lower	low	JJR
cord-352796-6einbent	52	52	respiratory	respiratory	JJ
cord-352796-6einbent	52	53	tract	tract	NN
cord-352796-6einbent	52	54	to	to	TO
cord-352796-6einbent	52	55	preferentially	preferentially	RB
cord-352796-6einbent	52	56	replicate	replicate	VB
cord-352796-6einbent	52	57	there	there	RB
cord-352796-6einbent	52	58	before	before	IN
cord-352796-6einbent	52	59	causing	cause	VBG
cord-352796-6einbent	52	60	disease	disease	NN
cord-352796-6einbent	52	61	.	.	.
cord-352796-6einbent	53	1	That	that	DT
cord-352796-6einbent	53	2	transmission	transmission	NN
cord-352796-6einbent	53	3	could	could	MD
cord-352796-6einbent	53	4	occur	occur	VB
cord-352796-6einbent	53	5	via	via	IN
cord-352796-6einbent	53	6	the	the	DT
cord-352796-6einbent	53	7	ocular	ocular	JJ
cord-352796-6einbent	53	8	-	-	HYPH
cord-352796-6einbent	53	9	nasolacrimal	nasolacrimal	JJ
cord-352796-6einbent	53	10	pathway	pathway	NN
cord-352796-6einbent	53	11	was	be	VBD
cord-352796-6einbent	53	12	not	not	RB
cord-352796-6einbent	53	13	considered	consider	VBN
cord-352796-6einbent	53	14	.	.	.
cord-352796-6einbent	54	1	Human	human	JJ
cord-352796-6einbent	54	2	eyes	eye	NNS
cord-352796-6einbent	54	3	are	be	VBP
cord-352796-6einbent	54	4	located	locate	VBN
cord-352796-6einbent	54	5	at	at	IN
cord-352796-6einbent	54	6	a	a	DT
cord-352796-6einbent	54	7	coign	coign	NN
cord-352796-6einbent	54	8	of	of	IN
cord-352796-6einbent	54	9	vantage	vantage	NN
cord-352796-6einbent	54	10	in	in	IN
cord-352796-6einbent	54	11	the	the	DT
cord-352796-6einbent	54	12	body	body	NN
cord-352796-6einbent	54	13	,	,	,
cord-352796-6einbent	54	14	simultaneously	simultaneously	RB
cord-352796-6einbent	54	15	providing	provide	VBG
cord-352796-6einbent	54	16	information	information	NN
cord-352796-6einbent	54	17	from	from	IN
cord-352796-6einbent	54	18	our	-PRON-	PRP$
cord-352796-6einbent	54	19	highest	high	JJS
cord-352796-6einbent	54	20	band	band	NN
cord-352796-6einbent	54	21	width	width	NN
cord-352796-6einbent	54	22	sense	sense	NN
cord-352796-6einbent	54	23	but	but	CC
cord-352796-6einbent	54	24	also	also	RB
cord-352796-6einbent	54	25	being	be	VBG
cord-352796-6einbent	54	26	exposed	expose	VBN
cord-352796-6einbent	54	27	to	to	IN
cord-352796-6einbent	54	28	risk	risk	NN
cord-352796-6einbent	54	29	of	of	IN
cord-352796-6einbent	54	30	exposure	exposure	NN
cord-352796-6einbent	54	31	including	include	VBG
cord-352796-6einbent	54	32	to	to	IN
cord-352796-6einbent	54	33	airborne	airborne	JJ
cord-352796-6einbent	54	34	virus	virus	NN
cord-352796-6einbent	54	35	.	.	.
cord-352796-6einbent	55	1	The	the	DT
cord-352796-6einbent	55	2	surface	surface	NN
cord-352796-6einbent	55	3	area	area	NN
cord-352796-6einbent	55	4	of	of	IN
cord-352796-6einbent	55	5	the	the	DT
cord-352796-6einbent	55	6	eye(s	eye(s	NN
cord-352796-6einbent	55	7	)	)	-RRB-
cord-352796-6einbent	55	8	is	be	VBZ
cord-352796-6einbent	55	9	large	large	JJ
cord-352796-6einbent	55	10	compared	compare	VBN
cord-352796-6einbent	55	11	to	to	IN
cord-352796-6einbent	55	12	that	that	DT
cord-352796-6einbent	55	13	of	of	IN
cord-352796-6einbent	55	14	the	the	DT
cord-352796-6einbent	55	15	mouth	mouth	NN
cord-352796-6einbent	55	16	and	and	CC
cord-352796-6einbent	55	17	nares	naris	NNS
cord-352796-6einbent	55	18	-	-	,
cord-352796-6einbent	55	19	(	(	-LRB-
cord-352796-6einbent	55	20	Figure	Figure	NNP
cord-352796-6einbent	55	21	2D	2d	NN
cord-352796-6einbent	55	22	)	)	-RRB-
cord-352796-6einbent	55	23	and	and	CC
cord-352796-6einbent	55	24	was	be	VBD
cord-352796-6einbent	55	25	recognized	recognize	VBN
cord-352796-6einbent	55	26	early	early	RB
cord-352796-6einbent	55	27	as	as	IN
cord-352796-6einbent	55	28	a	a	DT
cord-352796-6einbent	55	29	target	target	NN
cord-352796-6einbent	55	30	for	for	IN
cord-352796-6einbent	55	31	"	"	``
cord-352796-6einbent	55	32	promiscuous	promiscuous	JJ
cord-352796-6einbent	55	33	spraying	spraying	NN
cord-352796-6einbent	55	34	"	"	''
cord-352796-6einbent	56	1	whereby	whereby	WRB
cord-352796-6einbent	56	2	coughing	cough	VBG
cord-352796-6einbent	56	3	could	could	MD
cord-352796-6einbent	56	4	project	project	VB
cord-352796-6einbent	56	5	material	material	NN
cord-352796-6einbent	56	6	at	at	IN
cord-352796-6einbent	56	7	least	least	JJS
cord-352796-6einbent	56	8	10	10	CD
cord-352796-6einbent	56	9	feet	foot	NNS
cord-352796-6einbent	56	10	away	away	RB
cord-352796-6einbent	56	11	(	(	-LRB-
cord-352796-6einbent	56	12	5	5	CD
cord-352796-6einbent	56	13	)	)	-RRB-
cord-352796-6einbent	56	14	.	.	.
cord-352796-6einbent	57	1	Since	since	IN
cord-352796-6einbent	57	2	this	this	DT
cord-352796-6einbent	57	3	1919	1919	CD
cord-352796-6einbent	57	4	study	study	NN
cord-352796-6einbent	57	5	(	(	-LRB-
cord-352796-6einbent	57	6	5	5	CD
cord-352796-6einbent	57	7	)	)	-RRB-
cord-352796-6einbent	57	8	,	,	,
cord-352796-6einbent	57	9	a	a	DT
cord-352796-6einbent	57	10	number	number	NN
cord-352796-6einbent	57	11	of	of	IN
cord-352796-6einbent	57	12	other	other	JJ
cord-352796-6einbent	57	13	studies	study	NNS
cord-352796-6einbent	57	14	have	have	VBP
cord-352796-6einbent	57	15	investigated	investigate	VBN
cord-352796-6einbent	57	16	ocular	ocular	JJ
cord-352796-6einbent	57	17	surface	surface	NN
cord-352796-6einbent	57	18	area	area	NN
cord-352796-6einbent	57	19	and	and	CC
cord-352796-6einbent	57	20	reported	report	VBD
cord-352796-6einbent	57	21	as	as	IN
cord-352796-6einbent	57	22	a	a	DT
cord-352796-6einbent	57	23	total	total	NN
cord-352796-6einbent	57	24	(	(	-LRB-
cord-352796-6einbent	57	25	for	for	IN
cord-352796-6einbent	57	26	two	two	CD
cord-352796-6einbent	57	27	eyes	eye	NNS
cord-352796-6einbent	57	28	)	)	-RRB-
cord-352796-6einbent	57	29	as	as	IN
cord-352796-6einbent	57	30	226	226	CD
cord-352796-6einbent	57	31	-	-	SYM
cord-352796-6einbent	57	32	426	426	CD
cord-352796-6einbent	57	33	(	(	-LRB-
cord-352796-6einbent	57	34	25	25	CD
cord-352796-6einbent	57	35	)	)	-RRB-
cord-352796-6einbent	57	36	and	and	CC
cord-352796-6einbent	57	37	300	300	CD
cord-352796-6einbent	57	38	-	-	SYM
cord-352796-6einbent	57	39	640	640	CD
cord-352796-6einbent	57	40	mm	mm	CD
cord-352796-6einbent	57	41	2	2	CD
cord-352796-6einbent	57	42	(	(	-LRB-
cord-352796-6einbent	57	43	26	26	CD
cord-352796-6einbent	57	44	)	)	-RRB-
cord-352796-6einbent	57	45	,	,	,
cord-352796-6einbent	57	46	indicating	indicate	VBG
cord-352796-6einbent	57	47	that	that	IN
cord-352796-6einbent	57	48	the	the	DT
cord-352796-6einbent	57	49	figure	figure	NN
cord-352796-6einbent	57	50	from	from	IN
cord-352796-6einbent	57	51	Maxcy	Maxcy	NNP
cord-352796-6einbent	57	52	's	's	POS
cord-352796-6einbent	57	53	early	early	JJ
cord-352796-6einbent	57	54	study	study	NN
cord-352796-6einbent	57	55	(	(	-LRB-
cord-352796-6einbent	57	56	5	5	LS
cord-352796-6einbent	57	57	)	)	-RRB-
cord-352796-6einbent	57	58	was	be	VBD
cord-352796-6einbent	57	59	a	a	DT
cord-352796-6einbent	57	60	good	good	JJ
cord-352796-6einbent	57	61	estimate	estimate	NN
cord-352796-6einbent	57	62	(	(	-LRB-
cord-352796-6einbent	57	63	Table	table	NN
cord-352796-6einbent	57	64	1	1	CD
cord-352796-6einbent	57	65	)	)	-RRB-
cord-352796-6einbent	57	66	of	of	IN
cord-352796-6einbent	57	67	the	the	DT
cord-352796-6einbent	57	68	"	"	``
cord-352796-6einbent	57	69	visible	visible	JJ
cord-352796-6einbent	57	70	"	"	''
cord-352796-6einbent	57	71	ocular	ocular	JJ
cord-352796-6einbent	57	72	surface	surface	NN
cord-352796-6einbent	57	73	.	.	.
cord-352796-6einbent	58	1	The	the	DT
cord-352796-6einbent	58	2	later	later	JJ
cord-352796-6einbent	58	3	study	study	NN
cord-352796-6einbent	58	4	(	(	-LRB-
cord-352796-6einbent	58	5	26	26	CD
cord-352796-6einbent	58	6	)	)	-RRB-
cord-352796-6einbent	58	7	also	also	RB
cord-352796-6einbent	58	8	explains	explain	VBZ
cord-352796-6einbent	58	9	variability	variability	NN
cord-352796-6einbent	58	10	in	in	IN
cord-352796-6einbent	58	11	measurements	measurement	NNS
cord-352796-6einbent	58	12	,	,	,
cord-352796-6einbent	58	13	since	since	IN
cord-352796-6einbent	58	14	palpebral	palpebral	JJ
cord-352796-6einbent	58	15	aperture	aperture	NN
cord-352796-6einbent	58	16	is	be	VBZ
cord-352796-6einbent	58	17	dependent	dependent	JJ
cord-352796-6einbent	58	18	on	on	IN
cord-352796-6einbent	58	19	eye	eye	NN
cord-352796-6einbent	58	20	gaze	gaze	NN
cord-352796-6einbent	58	21	direction	direction	NN
cord-352796-6einbent	58	22	.	.	.
cord-352796-6einbent	59	1	However	however	RB
cord-352796-6einbent	59	2	,	,	,
cord-352796-6einbent	59	3	the	the	DT
cord-352796-6einbent	59	4	total	total	JJ
cord-352796-6einbent	59	5	ocular	ocular	JJ
cord-352796-6einbent	59	6	surface	surface	NN
cord-352796-6einbent	59	7	area	area	NN
cord-352796-6einbent	59	8	has	have	VBZ
cord-352796-6einbent	59	9	been	be	VBN
cord-352796-6einbent	59	10	estimated	estimate	VBN
cord-352796-6einbent	59	11	at	at	IN
cord-352796-6einbent	59	12	~	~	CD
cord-352796-6einbent	59	13	1600	1600	CD
cord-352796-6einbent	60	1	-1869	-1869	NNP
cord-352796-6einbent	60	2	sq	sq	NNP
cord-352796-6einbent	60	3	.	.	.
cord-352796-6einbent	61	1	mm	mm	NNP
cord-352796-6einbent	61	2	/	/	SYM
cord-352796-6einbent	61	3	eye	eye	NN
cord-352796-6einbent	61	4	(	(	-LRB-
cord-352796-6einbent	61	5	27	27	CD
cord-352796-6einbent	61	6	,	,	,
cord-352796-6einbent	61	7	28	28	CD
cord-352796-6einbent	61	8	)	)	-RRB-
cord-352796-6einbent	61	9	,	,	,
cord-352796-6einbent	61	10	including	include	VBG
cord-352796-6einbent	61	11	the	the	DT
cord-352796-6einbent	61	12	cornea	cornea	NN
cord-352796-6einbent	61	13	,	,	,
cord-352796-6einbent	61	14	this	this	DT
cord-352796-6einbent	61	15	representing	represent	VBG
cord-352796-6einbent	61	16	a	a	DT
cord-352796-6einbent	61	17	maximal	maximal	JJ
cord-352796-6einbent	61	18	absorptive	absorptive	JJ
cord-352796-6einbent	61	19	area	area	NN
cord-352796-6einbent	61	20	of	of	IN
cord-352796-6einbent	61	21	~	~	CD
cord-352796-6einbent	61	22	3738	3738	CD
cord-352796-6einbent	61	23	sq.mm	sq.mm	CD
cord-352796-6einbent	61	24	,	,	,
cord-352796-6einbent	61	25	accounting	account	VBG
cord-352796-6einbent	61	26	for	for	IN
cord-352796-6einbent	61	27	the	the	DT
cord-352796-6einbent	61	28	tarsal	tarsal	NN
cord-352796-6einbent	61	29	conjunctiva	conjunctiva	NN
cord-352796-6einbent	61	30	and	and	CC
cord-352796-6einbent	61	31	including	include	VBG
cord-352796-6einbent	61	32	the	the	DT
cord-352796-6einbent	61	33	palpebral	palpebral	JJ
cord-352796-6einbent	61	34	fornices	fornix	NNS
cord-352796-6einbent	61	35	.	.	.
cord-352796-6einbent	62	1	Even	even	RB
cord-352796-6einbent	62	2	this	this	DT
cord-352796-6einbent	62	3	consideration	consideration	NN
cord-352796-6einbent	62	4	underestimates	underestimate	VBZ
cord-352796-6einbent	62	5	the	the	DT
cord-352796-6einbent	62	6	potential	potential	JJ
cord-352796-6einbent	62	7	ocular	ocular	JJ
cord-352796-6einbent	62	8	/	/	SYM
cord-352796-6einbent	62	9	periocular	periocular	NN
cord-352796-6einbent	62	10	landing	landing	NN
cord-352796-6einbent	62	11	zone	zone	NN
cord-352796-6einbent	62	12	for	for	IN
cord-352796-6einbent	62	13	a	a	DT
cord-352796-6einbent	62	14	viral	viral	JJ
cord-352796-6einbent	62	15	particle	particle	NN
cord-352796-6einbent	62	16	.	.	.
cord-352796-6einbent	63	1	It	-PRON-	PRP
cord-352796-6einbent	63	2	is	be	VBZ
cord-352796-6einbent	63	3	not	not	RB
cord-352796-6einbent	63	4	an	an	DT
cord-352796-6einbent	63	5	uncommon	uncommon	JJ
cord-352796-6einbent	63	6	observation	observation	NN
cord-352796-6einbent	63	7	that	that	IN
cord-352796-6einbent	63	8	makeup	makeup	NN
cord-352796-6einbent	63	9	,	,	,
cord-352796-6einbent	63	10	applied	apply	VBD
cord-352796-6einbent	63	11	around	around	IN
cord-352796-6einbent	63	12	the	the	DT
cord-352796-6einbent	63	13	eye	eye	NN
cord-352796-6einbent	63	14	,	,	,
cord-352796-6einbent	63	15	can	can	MD
cord-352796-6einbent	63	16	"	"	``
cord-352796-6einbent	63	17	migrate	migrate	VB
cord-352796-6einbent	63	18	"	"	''
cord-352796-6einbent	63	19	onto	onto	IN
cord-352796-6einbent	63	20	the	the	DT
cord-352796-6einbent	63	21	ocular	ocular	JJ
cord-352796-6einbent	63	22	surface	surface	NN
cord-352796-6einbent	63	23	(	(	-LRB-
cord-352796-6einbent	63	24	29	29	CD
cord-352796-6einbent	63	25	)	)	-RRB-
cord-352796-6einbent	63	26	,	,	,
cord-352796-6einbent	63	27	similar	similar	JJ
cord-352796-6einbent	63	28	to	to	IN
cord-352796-6einbent	63	29	the	the	DT
cord-352796-6einbent	63	30	phenomenon	phenomenon	NN
cord-352796-6einbent	63	31	by	by	IN
cord-352796-6einbent	63	32	which	which	WDT
cord-352796-6einbent	63	33	noxious	noxious	JJ
cord-352796-6einbent	63	34	agents	agent	NNS
cord-352796-6einbent	63	35	in	in	IN
cord-352796-6einbent	63	36	minute	minute	NN
cord-352796-6einbent	63	37	quantities	quantity	NNS
cord-352796-6einbent	63	38	are	be	VBP
cord-352796-6einbent	63	39	easily	easily	RB
cord-352796-6einbent	63	40	transferred	transfer	VBN
cord-352796-6einbent	63	41	from	from	IN
cord-352796-6einbent	63	42	fingertip	fingertip	NN
cord-352796-6einbent	63	43	to	to	IN
cord-352796-6einbent	63	44	periocular	periocular	NN
cord-352796-6einbent	63	45	skin	skin	NN
cord-352796-6einbent	63	46	and	and	CC
cord-352796-6einbent	63	47	then	then	RB
cord-352796-6einbent	63	48	the	the	DT
cord-352796-6einbent	63	49	eye	eye	NN
cord-352796-6einbent	63	50	.	.	.
cord-352796-6einbent	64	1	This	this	DT
cord-352796-6einbent	64	2	may	may	MD
cord-352796-6einbent	64	3	be	be	VB
cord-352796-6einbent	64	4	due	due	JJ
cord-352796-6einbent	64	5	to	to	IN
cord-352796-6einbent	64	6	subtle	subtle	JJ
cord-352796-6einbent	64	7	actions	action	NNS
cord-352796-6einbent	64	8	of	of	IN
cord-352796-6einbent	64	9	Riolan	Riolan	NNP
cord-352796-6einbent	64	10	's	's	POS
cord-352796-6einbent	64	11	muscle	muscle	NN
cord-352796-6einbent	64	12	(	(	-LRB-
cord-352796-6einbent	64	13	30	30	CD
cord-352796-6einbent	64	14	)	)	-RRB-
cord-352796-6einbent	64	15	.	.	.
cord-352796-6einbent	65	1	In	in	IN
cord-352796-6einbent	65	2	fact	fact	NN
cord-352796-6einbent	65	3	,	,	,
cord-352796-6einbent	65	4	this	this	DT
cord-352796-6einbent	65	5	mechanism	mechanism	NN
cord-352796-6einbent	65	6	of	of	IN
cord-352796-6einbent	65	7	transport	transport	NN
cord-352796-6einbent	65	8	of	of	IN
cord-352796-6einbent	65	9	agents	agent	NNS
cord-352796-6einbent	65	10	from	from	IN
cord-352796-6einbent	65	11	the	the	DT
cord-352796-6einbent	65	12	periocular	periocular	NNP
cord-352796-6einbent	65	13	eye	eye	NN
cord-352796-6einbent	65	14	lid	lid	NN
cord-352796-6einbent	65	15	skin	skin	NN
cord-352796-6einbent	65	16	to	to	IN
cord-352796-6einbent	65	17	the	the	DT
cord-352796-6einbent	65	18	eye	eye	NN
cord-352796-6einbent	65	19	(	(	-LRB-
cord-352796-6einbent	65	20	obviating	obviate	VBG
cord-352796-6einbent	65	21	the	the	DT
cord-352796-6einbent	65	22	need	need	NN
cord-352796-6einbent	65	23	for	for	IN
cord-352796-6einbent	65	24	eyedrops	eyedrop	NNS
cord-352796-6einbent	65	25	)	)	-RRB-
cord-352796-6einbent	65	26	has	have	VBZ
cord-352796-6einbent	65	27	been	be	VBN
cord-352796-6einbent	65	28	termed	term	VBN
cord-352796-6einbent	65	29	supracutaneous	supracutaneous	JJ
cord-352796-6einbent	65	30	and	and	CC
cord-352796-6einbent	65	31	has	have	VBZ
cord-352796-6einbent	65	32	been	be	VBN
cord-352796-6einbent	65	33	developed	develop	VBN
cord-352796-6einbent	65	34	as	as	IN
cord-352796-6einbent	65	35	an	an	DT
cord-352796-6einbent	65	36	efficient	efficient	JJ
cord-352796-6einbent	65	37	delivery	delivery	NN
cord-352796-6einbent	65	38	system	system	NN
cord-352796-6einbent	65	39	for	for	IN
cord-352796-6einbent	65	40	management	management	NN
cord-352796-6einbent	65	41	of	of	IN
cord-352796-6einbent	65	42	dry	dry	JJ
cord-352796-6einbent	65	43	eye	eye	NN
cord-352796-6einbent	65	44	syndrome	syndrome	NN
cord-352796-6einbent	65	45	(	(	-LRB-
cord-352796-6einbent	65	46	31	31	CD
cord-352796-6einbent	65	47	)	)	-RRB-
cord-352796-6einbent	65	48	.	.	.
cord-352796-6einbent	66	1	This	this	DT
cord-352796-6einbent	66	2	supracutaneous	supracutaneous	JJ
cord-352796-6einbent	66	3	mechanism	mechanism	NN
cord-352796-6einbent	66	4	,	,	,
cord-352796-6einbent	66	5	might	may	MD
cord-352796-6einbent	66	6	provide	provide	VB
cord-352796-6einbent	66	7	a	a	DT
cord-352796-6einbent	66	8	substantial	substantial	JJ
cord-352796-6einbent	66	9	periocular	periocular	NN
cord-352796-6einbent	66	10	area	area	NN
cord-352796-6einbent	66	11	in	in	IN
cord-352796-6einbent	66	12	which	which	WDT
cord-352796-6einbent	66	13	viral	viral	JJ
cord-352796-6einbent	66	14	particles	particle	NNS
cord-352796-6einbent	66	15	could	could	MD
cord-352796-6einbent	66	16	land	land	VB
cord-352796-6einbent	66	17	and	and	CC
cord-352796-6einbent	66	18	be	be	VB
cord-352796-6einbent	66	19	"	"	``
cord-352796-6einbent	66	20	funnelled	funnel	VBN
cord-352796-6einbent	66	21	"	"	''
cord-352796-6einbent	66	22	onto	onto	IN
cord-352796-6einbent	66	23	the	the	DT
cord-352796-6einbent	66	24	ocular	ocular	JJ
cord-352796-6einbent	66	25	surface	surface	NN
cord-352796-6einbent	66	26	and	and	CC
cord-352796-6einbent	66	27	beyond	beyond	IN
cord-352796-6einbent	66	28	.	.	.
cord-352796-6einbent	67	1	Table	table	NN
cord-352796-6einbent	67	2	1	1	CD
cord-352796-6einbent	67	3	provides	provide	VBZ
cord-352796-6einbent	67	4	available	available	JJ
cord-352796-6einbent	67	5	information	information	NN
cord-352796-6einbent	67	6	on	on	IN
cord-352796-6einbent	67	7	the	the	DT
cord-352796-6einbent	67	8	size	size	NN
cord-352796-6einbent	67	9	of	of	IN
cord-352796-6einbent	67	10	the	the	DT
cord-352796-6einbent	67	11	orbital	orbital	JJ
cord-352796-6einbent	67	12	opening	opening	NN
cord-352796-6einbent	67	13	(	(	-LRB-
cord-352796-6einbent	67	14	32	32	CD
cord-352796-6einbent	67	15	and	and	CC
cord-352796-6einbent	67	16	reviewed	review	VBN
cord-352796-6einbent	67	17	in	in	IN
cord-352796-6einbent	67	18	33	33	CD
cord-352796-6einbent	67	19	)	)	-RRB-
cord-352796-6einbent	67	20	,	,	,
cord-352796-6einbent	67	21	which	which	WDT
cord-352796-6einbent	67	22	likely	likely	RB
cord-352796-6einbent	67	23	underestimates	underestimate	VBZ
cord-352796-6einbent	67	24	the	the	DT
cord-352796-6einbent	67	25	area	area	NN
cord-352796-6einbent	67	26	of	of	IN
cord-352796-6einbent	67	27	eyelid	eyelid	NN
cord-352796-6einbent	67	28	skin	skin	NN
cord-352796-6einbent	67	29	.	.	.
cord-352796-6einbent	68	1	We	-PRON-	PRP
cord-352796-6einbent	68	2	have	have	VBP
cord-352796-6einbent	68	3	estimated	estimate	VBN
cord-352796-6einbent	68	4	eyelid	eyelid	NN
cord-352796-6einbent	68	5	skin	skin	NN
cord-352796-6einbent	68	6	to	to	TO
cord-352796-6einbent	68	7	be	be	VB
cord-352796-6einbent	68	8	~	~	NFP
cord-352796-6einbent	68	9	4000	4000	CD
cord-352796-6einbent	68	10	mm	mm	CD
cord-352796-6einbent	68	11	2	2	CD
cord-352796-6einbent	68	12	and	and	CC
cord-352796-6einbent	68	13	that	that	DT
cord-352796-6einbent	68	14	of	of	IN
cord-352796-6einbent	68	15	the	the	DT
cord-352796-6einbent	68	16	brow	brow	NN
cord-352796-6einbent	68	17	to	to	TO
cord-352796-6einbent	68	18	be	be	VB
cord-352796-6einbent	68	19	~	~	NFP
cord-352796-6einbent	68	20	3000	3000	CD
cord-352796-6einbent	68	21	mm	mm	NN
cord-352796-6einbent	68	22	2	2	CD
cord-352796-6einbent	68	23	,	,	,
cord-352796-6einbent	68	24	so	so	IN
cord-352796-6einbent	68	25	that	that	IN
cord-352796-6einbent	68	26	in	in	IN
cord-352796-6einbent	68	27	total	total	NN
cord-352796-6einbent	68	28	with	with	IN
cord-352796-6einbent	68	29	the	the	DT
cord-352796-6einbent	68	30	ocular	ocular	JJ
cord-352796-6einbent	68	31	surface	surface	NN
cord-352796-6einbent	68	32	area	area	NN
cord-352796-6einbent	68	33	,	,	,
cord-352796-6einbent	68	34	a	a	DT
cord-352796-6einbent	68	35	landing	landing	NN
cord-352796-6einbent	68	36	site	site	NN
cord-352796-6einbent	68	37	of	of	IN
cord-352796-6einbent	68	38	~	~	CD
cord-352796-6einbent	68	39	10,000	10,000	CD
cord-352796-6einbent	68	40	mm	mm	CD
cord-352796-6einbent	68	41	2	2	CD
cord-352796-6einbent	68	42	would	would	MD
cord-352796-6einbent	68	43	be	be	VB
cord-352796-6einbent	68	44	available	available	JJ
cord-352796-6einbent	68	45	,	,	,
cord-352796-6einbent	68	46	-2	-2	NN
cord-352796-6einbent	68	47	orders	order	NNS
cord-352796-6einbent	68	48	of	of	IN
cord-352796-6einbent	68	49	magnitude	magnitude	NN
cord-352796-6einbent	68	50	greater	great	JJR
cord-352796-6einbent	68	51	than	than	IN
cord-352796-6einbent	68	52	for	for	IN
cord-352796-6einbent	68	53	the	the	DT
cord-352796-6einbent	68	54	nares	naris	NNS
cord-352796-6einbent	68	55	and	and	CC
cord-352796-6einbent	68	56	mouth	mouth	NN
cord-352796-6einbent	68	57	.	.	.
cord-352796-6einbent	69	1	This	this	DT
cord-352796-6einbent	69	2	does	do	VBZ
cord-352796-6einbent	69	3	not	not	RB
cord-352796-6einbent	69	4	take	take	VB
cord-352796-6einbent	69	5	into	into	IN
cord-352796-6einbent	69	6	account	account	NN
cord-352796-6einbent	69	7	the	the	DT
cord-352796-6einbent	69	8	surface	surface	NN
cord-352796-6einbent	69	9	area	area	NN
cord-352796-6einbent	69	10	that	that	WDT
cord-352796-6einbent	69	11	could	could	MD
cord-352796-6einbent	69	12	be	be	VB
cord-352796-6einbent	69	13	attributed	attribute	VBN
cord-352796-6einbent	69	14	to	to	IN
cord-352796-6einbent	69	15	the	the	DT
cord-352796-6einbent	69	16	hair	hair	NN
cord-352796-6einbent	69	17	of	of	IN
cord-352796-6einbent	69	18	the	the	DT
cord-352796-6einbent	69	19	eyebrows	eyebrow	NNS
cord-352796-6einbent	69	20	or	or	CC
cord-352796-6einbent	69	21	the	the	DT
cord-352796-6einbent	69	22	eyelashes	eyelash	NNS
cord-352796-6einbent	69	23	,	,	,
cord-352796-6einbent	69	24	for	for	IN
cord-352796-6einbent	69	25	which	which	WDT
cord-352796-6einbent	69	26	estimates	estimate	NNS
cord-352796-6einbent	69	27	have	have	VBP
cord-352796-6einbent	69	28	not	not	RB
cord-352796-6einbent	69	29	been	be	VBN
cord-352796-6einbent	69	30	made	make	VBN
cord-352796-6einbent	69	31	.	.	.
cord-352796-6einbent	70	1	Eyelash	eyelash	NN
cord-352796-6einbent	70	2	aerodynamics	aerodynamic	NNS
cord-352796-6einbent	70	3	may	may	MD
cord-352796-6einbent	70	4	also	also	RB
cord-352796-6einbent	70	5	play	play	VB
cord-352796-6einbent	70	6	a	a	DT
cord-352796-6einbent	70	7	role	role	NN
cord-352796-6einbent	70	8	(	(	-LRB-
cord-352796-6einbent	70	9	34	34	CD
cord-352796-6einbent	70	10	)	)	-RRB-
cord-352796-6einbent	70	11	.	.	.
cord-352796-6einbent	71	1	Eyelashes	eyelash	NNS
cord-352796-6einbent	71	2	have	have	VBP
cord-352796-6einbent	71	3	been	be	VBN
cord-352796-6einbent	71	4	shown	show	VBN
cord-352796-6einbent	71	5	to	to	TO
cord-352796-6einbent	71	6	divert	divert	VB
cord-352796-6einbent	71	7	airflows	airflow	NNS
cord-352796-6einbent	71	8	,	,	,
cord-352796-6einbent	71	9	acting	act	VBG
cord-352796-6einbent	71	10	as	as	IN
cord-352796-6einbent	71	11	a	a	DT
cord-352796-6einbent	71	12	passive	passive	JJ
cord-352796-6einbent	71	13	ocular	ocular	JJ
cord-352796-6einbent	71	14	dust	dust	NN
cord-352796-6einbent	71	15	controlling	control	VBG
cord-352796-6einbent	71	16	system	system	NN
cord-352796-6einbent	71	17	.	.	.
cord-352796-6einbent	72	1	They	-PRON-	PRP
cord-352796-6einbent	72	2	reduce	reduce	VBP
cord-352796-6einbent	72	3	evaporation	evaporation	NN
cord-352796-6einbent	72	4	and	and	CC
cord-352796-6einbent	72	5	particle	particle	NN
cord-352796-6einbent	72	6	deposition	deposition	NN
cord-352796-6einbent	72	7	up	up	IN
cord-352796-6einbent	72	8	to	to	TO
cord-352796-6einbent	72	9	50	50	CD
cord-352796-6einbent	72	10	%	%	NN
cord-352796-6einbent	72	11	.	.	.
cord-352796-6einbent	73	1	In	in	IN
cord-352796-6einbent	73	2	a	a	DT
cord-352796-6einbent	73	3	comparative	comparative	JJ
cord-352796-6einbent	73	4	study	study	NN
cord-352796-6einbent	73	5	(	(	-LRB-
cord-352796-6einbent	73	6	35	35	CD
cord-352796-6einbent	73	7	)	)	-RRB-
cord-352796-6einbent	73	8	,	,	,
cord-352796-6einbent	73	9	Asian	asian	JJ
cord-352796-6einbent	73	10	eyelashes	eyelash	NNS
cord-352796-6einbent	73	11	had	have	VBD
cord-352796-6einbent	73	12	lower	low	JJR
cord-352796-6einbent	73	13	lift	lift	NN
cord-352796-6einbent	73	14	-	-	HYPH
cord-352796-6einbent	73	15	up	up	NN
cord-352796-6einbent	73	16	and	and	CC
cord-352796-6einbent	73	17	curl	curl	VB
cord-352796-6einbent	73	18	-	-	HYPH
cord-352796-6einbent	73	19	up	up	RP
cord-352796-6einbent	73	20	angles	angle	NNS
cord-352796-6einbent	73	21	,	,	,
cord-352796-6einbent	73	22	fewer	few	JJR
cord-352796-6einbent	73	23	numbers	number	NNS
cord-352796-6einbent	73	24	and	and	CC
cord-352796-6einbent	73	25	a	a	DT
cord-352796-6einbent	73	26	thicker	thick	JJR
cord-352796-6einbent	73	27	transverse	transverse	JJ
cord-352796-6einbent	73	28	diameter	diameter	NN
cord-352796-6einbent	73	29	as	as	IN
cord-352796-6einbent	73	30	compared	compare	VBN
cord-352796-6einbent	73	31	to	to	IN
cord-352796-6einbent	73	32	Caucasian	caucasian	JJ
cord-352796-6einbent	73	33	eyelashes	eyelash	NNS
cord-352796-6einbent	73	34	.	.	.
cord-352796-6einbent	74	1	Whether	whether	IN
cord-352796-6einbent	74	2	these	these	DT
cord-352796-6einbent	74	3	differences	difference	NNS
cord-352796-6einbent	74	4	play	play	VBP
cord-352796-6einbent	74	5	any	any	DT
cord-352796-6einbent	74	6	role	role	NN
cord-352796-6einbent	74	7	in	in	IN
cord-352796-6einbent	74	8	influencing	influence	VBG
cord-352796-6einbent	74	9	the	the	DT
cord-352796-6einbent	74	10	rate	rate	NN
cord-352796-6einbent	74	11	at	at	IN
cord-352796-6einbent	74	12	which	which	WDT
cord-352796-6einbent	74	13	particles	particle	VBZ
cord-352796-6einbent	74	14	land	land	NN
cord-352796-6einbent	74	15	on	on	IN
cord-352796-6einbent	74	16	the	the	DT
cord-352796-6einbent	74	17	ocular	ocular	JJ
cord-352796-6einbent	74	18	surface	surface	NN
cord-352796-6einbent	74	19	is	be	VBZ
cord-352796-6einbent	74	20	unknown	unknown	JJ
cord-352796-6einbent	74	21	.	.	.
cord-352796-6einbent	75	1	However	however	RB
cord-352796-6einbent	75	2	,	,	,
cord-352796-6einbent	75	3	it	-PRON-	PRP
cord-352796-6einbent	75	4	is	be	VBZ
cord-352796-6einbent	75	5	possible	possible	JJ
cord-352796-6einbent	75	6	that	that	IN
cord-352796-6einbent	75	7	a	a	DT
cord-352796-6einbent	75	8	deficiency	deficiency	NN
cord-352796-6einbent	75	9	in	in	IN
cord-352796-6einbent	75	10	this	this	DT
cord-352796-6einbent	75	11	mechanism	mechanism	NN
cord-352796-6einbent	75	12	could	could	MD
cord-352796-6einbent	75	13	increase	increase	VB
cord-352796-6einbent	75	14	the	the	DT
cord-352796-6einbent	75	15	risk	risk	NN
cord-352796-6einbent	75	16	of	of	IN
cord-352796-6einbent	75	17	infection	infection	NN
cord-352796-6einbent	75	18	.	.	.
cord-352796-6einbent	76	1	In	in	IN
cord-352796-6einbent	76	2	the	the	DT
cord-352796-6einbent	76	3	1919	1919	CD
cord-352796-6einbent	76	4	study	study	NN
cord-352796-6einbent	76	5	(	(	-LRB-
cord-352796-6einbent	76	6	5	5	CD
cord-352796-6einbent	76	7	)	)	-RRB-
cord-352796-6einbent	76	8	,	,	,
cord-352796-6einbent	76	9	Bacillus	Bacillus	NNP
cord-352796-6einbent	76	10	prodigiosus	prodigiosus	NNP
cord-352796-6einbent	76	11	(	(	-LRB-
cord-352796-6einbent	76	12	Serratia	Serratia	NNP
cord-352796-6einbent	76	13	marcescens	marcescen	NNS
cord-352796-6einbent	76	14	)	)	-RRB-
cord-352796-6einbent	76	15	was	be	VBD
cord-352796-6einbent	76	16	instilled	instill	VBN
cord-352796-6einbent	76	17	into	into	IN
cord-352796-6einbent	76	18	the	the	DT
cord-352796-6einbent	76	19	lacrimal	lacrimal	JJ
cord-352796-6einbent	76	20	sac	sac	NN
cord-352796-6einbent	76	21	of	of	IN
cord-352796-6einbent	76	22	5	5	CD
cord-352796-6einbent	76	23	volunteers	volunteer	NNS
cord-352796-6einbent	76	24	and	and	CC
cord-352796-6einbent	76	25	subsequently	subsequently	RB
cord-352796-6einbent	76	26	was	be	VBD
cord-352796-6einbent	76	27	recoverable	recoverable	JJ
cord-352796-6einbent	76	28	from	from	IN
cord-352796-6einbent	76	29	the	the	DT
cord-352796-6einbent	76	30	nose	nose	NN
cord-352796-6einbent	76	31	,	,	,
cord-352796-6einbent	76	32	throat	throat	NN
cord-352796-6einbent	76	33	and	and	CC
cord-352796-6einbent	76	34	stool	stool	NN
cord-352796-6einbent	76	35	after	after	IN
cord-352796-6einbent	76	36	5	5	CD
cord-352796-6einbent	76	37	mins	min	NNS
cord-352796-6einbent	76	38	,	,	,
cord-352796-6einbent	76	39	15	15	CD
cord-352796-6einbent	76	40	mins	min	NNS
cord-352796-6einbent	76	41	and	and	CC
cord-352796-6einbent	76	42	24	24	CD
cord-352796-6einbent	76	43	hours	hour	NNS
cord-352796-6einbent	76	44	respectively	respectively	RB
cord-352796-6einbent	76	45	.	.	.
cord-352796-6einbent	77	1	It	-PRON-	PRP
cord-352796-6einbent	77	2	was	be	VBD
cord-352796-6einbent	77	3	concluded	conclude	VBN
cord-352796-6einbent	77	4	that	that	IN
cord-352796-6einbent	77	5	via	via	IN
cord-352796-6einbent	77	6	this	this	DT
cord-352796-6einbent	77	7	ocular	ocular	JJ
cord-352796-6einbent	77	8	lacrimatory	lacrimatory	NN
cord-352796-6einbent	77	9	-	-	HYPH
cord-352796-6einbent	77	10	nasal	nasal	NN
cord-352796-6einbent	77	11	mechanism	mechanism	NN
cord-352796-6einbent	77	12	(	(	-LRB-
cord-352796-6einbent	77	13	Figures	figure	NNS
cord-352796-6einbent	77	14	1	1	CD
cord-352796-6einbent	77	15	and	and	CC
cord-352796-6einbent	77	16	2	2	CD
cord-352796-6einbent	77	17	)	)	-RRB-
cord-352796-6einbent	77	18	,	,	,
cord-352796-6einbent	77	19	the	the	DT
cord-352796-6einbent	77	20	upper	upper	JJ
cord-352796-6einbent	77	21	respiratory	respiratory	JJ
cord-352796-6einbent	77	22	tract	tract	NN
cord-352796-6einbent	77	23	of	of	IN
cord-352796-6einbent	77	24	a	a	DT
cord-352796-6einbent	77	25	person	person	NN
cord-352796-6einbent	77	26	wearing	wear	VBG
cord-352796-6einbent	77	27	a	a	DT
cord-352796-6einbent	77	28	properly	properly	RB
cord-352796-6einbent	77	29	constructed	construct	VBN
cord-352796-6einbent	77	30	mask	mask	NN
cord-352796-6einbent	77	31	may	may	MD
cord-352796-6einbent	77	32	be	be	VB
cord-352796-6einbent	77	33	infected	infect	VBN
cord-352796-6einbent	77	34	by	by	IN
cord-352796-6einbent	77	35	exposing	expose	VBG
cord-352796-6einbent	77	36	the	the	DT
cord-352796-6einbent	77	37	eye	eye	NN
cord-352796-6einbent	77	38	briefly	briefly	NN
cord-352796-6einbent	77	39	to	to	IN
cord-352796-6einbent	77	40	direct	direct	JJ
cord-352796-6einbent	77	41	droplet	droplet	NN
cord-352796-6einbent	77	42	spray	spray	NN
cord-352796-6einbent	77	43	.	.	.
cord-352796-6einbent	78	1	Identification	identification	NN
cord-352796-6einbent	78	2	of	of	IN
cord-352796-6einbent	78	3	ocular	ocular	JJ
cord-352796-6einbent	78	4	surface	surface	NN
cord-352796-6einbent	78	5	cellular	cellular	JJ
cord-352796-6einbent	78	6	receptors	receptor	NNS
cord-352796-6einbent	78	7	utilized	utilize	VBN
cord-352796-6einbent	78	8	by	by	IN
cord-352796-6einbent	78	9	respiratory	respiratory	JJ
cord-352796-6einbent	78	10	viruses	virus	NNS
cord-352796-6einbent	78	11	has	have	VBZ
cord-352796-6einbent	78	12	provided	provide	VBN
cord-352796-6einbent	78	13	information	information	NN
cord-352796-6einbent	78	14	as	as	IN
cord-352796-6einbent	78	15	to	to	IN
cord-352796-6einbent	78	16	the	the	DT
cord-352796-6einbent	78	17	permissiveness	permissiveness	NN
cord-352796-6einbent	78	18	of	of	IN
cord-352796-6einbent	78	19	ocular	ocular	JJ
cord-352796-6einbent	78	20	tissue	tissue	NN
cord-352796-6einbent	78	21	to	to	IN
cord-352796-6einbent	78	22	infection	infection	NN
cord-352796-6einbent	78	23	with	with	IN
cord-352796-6einbent	78	24	these	these	DT
cord-352796-6einbent	78	25	agents	agent	NNS
cord-352796-6einbent	78	26	(	(	-LRB-
cord-352796-6einbent	78	27	6	6	CD
cord-352796-6einbent	78	28	,	,	,
cord-352796-6einbent	78	29	36	36	CD
cord-352796-6einbent	78	30	)	)	-RRB-
cord-352796-6einbent	78	31	.	.	.
cord-352796-6einbent	79	1	Central	central	JJ
cord-352796-6einbent	79	2	to	to	IN
cord-352796-6einbent	79	3	COVID-19	covid-19	JJ
cord-352796-6einbent	79	4	pathogenicity	pathogenicity	NN
cord-352796-6einbent	79	5	is	be	VBZ
cord-352796-6einbent	79	6	that	that	DT
cord-352796-6einbent	79	7	cellular	cellular	JJ
cord-352796-6einbent	79	8	entry	entry	NN
cord-352796-6einbent	79	9	is	be	VBZ
cord-352796-6einbent	79	10	via	via	IN
cord-352796-6einbent	79	11	the	the	DT
cord-352796-6einbent	79	12	cell	cell	NN
cord-352796-6einbent	79	13	surface	surface	NN
cord-352796-6einbent	79	14	angiotensin	angiotensin	NN
cord-352796-6einbent	79	15	converting	convert	VBG
cord-352796-6einbent	79	16	enzyme	enzyme	NN
cord-352796-6einbent	79	17	2	2	CD
cord-352796-6einbent	79	18	(	(	-LRB-
cord-352796-6einbent	79	19	ACE2	ACE2	NNP
cord-352796-6einbent	79	20	)	)	-RRB-
cord-352796-6einbent	79	21	receptor	receptor	NN
cord-352796-6einbent	79	22	(	(	-LRB-
cord-352796-6einbent	79	23	37	37	CD
cord-352796-6einbent	79	24	,	,	,
cord-352796-6einbent	79	25	38	38	CD
cord-352796-6einbent	79	26	)	)	-RRB-
cord-352796-6einbent	79	27	.	.	.
cord-352796-6einbent	80	1	It	-PRON-	PRP
cord-352796-6einbent	80	2	is	be	VBZ
cord-352796-6einbent	80	3	the	the	DT
cord-352796-6einbent	80	4	only	only	JJ
cord-352796-6einbent	80	5	mammalian	mammalian	JJ
cord-352796-6einbent	80	6	group	group	NN
cord-352796-6einbent	80	7	I	-PRON-	PRP
cord-352796-6einbent	80	8	coronavirus	coronavirus	VBP
cord-352796-6einbent	80	9	known	know	VBN
cord-352796-6einbent	80	10	to	to	TO
cord-352796-6einbent	80	11	use	use	VB
cord-352796-6einbent	80	12	ACE2	ACE2	NNP
cord-352796-6einbent	80	13	as	as	IN
cord-352796-6einbent	80	14	its	-PRON-	PRP$
cord-352796-6einbent	80	15	receptor	receptor	NN
cord-352796-6einbent	80	16	(	(	-LRB-
cord-352796-6einbent	80	17	39	39	CD
cord-352796-6einbent	80	18	)	)	-RRB-
cord-352796-6einbent	80	19	.	.	.
cord-352796-6einbent	81	1	ACE2	ACE2	NNP
cord-352796-6einbent	81	2	was	be	VBD
cord-352796-6einbent	81	3	previously	previously	RB
cord-352796-6einbent	81	4	identified	identify	VBN
cord-352796-6einbent	81	5	as	as	IN
cord-352796-6einbent	81	6	the	the	DT
cord-352796-6einbent	81	7	receptor	receptor	NN
cord-352796-6einbent	81	8	for	for	IN
cord-352796-6einbent	81	9	SARS	SARS	NNP
cord-352796-6einbent	81	10	-	-	HYPH
cord-352796-6einbent	81	11	Cov	Cov	NNP
cord-352796-6einbent	81	12	and	and	CC
cord-352796-6einbent	81	13	NL63	NL63	NNP
cord-352796-6einbent	81	14	(	(	-LRB-
cord-352796-6einbent	81	15	40	40	CD
cord-352796-6einbent	81	16	)	)	-RRB-
cord-352796-6einbent	81	17	.	.	.
cord-352796-6einbent	82	1	Virus	virus	NN
cord-352796-6einbent	82	2	infectivity	infectivity	NN
cord-352796-6einbent	82	3	studies	study	NNS
cord-352796-6einbent	82	4	have	have	VBP
cord-352796-6einbent	82	5	shown	show	VBN
cord-352796-6einbent	82	6	that	that	IN
cord-352796-6einbent	82	7	ACE2	ACE2	NNP
cord-352796-6einbent	82	8	is	be	VBZ
cord-352796-6einbent	82	9	essential	essential	JJ
cord-352796-6einbent	82	10	for	for	IN
cord-352796-6einbent	82	11	SARS	SARS	NNP
cord-352796-6einbent	82	12	-	-	HYPH
cord-352796-6einbent	82	13	CoV-2	CoV-2	NNP
cord-352796-6einbent	82	14	to	to	TO
cord-352796-6einbent	82	15	enter	enter	VB
cord-352796-6einbent	82	16	HeLa	HeLa	NNP
cord-352796-6einbent	82	17	cells	cell	NNS
cord-352796-6einbent	82	18	(	(	-LRB-
cord-352796-6einbent	82	19	41	41	CD
cord-352796-6einbent	82	20	)	)	-RRB-
cord-352796-6einbent	82	21	.	.	.
cord-352796-6einbent	83	1	While	while	IN
cord-352796-6einbent	83	2	ACE2	ACE2	NNP
cord-352796-6einbent	83	3	mRNA	mRNA	NNP
cord-352796-6einbent	83	4	is	be	VBZ
cord-352796-6einbent	83	5	known	know	VBN
cord-352796-6einbent	83	6	to	to	TO
cord-352796-6einbent	83	7	be	be	VB
cord-352796-6einbent	83	8	present	present	JJ
cord-352796-6einbent	83	9	in	in	IN
cord-352796-6einbent	83	10	virtually	virtually	RB
cord-352796-6einbent	83	11	all	all	DT
cord-352796-6einbent	83	12	organs	organ	NNS
cord-352796-6einbent	83	13	,	,	,
cord-352796-6einbent	83	14	surface	surface	NN
cord-352796-6einbent	83	15	expression	expression	NN
cord-352796-6einbent	83	16	of	of	IN
cord-352796-6einbent	83	17	ACE2	ACE2	NNP
cord-352796-6einbent	83	18	protein	protein	NN
cord-352796-6einbent	83	19	was	be	VBD
cord-352796-6einbent	83	20	described	describe	VBN
cord-352796-6einbent	83	21	in	in	IN
cord-352796-6einbent	83	22	lung	lung	NN
cord-352796-6einbent	83	23	alveolar	alveolar	NN
cord-352796-6einbent	83	24	epithelial	epithelial	JJ
cord-352796-6einbent	83	25	cells	cell	NNS
cord-352796-6einbent	83	26	and	and	CC
cord-352796-6einbent	83	27	small	small	JJ
cord-352796-6einbent	83	28	intestinal	intestinal	JJ
cord-352796-6einbent	83	29	enterocytes	enterocyte	NNS
cord-352796-6einbent	83	30	(	(	-LRB-
cord-352796-6einbent	83	31	42	42	CD
cord-352796-6einbent	83	32	)	)	-RRB-
cord-352796-6einbent	83	33	and	and	CC
cord-352796-6einbent	83	34	it	-PRON-	PRP
cord-352796-6einbent	83	35	was	be	VBD
cord-352796-6einbent	83	36	postulated	postulate	VBN
cord-352796-6einbent	83	37	that	that	IN
cord-352796-6einbent	83	38	ACE2	ACE2	NNP
cord-352796-6einbent	83	39	might	may	MD
cord-352796-6einbent	83	40	provide	provide	VB
cord-352796-6einbent	83	41	the	the	DT
cord-352796-6einbent	83	42	coronavirus	coronavirus	NN
cord-352796-6einbent	83	43	entry	entry	NN
cord-352796-6einbent	83	44	route	route	NN
cord-352796-6einbent	83	45	.	.	.
cord-352796-6einbent	84	1	The	the	DT
cord-352796-6einbent	84	2	eye	eye	NN
cord-352796-6einbent	84	3	and	and	CC
cord-352796-6einbent	84	4	its	-PRON-	PRP$
cord-352796-6einbent	84	5	adnexae	adnexae	NN
cord-352796-6einbent	84	6	were	be	VBD
cord-352796-6einbent	84	7	not	not	RB
cord-352796-6einbent	84	8	investigated	investigate	VBN
cord-352796-6einbent	84	9	in	in	IN
cord-352796-6einbent	84	10	this	this	DT
cord-352796-6einbent	84	11	study	study	NN
cord-352796-6einbent	84	12	.	.	.
cord-352796-6einbent	85	1	It	-PRON-	PRP
cord-352796-6einbent	85	2	was	be	VBD
cord-352796-6einbent	85	3	subsequently	subsequently	RB
cord-352796-6einbent	85	4	shown	show	VBN
cord-352796-6einbent	85	5	that	that	IN
cord-352796-6einbent	85	6	ACE2	ACE2	NNP
cord-352796-6einbent	85	7	protein	protein	NN
cord-352796-6einbent	85	8	is	be	VBZ
cord-352796-6einbent	85	9	more	more	RBR
cord-352796-6einbent	85	10	abundantly	abundantly	RB
cord-352796-6einbent	85	11	expressed	express	VBN
cord-352796-6einbent	85	12	on	on	IN
cord-352796-6einbent	85	13	the	the	DT
cord-352796-6einbent	85	14	apical	apical	JJ
cord-352796-6einbent	85	15	than	than	IN
cord-352796-6einbent	85	16	the	the	DT
cord-352796-6einbent	85	17	basolateral	basolateral	JJ
cord-352796-6einbent	85	18	surface	surface	NN
cord-352796-6einbent	85	19	of	of	IN
cord-352796-6einbent	85	20	polarized	polarized	JJ
cord-352796-6einbent	85	21	airway	airway	NN
cord-352796-6einbent	85	22	epithelia	epithelium	NNS
cord-352796-6einbent	85	23	(	(	-LRB-
cord-352796-6einbent	85	24	43	43	CD
cord-352796-6einbent	85	25	)	)	-RRB-
cord-352796-6einbent	85	26	and	and	CC
cord-352796-6einbent	85	27	thus	thus	RB
cord-352796-6einbent	85	28	accessible	accessible	JJ
cord-352796-6einbent	85	29	by	by	IN
cord-352796-6einbent	85	30	topical	topical	JJ
cord-352796-6einbent	85	31	agents	agent	NNS
cord-352796-6einbent	85	32	.	.	.
cord-352796-6einbent	86	1	An	an	DT
cord-352796-6einbent	86	2	immunohistochemical	immunohistochemical	JJ
cord-352796-6einbent	86	3	study	study	NN
cord-352796-6einbent	86	4	revealed	reveal	VBD
cord-352796-6einbent	86	5	both	both	DT
cord-352796-6einbent	86	6	extra	extra	JJ
cord-352796-6einbent	86	7	-	-	HYPH
cord-352796-6einbent	86	8	and	and	CC
cord-352796-6einbent	86	9	intraocular	intraocular	JJ
cord-352796-6einbent	86	10	localisation	localisation	NN
cord-352796-6einbent	86	11	of	of	IN
cord-352796-6einbent	86	12	ACE	ACE	NNP
cord-352796-6einbent	86	13	in	in	IN
cord-352796-6einbent	86	14	human	human	JJ
cord-352796-6einbent	86	15	eyes	eye	NNS
cord-352796-6einbent	86	16	(	(	-LRB-
cord-352796-6einbent	86	17	44	44	CD
cord-352796-6einbent	86	18	)	)	-RRB-
cord-352796-6einbent	86	19	.	.	.
cord-352796-6einbent	87	1	Of	of	IN
cord-352796-6einbent	87	2	particular	particular	JJ
cord-352796-6einbent	87	3	interest	interest	NN
cord-352796-6einbent	87	4	was	be	VBD
cord-352796-6einbent	87	5	the	the	DT
cord-352796-6einbent	87	6	localisation	localisation	NN
cord-352796-6einbent	87	7	of	of	IN
cord-352796-6einbent	87	8	ACE	ACE	NNP
cord-352796-6einbent	87	9	to	to	IN
cord-352796-6einbent	87	10	the	the	DT
cord-352796-6einbent	87	11	epithelial	epithelial	JJ
cord-352796-6einbent	87	12	cells	cell	NNS
cord-352796-6einbent	87	13	of	of	IN
cord-352796-6einbent	87	14	both	both	CC
cord-352796-6einbent	87	15	the	the	DT
cord-352796-6einbent	87	16	cornea	cornea	NN
cord-352796-6einbent	87	17	and	and	CC
cord-352796-6einbent	87	18	conjunctiva	conjunctiva	NN
cord-352796-6einbent	87	19	.	.	.
cord-352796-6einbent	88	1	Apical	Apical	NNP
cord-352796-6einbent	88	2	epithelia	epithelia	NN
cord-352796-6einbent	88	3	location	location	NN
cord-352796-6einbent	88	4	and	and	CC
cord-352796-6einbent	88	5	whether	whether	IN
cord-352796-6einbent	88	6	receptors	receptor	NNS
cord-352796-6einbent	88	7	are	be	VBP
cord-352796-6einbent	88	8	ACE2	ACE2	NNP
cord-352796-6einbent	88	9	remains	remain	VBZ
cord-352796-6einbent	88	10	to	to	TO
cord-352796-6einbent	88	11	be	be	VB
cord-352796-6einbent	88	12	confirmed	confirm	VBN
cord-352796-6einbent	88	13	.	.	.
cord-352796-6einbent	89	1	Recently	recently	RB
cord-352796-6einbent	89	2	,	,	,
cord-352796-6einbent	89	3	more	more	RBR
cord-352796-6einbent	89	4	widespread	widespread	JJ
cord-352796-6einbent	89	5	distribution	distribution	NN
cord-352796-6einbent	89	6	of	of	IN
cord-352796-6einbent	89	7	SARS	SARS	NNP
cord-352796-6einbent	89	8	-	-	HYPH
cord-352796-6einbent	89	9	CoV-2	CoV-2	NNP
cord-352796-6einbent	89	10	entry	entry	NN
cord-352796-6einbent	89	11	factors	factor	NNS
cord-352796-6einbent	89	12	,	,	,
cord-352796-6einbent	89	13	ACE2	ACE2	NNP
cord-352796-6einbent	89	14	as	as	RB
cord-352796-6einbent	89	15	well	well	RB
cord-352796-6einbent	89	16	as	as	IN
cord-352796-6einbent	89	17	TMPRSS2	TMPRSS2	NNP
cord-352796-6einbent	89	18	protease	protease	NN
cord-352796-6einbent	89	19	and	and	CC
cord-352796-6einbent	89	20	cathepsin	cathepsin	NN
cord-352796-6einbent	89	21	B	B	NNP
cord-352796-6einbent	89	22	/	/	SYM
cord-352796-6einbent	89	23	L	l	NN
cord-352796-6einbent	89	24	activity	activity	NN
cord-352796-6einbent	89	25	(	(	-LRB-
cord-352796-6einbent	89	26	for	for	IN
cord-352796-6einbent	89	27	post	post	JJ
cord-352796-6einbent	89	28	-	-	JJ
cord-352796-6einbent	89	29	binding	binding	JJ
cord-352796-6einbent	89	30	spike	spike	NN
cord-352796-6einbent	89	31	protein	protein	NN
cord-352796-6einbent	89	32	priming	priming	NN
cord-352796-6einbent	89	33	)	)	-RRB-
cord-352796-6einbent	89	34	have	have	VBP
cord-352796-6einbent	89	35	been	be	VBN
cord-352796-6einbent	89	36	documented	document	VBN
cord-352796-6einbent	89	37	using	use	VBG
cord-352796-6einbent	89	38	single	single	JJ
cord-352796-6einbent	89	39	-	-	HYPH
cord-352796-6einbent	89	40	cell	cell	NN
cord-352796-6einbent	89	41	RNA	rna	NN
cord-352796-6einbent	89	42	-	-	HYPH
cord-352796-6einbent	89	43	sequencing	sequence	VBG
cord-352796-6einbent	89	44	data	datum	NNS
cord-352796-6einbent	89	45	(	(	-LRB-
cord-352796-6einbent	89	46	45	45	CD
cord-352796-6einbent	89	47	)	)	-RRB-
cord-352796-6einbent	89	48	.	.	.
cord-352796-6einbent	90	1	While	while	IN
cord-352796-6einbent	90	2	it	-PRON-	PRP
cord-352796-6einbent	90	3	was	be	VBD
cord-352796-6einbent	90	4	recognized	recognize	VBN
cord-352796-6einbent	90	5	that	that	IN
cord-352796-6einbent	90	6	binding	bind	VBG
cord-352796-6einbent	90	7	affinity	affinity	NN
cord-352796-6einbent	90	8	of	of	IN
cord-352796-6einbent	90	9	the	the	DT
cord-352796-6einbent	90	10	spike	spike	NN
cord-352796-6einbent	90	11	protein	protein	NN
cord-352796-6einbent	90	12	and	and	CC
cord-352796-6einbent	90	13	ACE2	ACE2	NNP
cord-352796-6einbent	90	14	is	be	VBZ
cord-352796-6einbent	90	15	the	the	DT
cord-352796-6einbent	90	16	major	major	JJ
cord-352796-6einbent	90	17	determinant	determinant	NN
cord-352796-6einbent	90	18	of	of	IN
cord-352796-6einbent	90	19	SARS	SARS	NNP
cord-352796-6einbent	90	20	-	-	HYPH
cord-352796-6einbent	90	21	CoV	cov	NN
cord-352796-6einbent	90	22	replication	replication	NN
cord-352796-6einbent	90	23	rate	rate	NN
cord-352796-6einbent	90	24	and	and	CC
cord-352796-6einbent	90	25	disease	disease	NN
cord-352796-6einbent	90	26	severity	severity	NN
cord-352796-6einbent	90	27	and	and	CC
cord-352796-6einbent	90	28	that	that	IN
cord-352796-6einbent	90	29	viral	viral	JJ
cord-352796-6einbent	90	30	entry	entry	NN
cord-352796-6einbent	90	31	also	also	RB
cord-352796-6einbent	90	32	depends	depend	VBZ
cord-352796-6einbent	90	33	on	on	IN
cord-352796-6einbent	90	34	protease	protease	NN
cord-352796-6einbent	90	35	activity	activity	NN
cord-352796-6einbent	90	36	,	,	,
cord-352796-6einbent	90	37	ACE2	ACE2	NNP
cord-352796-6einbent	90	38	,	,	,
cord-352796-6einbent	90	39	rather	rather	RB
cord-352796-6einbent	90	40	than	than	IN
cord-352796-6einbent	90	41	protease	protease	NN
cord-352796-6einbent	90	42	activity	activity	NN
cord-352796-6einbent	90	43	,	,	,
cord-352796-6einbent	90	44	may	may	MD
cord-352796-6einbent	90	45	be	be	VB
cord-352796-6einbent	90	46	a	a	DT
cord-352796-6einbent	90	47	limiting	limit	VBG
cord-352796-6einbent	90	48	factor	factor	NN
cord-352796-6einbent	90	49	for	for	IN
cord-352796-6einbent	90	50	initial	initial	JJ
cord-352796-6einbent	90	51	viral	viral	JJ
cord-352796-6einbent	90	52	entry	entry	NN
cord-352796-6einbent	90	53	.	.	.
cord-352796-6einbent	91	1	This	this	DT
cord-352796-6einbent	91	2	study	study	NN
cord-352796-6einbent	91	3	confirmed	confirm	VBD
cord-352796-6einbent	91	4	evidence	evidence	NN
cord-352796-6einbent	91	5	of	of	IN
cord-352796-6einbent	91	6	ACE2	ACE2	NNP
cord-352796-6einbent	91	7	in	in	IN
cord-352796-6einbent	91	8	the	the	DT
cord-352796-6einbent	91	9	limbus	limbus	NN
cord-352796-6einbent	91	10	,	,	,
cord-352796-6einbent	91	11	corneal	corneal	JJ
cord-352796-6einbent	91	12	epithelium	epithelium	NN
cord-352796-6einbent	91	13	(	(	-LRB-
cord-352796-6einbent	91	14	basal	basal	NN
cord-352796-6einbent	91	15	/	/	SYM
cord-352796-6einbent	91	16	suprabasal	suprabasal	NN
cord-352796-6einbent	91	17	,	,	,
cord-352796-6einbent	91	18	superficial	superficial	JJ
cord-352796-6einbent	91	19	and	and	CC
cord-352796-6einbent	91	20	wing	wing	NN
cord-352796-6einbent	91	21	cells	cell	NNS
cord-352796-6einbent	91	22	)	)	-RRB-
cord-352796-6einbent	91	23	and	and	CC
cord-352796-6einbent	91	24	conjunctiva	conjunctiva	NN
cord-352796-6einbent	91	25	(	(	-LRB-
cord-352796-6einbent	91	26	basal	basal	JJ
cord-352796-6einbent	91	27	and	and	CC
cord-352796-6einbent	91	28	superficial	superficial	JJ
cord-352796-6einbent	91	29	cells	cell	NNS
cord-352796-6einbent	91	30	)	)	-RRB-
cord-352796-6einbent	91	31	and	and	CC
cord-352796-6einbent	91	32	co	co	NN
cord-352796-6einbent	91	33	-	-	NN
cord-352796-6einbent	91	34	location	location	NN
cord-352796-6einbent	91	35	with	with	IN
cord-352796-6einbent	91	36	TMPRSS2	TMPRSS2	NNP
cord-352796-6einbent	91	37	in	in	IN
cord-352796-6einbent	91	38	superficial	superficial	JJ
cord-352796-6einbent	91	39	conjunctival	conjunctival	NN
cord-352796-6einbent	91	40	cells	cell	NNS
cord-352796-6einbent	91	41	.	.	.
cord-352796-6einbent	92	1	Of	of	IN
cord-352796-6einbent	92	2	interest	interest	NN
cord-352796-6einbent	92	3	is	be	VBZ
cord-352796-6einbent	92	4	that	that	IN
cord-352796-6einbent	92	5	this	this	DT
cord-352796-6einbent	92	6	study	study	NN
cord-352796-6einbent	92	7	demonstrated	demonstrate	VBD
cord-352796-6einbent	92	8	evidence	evidence	NN
cord-352796-6einbent	92	9	of	of	IN
cord-352796-6einbent	92	10	ACE2	ACE2	NNP
cord-352796-6einbent	92	11	in	in	IN
cord-352796-6einbent	92	12	nasal	nasal	JJ
cord-352796-6einbent	92	13	goblet	goblet	NN
cord-352796-6einbent	92	14	cells	cell	NNS
cord-352796-6einbent	92	15	which	which	WDT
cord-352796-6einbent	92	16	also	also	RB
cord-352796-6einbent	92	17	express	express	VBP
cord-352796-6einbent	92	18	genes	gene	NNS
cord-352796-6einbent	92	19	associated	associate	VBN
cord-352796-6einbent	92	20	with	with	IN
cord-352796-6einbent	92	21	immune	immune	JJ
cord-352796-6einbent	92	22	functions	function	NNS
cord-352796-6einbent	92	23	including	include	VBG
cord-352796-6einbent	92	24	innate	innate	JJ
cord-352796-6einbent	92	25	and	and	CC
cord-352796-6einbent	92	26	antiviral	antiviral	JJ
cord-352796-6einbent	92	27	immune	immune	JJ
cord-352796-6einbent	92	28	functions	function	NNS
cord-352796-6einbent	92	29	.	.	.
cord-352796-6einbent	93	1	There	there	EX
cord-352796-6einbent	93	2	should	should	MD
cord-352796-6einbent	93	3	be	be	VB
cord-352796-6einbent	93	4	some	some	DT
cord-352796-6einbent	93	5	priority	priority	NN
cord-352796-6einbent	93	6	for	for	IN
cord-352796-6einbent	93	7	re	re	NN
cord-352796-6einbent	93	8	-	-	NN
cord-352796-6einbent	93	9	evaluation	evaluation	NN
cord-352796-6einbent	93	10	of	of	IN
cord-352796-6einbent	93	11	these	these	DT
cord-352796-6einbent	93	12	elements	element	NNS
cord-352796-6einbent	93	13	in	in	IN
cord-352796-6einbent	93	14	the	the	DT
cord-352796-6einbent	93	15	ocular	ocular	JJ
cord-352796-6einbent	93	16	surface	surface	NN
cord-352796-6einbent	93	17	(	(	-LRB-
cord-352796-6einbent	93	18	46	46	CD
cord-352796-6einbent	93	19	)	)	-RRB-
cord-352796-6einbent	93	20	.	.	.
cord-352796-6einbent	94	1	The	the	DT
cord-352796-6einbent	94	2	density	density	NN
cord-352796-6einbent	94	3	of	of	IN
cord-352796-6einbent	94	4	SARS	SARS	NNP
cord-352796-6einbent	94	5	-	-	HYPH
cord-352796-6einbent	94	6	CoV-2	CoV-2	NNP
cord-352796-6einbent	94	7	entry	entry	NN
cord-352796-6einbent	94	8	factors	factor	NNS
cord-352796-6einbent	94	9	and	and	CC
cord-352796-6einbent	94	10	their	-PRON-	PRP$
cord-352796-6einbent	94	11	presence	presence	NN
cord-352796-6einbent	94	12	or	or	CC
cord-352796-6einbent	94	13	absence	absence	NN
cord-352796-6einbent	94	14	in	in	IN
cord-352796-6einbent	94	15	the	the	DT
cord-352796-6einbent	94	16	lacrimal	lacrimal	JJ
cord-352796-6einbent	94	17	drainage	drainage	NN
cord-352796-6einbent	94	18	system	system	NN
cord-352796-6einbent	94	19	would	would	MD
cord-352796-6einbent	94	20	be	be	VB
cord-352796-6einbent	94	21	of	of	IN
cord-352796-6einbent	94	22	interest	interest	NN
cord-352796-6einbent	94	23	,	,	,
cord-352796-6einbent	94	24	since	since	IN
cord-352796-6einbent	94	25	viral	viral	JJ
cord-352796-6einbent	94	26	particles	particle	NNS
cord-352796-6einbent	94	27	that	that	WDT
cord-352796-6einbent	94	28	land	land	VBP
cord-352796-6einbent	94	29	in	in	IN
cord-352796-6einbent	94	30	the	the	DT
cord-352796-6einbent	94	31	tear	tear	JJ
cord-352796-6einbent	94	32	film	film	NN
cord-352796-6einbent	94	33	need	need	VBP
cord-352796-6einbent	94	34	not	not	RB
cord-352796-6einbent	94	35	necessarily	necessarily	RB
cord-352796-6einbent	94	36	bind	bind	VB
cord-352796-6einbent	94	37	to	to	IN
cord-352796-6einbent	94	38	an	an	DT
cord-352796-6einbent	94	39	epithelial	epithelial	JJ
cord-352796-6einbent	94	40	cell	cell	NN
cord-352796-6einbent	94	41	immediately	immediately	RB
cord-352796-6einbent	94	42	but	but	CC
cord-352796-6einbent	94	43	could	could	MD
cord-352796-6einbent	94	44	be	be	VB
cord-352796-6einbent	94	45	presented	present	VBN
cord-352796-6einbent	94	46	with	with	IN
cord-352796-6einbent	94	47	a	a	DT
cord-352796-6einbent	94	48	second	second	JJ
cord-352796-6einbent	94	49	opportunity	opportunity	NN
cord-352796-6einbent	94	50	(	(	-LRB-
cord-352796-6einbent	94	51	a	a	DT
cord-352796-6einbent	94	52	"	"	``
cord-352796-6einbent	94	53	wash	wash	VB
cord-352796-6einbent	94	54	through	through	IN
cord-352796-6einbent	94	55	"	"	``
cord-352796-6einbent	94	56	effect	effect	NN
cord-352796-6einbent	94	57	)	)	-RRB-
cord-352796-6einbent	94	58	in	in	IN
cord-352796-6einbent	94	59	the	the	DT
cord-352796-6einbent	94	60	lacrimal	lacrimal	JJ
cord-352796-6einbent	94	61	drainage	drainage	NN
cord-352796-6einbent	94	62	system	system	NN
cord-352796-6einbent	94	63	.	.	.
cord-352796-6einbent	95	1	Tear	tear	JJ
cord-352796-6einbent	95	2	film	film	NN
cord-352796-6einbent	95	3	resilience	resilience	NN
cord-352796-6einbent	95	4	may	may	MD
cord-352796-6einbent	95	5	well	well	RB
cord-352796-6einbent	95	6	protect	protect	VB
cord-352796-6einbent	95	7	the	the	DT
cord-352796-6einbent	95	8	underlying	underlie	VBG
cord-352796-6einbent	95	9	corneal	corneal	NN
cord-352796-6einbent	95	10	and	and	CC
cord-352796-6einbent	95	11	conjunctival	conjunctival	JJ
cord-352796-6einbent	95	12	epithelium	epithelium	NN
cord-352796-6einbent	95	13	so	so	IN
cord-352796-6einbent	95	14	that	that	IN
cord-352796-6einbent	95	15	viral	viral	JJ
cord-352796-6einbent	95	16	adherence	adherence	NN
cord-352796-6einbent	95	17	to	to	IN
cord-352796-6einbent	95	18	the	the	DT
cord-352796-6einbent	95	19	tear	tear	JJ
cord-352796-6einbent	95	20	film	film	NN
cord-352796-6einbent	95	21	could	could	MD
cord-352796-6einbent	95	22	prevent	prevent	VB
cord-352796-6einbent	95	23	access	access	NN
cord-352796-6einbent	95	24	to	to	IN
cord-352796-6einbent	95	25	the	the	DT
cord-352796-6einbent	95	26	apical	apical	JJ
cord-352796-6einbent	95	27	epithelial	epithelial	JJ
cord-352796-6einbent	95	28	surface	surface	NN
cord-352796-6einbent	95	29	,	,	,
cord-352796-6einbent	95	30	which	which	WDT
cord-352796-6einbent	95	31	may	may	MD
cord-352796-6einbent	95	32	account	account	VB
cord-352796-6einbent	95	33	for	for	IN
cord-352796-6einbent	95	34	the	the	DT
cord-352796-6einbent	95	35	relatively	relatively	RB
cord-352796-6einbent	95	36	low	low	JJ
cord-352796-6einbent	95	37	incidence	incidence	NN
cord-352796-6einbent	95	38	of	of	IN
cord-352796-6einbent	95	39	keratitis	keratitis	NN
cord-352796-6einbent	95	40	/	/	SYM
cord-352796-6einbent	95	41	conjunctivitis	conjunctivitis	NN
cord-352796-6einbent	95	42	reported	report	VBD
cord-352796-6einbent	95	43	to	to	IN
cord-352796-6einbent	95	44	date	date	NN
cord-352796-6einbent	95	45	(	(	-LRB-
cord-352796-6einbent	95	46	7	7	CD
cord-352796-6einbent	95	47	,	,	,
cord-352796-6einbent	95	48	486	486	CD
cord-352796-6einbent	95	49	)	)	-RRB-
cord-352796-6einbent	95	50	.	.	.
cord-352796-6einbent	96	1	The	the	DT
cord-352796-6einbent	96	2	tear	tear	JJ
cord-352796-6einbent	96	3	film	film	NN
cord-352796-6einbent	96	4	lipid	lipid	NN
cord-352796-6einbent	96	5	layer	layer	NN
cord-352796-6einbent	96	6	plays	play	VBZ
cord-352796-6einbent	96	7	an	an	DT
cord-352796-6einbent	96	8	important	important	JJ
cord-352796-6einbent	96	9	role	role	NN
cord-352796-6einbent	96	10	in	in	IN
cord-352796-6einbent	96	11	retarding	retard	VBG
cord-352796-6einbent	96	12	tear	tear	JJ
cord-352796-6einbent	96	13	film	film	NN
cord-352796-6einbent	96	14	evaporation	evaporation	NN
cord-352796-6einbent	96	15	and	and	CC
cord-352796-6einbent	96	16	tear	tear	NN
cord-352796-6einbent	96	17	spillage	spillage	NN
cord-352796-6einbent	96	18	(	(	-LRB-
cord-352796-6einbent	96	19	49	49	CD
cord-352796-6einbent	96	20	)	)	-RRB-
cord-352796-6einbent	96	21	.	.	.
cord-352796-6einbent	97	1	However	however	RB
cord-352796-6einbent	97	2	,	,	,
cord-352796-6einbent	97	3	this	this	DT
cord-352796-6einbent	97	4	lipophilicity	lipophilicity	NN
cord-352796-6einbent	97	5	and	and	CC
cord-352796-6einbent	97	6	that	that	DT
cord-352796-6einbent	97	7	of	of	IN
cord-352796-6einbent	97	8	the	the	DT
cord-352796-6einbent	97	9	periocular	periocular	NN
cord-352796-6einbent	97	10	skin	skin	NN
cord-352796-6einbent	97	11	(	(	-LRB-
cord-352796-6einbent	97	12	50	50	CD
cord-352796-6einbent	97	13	)	)	-RRB-
cord-352796-6einbent	97	14	(	(	-LRB-
cord-352796-6einbent	97	15	57	57	CD
cord-352796-6einbent	97	16	)	)	-RRB-
cord-352796-6einbent	97	17	(	(	-LRB-
cord-352796-6einbent	97	18	58	58	CD
cord-352796-6einbent	97	19	)	)	-RRB-
cord-352796-6einbent	97	20	(	(	-LRB-
cord-352796-6einbent	97	21	59	59	CD
cord-352796-6einbent	97	22	)	)	-RRB-
cord-352796-6einbent	97	23	.	.	.
cord-352796-6einbent	98	1	While	while	IN
cord-352796-6einbent	98	2	it	-PRON-	PRP
cord-352796-6einbent	98	3	was	be	VBD
cord-352796-6einbent	98	4	found	find	VBN
cord-352796-6einbent	98	5	that	that	IN
cord-352796-6einbent	98	6	no	no	DT
cord-352796-6einbent	98	7	viral	viral	JJ
cord-352796-6einbent	98	8	RNA	RNA	NNP
cord-352796-6einbent	98	9	was	be	VBD
cord-352796-6einbent	98	10	detected	detect	VBN
cord-352796-6einbent	98	11	in	in	IN
cord-352796-6einbent	98	12	the	the	DT
cord-352796-6einbent	98	13	tear	tear	JJ
cord-352796-6einbent	98	14	fluid	fluid	NN
cord-352796-6einbent	98	15	and	and	CC
cord-352796-6einbent	98	16	conjunctival	conjunctival	JJ
cord-352796-6einbent	98	17	secretions	secretion	NNS
cord-352796-6einbent	98	18	of	of	IN
cord-352796-6einbent	98	19	infected	infected	JJ
cord-352796-6einbent	98	20	patients	patient	NNS
cord-352796-6einbent	98	21	without	without	IN
cord-352796-6einbent	98	22	conjunctivitis	conjunctivitis	NN
cord-352796-6einbent	98	23	in	in	IN
cord-352796-6einbent	98	24	one	one	CD
cord-352796-6einbent	98	25	study	study	NN
cord-352796-6einbent	98	26	,	,	,
cord-352796-6einbent	98	27	it	-PRON-	PRP
cord-352796-6einbent	98	28	was	be	VBD
cord-352796-6einbent	98	29	felt	feel	VBN
cord-352796-6einbent	98	30	that	that	IN
cord-352796-6einbent	98	31	this	this	DT
cord-352796-6einbent	98	32	did	do	VBD
cord-352796-6einbent	98	33	not	not	RB
cord-352796-6einbent	98	34	eliminate	eliminate	VB
cord-352796-6einbent	98	35	the	the	DT
cord-352796-6einbent	98	36	risk	risk	NN
cord-352796-6einbent	98	37	of	of	IN
cord-352796-6einbent	98	38	transmission	transmission	NN
cord-352796-6einbent	98	39	via	via	IN
cord-352796-6einbent	98	40	this	this	DT
cord-352796-6einbent	98	41	pathway	pathway	NN
cord-352796-6einbent	98	42	(	(	-LRB-
cord-352796-6einbent	98	43	57	57	CD
cord-352796-6einbent	98	44	)	)	-RRB-
cord-352796-6einbent	98	45	.	.	.
cord-352796-6einbent	99	1	The	the	DT
cord-352796-6einbent	99	2	finding	finding	NN
cord-352796-6einbent	99	3	that	that	IN
cord-352796-6einbent	99	4	human	human	JJ
cord-352796-6einbent	99	5	conjunctival	conjunctival	NN
cord-352796-6einbent	99	6	explant	explant	NN
cord-352796-6einbent	99	7	cultures	culture	NNS
cord-352796-6einbent	99	8	were	be	VBD
cord-352796-6einbent	99	9	more	more	RBR
cord-352796-6einbent	99	10	extensively	extensively	RB
cord-352796-6einbent	99	11	infected	infect	VBN
cord-352796-6einbent	99	12	by	by	IN
cord-352796-6einbent	99	13	SARS	SARS	NNP
cord-352796-6einbent	99	14	-	-	HYPH
cord-352796-6einbent	99	15	CoV-2	CoV-2	NNP
cord-352796-6einbent	99	16	than	than	IN
cord-352796-6einbent	99	17	by	by	IN
cord-352796-6einbent	99	18	SARS	SARS	NNP
cord-352796-6einbent	99	19	-	-	HYPH
cord-352796-6einbent	99	20	CoV	CoV	NNP
cord-352796-6einbent	99	21	is	be	VBZ
cord-352796-6einbent	99	22	also	also	RB
cord-352796-6einbent	99	23	significant	significant	JJ
cord-352796-6einbent	99	24	(	(	-LRB-
cord-352796-6einbent	99	25	46	46	CD
cord-352796-6einbent	99	26	)	)	-RRB-
cord-352796-6einbent	99	27	.	.	.
cord-352796-6einbent	100	1	Taken	take	VBN
cord-352796-6einbent	100	2	together	together	RB
cord-352796-6einbent	100	3	,	,	,
cord-352796-6einbent	100	4	these	these	DT
cord-352796-6einbent	100	5	findings	finding	NNS
cord-352796-6einbent	100	6	are	be	VBP
cord-352796-6einbent	100	7	also	also	RB
cord-352796-6einbent	100	8	consistent	consistent	JJ
cord-352796-6einbent	100	9	with	with	IN
cord-352796-6einbent	100	10	the	the	DT
cord-352796-6einbent	100	11	concept	concept	NN
cord-352796-6einbent	100	12	that	that	IN
cord-352796-6einbent	100	13	the	the	DT
cord-352796-6einbent	100	14	tear	tear	JJ
cord-352796-6einbent	100	15	film	film	NN
cord-352796-6einbent	100	16	may	may	MD
cord-352796-6einbent	100	17	protect	protect	VB
cord-352796-6einbent	100	18	the	the	DT
cord-352796-6einbent	100	19	ocular	ocular	JJ
cord-352796-6einbent	100	20	surface	surface	NN
cord-352796-6einbent	100	21	from	from	IN
cord-352796-6einbent	100	22	epithelial	epithelial	JJ
cord-352796-6einbent	100	23	infection	infection	NN
cord-352796-6einbent	100	24	and	and	CC
cord-352796-6einbent	100	25	convey	convey	VB
cord-352796-6einbent	100	26	virus	virus	NN
cord-352796-6einbent	100	27	downstream	downstream	RB
cord-352796-6einbent	100	28	.	.	.
cord-352796-6einbent	101	1	The	the	DT
cord-352796-6einbent	101	2	nasolacrimal	nasolacrimal	NN
cord-352796-6einbent	101	3	system	system	NN
cord-352796-6einbent	101	4	,	,	,
cord-352796-6einbent	101	5	via	via	IN
cord-352796-6einbent	101	6	the	the	DT
cord-352796-6einbent	101	7	nasopharynx	nasopharynx	NN
cord-352796-6einbent	101	8	(	(	-LRB-
cord-352796-6einbent	101	9	considered	consider	VBN
cord-352796-6einbent	101	10	crucial	crucial	JJ
cord-352796-6einbent	101	11	for	for	IN
cord-352796-6einbent	101	12	viral	viral	JJ
cord-352796-6einbent	101	13	replication	replication	NN
cord-352796-6einbent	101	14	(	(	-LRB-
cord-352796-6einbent	101	15	46	46	CD
cord-352796-6einbent	101	16	)	)	-RRB-
cord-352796-6einbent	101	17	)	)	-RRB-
cord-352796-6einbent	101	18	thus	thus	RB
cord-352796-6einbent	101	19	provides	provide	VBZ
cord-352796-6einbent	101	20	a	a	DT
cord-352796-6einbent	101	21	bridge	bridge	NN
cord-352796-6einbent	101	22	between	between	IN
cord-352796-6einbent	101	23	ocular	ocular	JJ
cord-352796-6einbent	101	24	and	and	CC
cord-352796-6einbent	101	25	respiratory	respiratory	JJ
cord-352796-6einbent	101	26	tissues	tissue	NNS
cord-352796-6einbent	101	27	,	,	,
cord-352796-6einbent	101	28	serving	serve	VBG
cord-352796-6einbent	101	29	as	as	IN
cord-352796-6einbent	101	30	a	a	DT
cord-352796-6einbent	101	31	conduit	conduit	NN
cord-352796-6einbent	101	32	for	for	IN
cord-352796-6einbent	101	33	viruscontaining	viruscontaine	VBG
cord-352796-6einbent	101	34	fluid	fluid	JJ
cord-352796-6einbent	101	35	exchange	exchange	NN
cord-352796-6einbent	101	36	between	between	IN
cord-352796-6einbent	101	37	these	these	DT
cord-352796-6einbent	101	38	sites	site	NNS
cord-352796-6einbent	101	39	(	(	-LRB-
cord-352796-6einbent	101	40	60	60	CD
cord-352796-6einbent	101	41	)	)	-RRB-
cord-352796-6einbent	101	42	.	.	.
cord-352796-6einbent	102	1	Furthermore	furthermore	RB
cord-352796-6einbent	102	2	,	,	,
cord-352796-6einbent	102	3	beyond	beyond	IN
cord-352796-6einbent	102	4	the	the	DT
cord-352796-6einbent	102	5	anatomical	anatomical	JJ
cord-352796-6einbent	102	6	linkage	linkage	NN
cord-352796-6einbent	102	7	,	,	,
cord-352796-6einbent	102	8	it	-PRON-	PRP
cord-352796-6einbent	102	9	was	be	VBD
cord-352796-6einbent	102	10	recognized	recognize	VBN
cord-352796-6einbent	102	11	that	that	IN
cord-352796-6einbent	102	12	the	the	DT
cord-352796-6einbent	102	13	structure	structure	NN
cord-352796-6einbent	102	14	and	and	CC
cord-352796-6einbent	102	15	distribution	distribution	NN
cord-352796-6einbent	102	16	of	of	IN
cord-352796-6einbent	102	17	cellular	cellular	JJ
cord-352796-6einbent	102	18	receptors	receptor	NNS
cord-352796-6einbent	102	19	in	in	IN
cord-352796-6einbent	102	20	these	these	DT
cord-352796-6einbent	102	21	systems	system	NNS
cord-352796-6einbent	102	22	is	be	VBZ
cord-352796-6einbent	102	23	likely	likely	RB
cord-352796-6einbent	102	24	contributing	contribute	VBG
cord-352796-6einbent	102	25	to	to	IN
cord-352796-6einbent	102	26	the	the	DT
cord-352796-6einbent	102	27	tissue	tissue	NN
cord-352796-6einbent	102	28	tropism	tropism	NN
cord-352796-6einbent	102	29	of	of	IN
cord-352796-6einbent	102	30	respiratory	respiratory	JJ
cord-352796-6einbent	102	31	viruses	virus	NNS
cord-352796-6einbent	102	32	(	(	-LRB-
cord-352796-6einbent	102	33	60	60	CD
cord-352796-6einbent	102	34	)	)	-RRB-
cord-352796-6einbent	102	35	.	.	.
cord-352796-6einbent	103	1	Furthermore	furthermore	RB
cord-352796-6einbent	103	2	,	,	,
cord-352796-6einbent	103	3	there	there	EX
cord-352796-6einbent	103	4	is	be	VBZ
cord-352796-6einbent	103	5	respiratory	respiratory	JJ
cord-352796-6einbent	103	6	-	-	HYPH
cord-352796-6einbent	103	7	ocular	ocular	JJ
cord-352796-6einbent	103	8	mucosal	mucosal	JJ
cord-352796-6einbent	103	9	immune	immune	JJ
cord-352796-6einbent	103	10	interdependence	interdependence	NN
cord-352796-6einbent	103	11	with	with	IN
cord-352796-6einbent	103	12	linkage	linkage	NN
cord-352796-6einbent	103	13	via	via	IN
cord-352796-6einbent	103	14	the	the	DT
cord-352796-6einbent	103	15	nasolacrimal	nasolacrimal	JJ
cord-352796-6einbent	103	16	lymphoid	lymphoid	JJ
cord-352796-6einbent	103	17	tissue	tissue	NN
cord-352796-6einbent	103	18	(	(	-LRB-
cord-352796-6einbent	103	19	6	6	CD
cord-352796-6einbent	103	20	,	,	,
cord-352796-6einbent	103	21	61	61	CD
cord-352796-6einbent	103	22	)	)	-RRB-
cord-352796-6einbent	103	23	.	.	.
cord-352796-6einbent	104	1	Despite	despite	IN
cord-352796-6einbent	104	2	early	early	JJ
cord-352796-6einbent	104	3	suggestions	suggestion	NNS
cord-352796-6einbent	104	4	of	of	IN
cord-352796-6einbent	104	5	ocular	ocular	JJ
cord-352796-6einbent	104	6	involvement	involvement	NN
cord-352796-6einbent	104	7	(	(	-LRB-
cord-352796-6einbent	104	8	62	62	CD
cord-352796-6einbent	104	9	)	)	-RRB-
cord-352796-6einbent	104	10	in	in	IN
cord-352796-6einbent	104	11	this	this	DT
cord-352796-6einbent	104	12	process	process	NN
cord-352796-6einbent	104	13	,	,	,
cord-352796-6einbent	104	14	it	-PRON-	PRP
cord-352796-6einbent	104	15	appears	appear	VBZ
cord-352796-6einbent	104	16	that	that	IN
cord-352796-6einbent	104	17	this	this	DT
cord-352796-6einbent	104	18	was	be	VBD
cord-352796-6einbent	104	19	not	not	RB
cord-352796-6einbent	104	20	taken	take	VBN
cord-352796-6einbent	104	21	into	into	IN
cord-352796-6einbent	104	22	consideration	consideration	NN
cord-352796-6einbent	104	23	in	in	IN
cord-352796-6einbent	104	24	framing	frame	VBG
cord-352796-6einbent	104	25	early	early	JJ
cord-352796-6einbent	104	26	guidelines	guideline	NNS
cord-352796-6einbent	104	27	for	for	IN
cord-352796-6einbent	104	28	protection	protection	NN
cord-352796-6einbent	104	29	against	against	IN
cord-352796-6einbent	104	30	infection	infection	NN
cord-352796-6einbent	104	31	.	.	.
cord-352796-6einbent	105	1	More	more	RBR
cord-352796-6einbent	105	2	recently	recently	RB
cord-352796-6einbent	105	3	,	,	,
cord-352796-6einbent	105	4	American	American	NNP
cord-352796-6einbent	105	5	Academy	Academy	NNP
cord-352796-6einbent	105	6	of	of	IN
cord-352796-6einbent	105	7	Ophthalmology	Ophthalmology	NNP
cord-352796-6einbent	105	8	recommendations	recommendation	NNS
cord-352796-6einbent	105	9	include	include	VBP
cord-352796-6einbent	105	10	protection	protection	NN
cord-352796-6einbent	105	11	for	for	IN
cord-352796-6einbent	105	12	the	the	DT
cord-352796-6einbent	105	13	mouth	mouth	NN
cord-352796-6einbent	105	14	,	,	,
cord-352796-6einbent	105	15	nose	nose	NN
cord-352796-6einbent	105	16	and	and	CC
cord-352796-6einbent	105	17	eyes	eye	NNS
cord-352796-6einbent	105	18	when	when	WRB
cord-352796-6einbent	105	19	caring	care	VBG
cord-352796-6einbent	105	20	for	for	IN
cord-352796-6einbent	105	21	patients	patient	NNS
cord-352796-6einbent	105	22	potentially	potentially	RB
cord-352796-6einbent	105	23	infected	infect	VBN
cord-352796-6einbent	105	24	with	with	IN
cord-352796-6einbent	105	25	this	this	DT
cord-352796-6einbent	105	26	virus	virus	NN
cord-352796-6einbent	105	27	(	(	-LRB-
cord-352796-6einbent	105	28	63	63	CD
cord-352796-6einbent	105	29	)	)	-RRB-
cord-352796-6einbent	105	30	.	.	.
cord-352796-6einbent	106	1	Thus	thus	RB
cord-352796-6einbent	106	2	,	,	,
cord-352796-6einbent	106	3	the	the	DT
cord-352796-6einbent	106	4	pathophysiology	pathophysiology	NN
cord-352796-6einbent	106	5	of	of	IN
cord-352796-6einbent	106	6	ocular	ocular	JJ
cord-352796-6einbent	106	7	surface	surface	NN
cord-352796-6einbent	106	8	-	-	HYPH
cord-352796-6einbent	106	9	SARS	SARS	NNP
cord-352796-6einbent	106	10	-	-	HYPH
cord-352796-6einbent	106	11	CoV-2	CoV-2	NNP
cord-352796-6einbent	106	12	interactions	interaction	NNS
cord-352796-6einbent	106	13	requires	require	VBZ
cord-352796-6einbent	106	14	reevaluation	reevaluation	NN
cord-352796-6einbent	106	15	,	,	,
cord-352796-6einbent	106	16	not	not	RB
cord-352796-6einbent	106	17	only	only	RB
cord-352796-6einbent	106	18	to	to	TO
cord-352796-6einbent	106	19	determine	determine	VB
cord-352796-6einbent	106	20	the	the	DT
cord-352796-6einbent	106	21	dynamics	dynamic	NNS
cord-352796-6einbent	106	22	of	of	IN
cord-352796-6einbent	106	23	ocular	ocular	JJ
cord-352796-6einbent	106	24	surface	surface	NN
cord-352796-6einbent	106	25	viral	viral	JJ
cord-352796-6einbent	106	26	exposure	exposure	NN
cord-352796-6einbent	106	27	and	and	CC
cord-352796-6einbent	106	28	binding	binding	NN
cord-352796-6einbent	106	29	but	but	CC
cord-352796-6einbent	106	30	also	also	RB
cord-352796-6einbent	106	31	transmission	transmission	NN
cord-352796-6einbent	106	32	via	via	IN
cord-352796-6einbent	106	33	the	the	DT
cord-352796-6einbent	106	34	lacrimal	lacrimal	JJ
cord-352796-6einbent	106	35	drainage	drainage	NN
cord-352796-6einbent	106	36	system	system	NN
cord-352796-6einbent	106	37	.	.	.
cord-352796-6einbent	107	1	Less	less	RBR
cord-352796-6einbent	107	2	pathogenic	pathogenic	JJ
cord-352796-6einbent	107	3	coronaviruses	coronaviruse	NNS
cord-352796-6einbent	107	4	as	as	RB
cord-352796-6einbent	107	5	well	well	RB
cord-352796-6einbent	107	6	as	as	IN
cord-352796-6einbent	107	7	other	other	JJ
cord-352796-6einbent	107	8	respiratory	respiratory	JJ
cord-352796-6einbent	107	9	viruses	virus	NNS
cord-352796-6einbent	107	10	could	could	MD
cord-352796-6einbent	107	11	be	be	VB
cord-352796-6einbent	107	12	used	use	VBN
cord-352796-6einbent	107	13	in	in	IN
cord-352796-6einbent	107	14	animal	animal	NN
cord-352796-6einbent	107	15	models	model	NNS
cord-352796-6einbent	107	16	to	to	TO
cord-352796-6einbent	107	17	better	better	RB
cord-352796-6einbent	107	18	elucidate	elucidate	VB
cord-352796-6einbent	107	19	this	this	DT
cord-352796-6einbent	107	20	relatively	relatively	RB
cord-352796-6einbent	107	21	unexplored	unexplored	JJ
cord-352796-6einbent	107	22	pathway	pathway	NN
cord-352796-6einbent	107	23	.	.	.
cord-352796-6einbent	108	1	Thus	thus	RB
cord-352796-6einbent	108	2	,	,	,
cord-352796-6einbent	108	3	the	the	DT
cord-352796-6einbent	108	4	ocular	ocular	JJ
cord-352796-6einbent	108	5	surface	surface	NN
cord-352796-6einbent	108	6	,	,	,
cord-352796-6einbent	108	7	representing	represent	VBG
cord-352796-6einbent	108	8	a	a	DT
cord-352796-6einbent	108	9	large	large	JJ
cord-352796-6einbent	108	10	surface	surface	NN
cord-352796-6einbent	108	11	area	area	NN
cord-352796-6einbent	108	12	,	,	,
cord-352796-6einbent	108	13	exposed	expose	VBN
cord-352796-6einbent	108	14	to	to	IN
cord-352796-6einbent	108	15	and	and	CC
cord-352796-6einbent	108	16	likely	likely	RB
cord-352796-6einbent	108	17	receptive	receptive	JJ
cord-352796-6einbent	108	18	to	to	IN
cord-352796-6einbent	108	19	coronavirus	coronavirus	NN
cord-352796-6einbent	108	20	,	,	,
cord-352796-6einbent	108	21	bearing	bear	VBG
cord-352796-6einbent	108	22	the	the	DT
cord-352796-6einbent	108	23	appropriate	appropriate	JJ
cord-352796-6einbent	108	24	SARS	SARS	NNP
cord-352796-6einbent	108	25	-	-	HYPH
cord-352796-6einbent	108	26	CoV-2	CoV-2	NNP
cord-352796-6einbent	108	27	entry	entry	NN
cord-352796-6einbent	108	28	factors	factor	NNS
cord-352796-6einbent	108	29	,	,	,
cord-352796-6einbent	108	30	may	may	MD
cord-352796-6einbent	108	31	be	be	VB
cord-352796-6einbent	108	32	an	an	DT
cord-352796-6einbent	108	33	ideal	ideal	JJ
cord-352796-6einbent	108	34	point	point	NN
cord-352796-6einbent	108	35	of	of	IN
cord-352796-6einbent	108	36	intervention	intervention	NN
cord-352796-6einbent	108	37	.	.	.
cord-352796-6einbent	109	1	Efforts	effort	NNS
cord-352796-6einbent	109	2	in	in	IN
cord-352796-6einbent	109	3	directly	directly	RB
cord-352796-6einbent	109	4	targeting	target	VBG
cord-352796-6einbent	109	5	the	the	DT
cord-352796-6einbent	109	6	ACE2	ACE2	NNP
cord-352796-6einbent	109	7	receptor	receptor	NN
cord-352796-6einbent	109	8	in	in	IN
cord-352796-6einbent	109	9	this	this	DT
cord-352796-6einbent	109	10	way	way	NN
cord-352796-6einbent	109	11	are	be	VBP
cord-352796-6einbent	109	12	limited	limit	VBN
cord-352796-6einbent	109	13	(	(	-LRB-
cord-352796-6einbent	109	14	64	64	CD
cord-352796-6einbent	109	15	)	)	-RRB-
cord-352796-6einbent	109	16	.	.	.
cord-352796-6einbent	110	1	Potentially	potentially	RB
cord-352796-6einbent	110	2	,	,	,
cord-352796-6einbent	110	3	blocking	block	VBG
cord-352796-6einbent	110	4	the	the	DT
cord-352796-6einbent	110	5	ACE2	ACE2	NNP
cord-352796-6einbent	110	6	receptor	receptor	NN
cord-352796-6einbent	110	7	would	would	MD
cord-352796-6einbent	110	8	deprive	deprive	VB
cord-352796-6einbent	110	9	coronaviruses	coronaviruse	NNS
cord-352796-6einbent	110	10	from	from	IN
cord-352796-6einbent	110	11	their	-PRON-	PRP$
cord-352796-6einbent	110	12	main	main	JJ
cord-352796-6einbent	110	13	point	point	NN
cord-352796-6einbent	110	14	of	of	IN
cord-352796-6einbent	110	15	tissue	tissue	NN
cord-352796-6einbent	110	16	binding	binding	NN
cord-352796-6einbent	110	17	.	.	.
cord-352796-6einbent	111	1	P4	p4	NN
cord-352796-6einbent	111	2	and	and	CC
cord-352796-6einbent	111	3	P5	p5	NN
cord-352796-6einbent	111	4	peptides	peptide	NNS
cord-352796-6einbent	111	5	and	and	CC
cord-352796-6einbent	111	6	NAAE	NAAE	NNP
cord-352796-6einbent	112	1	,	,	,
cord-352796-6einbent	112	2	a	a	DT
cord-352796-6einbent	112	3	small	small	JJ
cord-352796-6einbent	112	4	molecule	molecule	NN
cord-352796-6einbent	112	5	targeting	target	VBG
cord-352796-6einbent	112	6	ACE2	ACE2	NNP
cord-352796-6einbent	112	7	have	have	VBP
cord-352796-6einbent	112	8	been	be	VBN
cord-352796-6einbent	112	9	developed	develop	VBN
cord-352796-6einbent	112	10	but	but	CC
cord-352796-6einbent	112	11	there	there	EX
cord-352796-6einbent	112	12	have	have	VBP
cord-352796-6einbent	112	13	been	be	VBN
cord-352796-6einbent	112	14	concerns	concern	NNS
cord-352796-6einbent	112	15	about	about	IN
cord-352796-6einbent	112	16	a	a	DT
cord-352796-6einbent	112	17	narrow	narrow	JJ
cord-352796-6einbent	112	18	spectrum	spectrum	NN
cord-352796-6einbent	112	19	of	of	IN
cord-352796-6einbent	112	20	activity	activity	NN
cord-352796-6einbent	112	21	and	and	CC
cord-352796-6einbent	112	22	effects	effect	NNS
cord-352796-6einbent	112	23	on	on	IN
cord-352796-6einbent	112	24	blood	blood	NN
cord-352796-6einbent	112	25	pressure	pressure	NN
cord-352796-6einbent	112	26	regulation	regulation	NN
cord-352796-6einbent	112	27	(	(	-LRB-
cord-352796-6einbent	112	28	65	65	CD
cord-352796-6einbent	112	29	)	)	-RRB-
cord-352796-6einbent	112	30	.	.	.
cord-352796-6einbent	113	1	This	this	DT
cord-352796-6einbent	113	2	strategy	strategy	NN
cord-352796-6einbent	113	3	has	have	VBZ
cord-352796-6einbent	113	4	previously	previously	RB
cord-352796-6einbent	113	5	been	be	VBN
cord-352796-6einbent	113	6	employed	employ	VBN
cord-352796-6einbent	113	7	,	,	,
cord-352796-6einbent	113	8	using	use	VBG
cord-352796-6einbent	113	9	antibodies	antibody	NNS
cord-352796-6einbent	113	10	(	(	-LRB-
cord-352796-6einbent	113	11	66	66	CD
cord-352796-6einbent	113	12	)	)	-RRB-
cord-352796-6einbent	113	13	-anti	-anti	NNS
cord-352796-6einbent	113	14	-	-	:
cord-352796-6einbent	113	15	ACE2	ACE2	NNP
cord-352796-6einbent	113	16	but	but	CC
cord-352796-6einbent	113	17	not	not	RB
cord-352796-6einbent	113	18	anti	anti	JJ
cord-352796-6einbent	113	19	-	-	JJ
cord-352796-6einbent	113	20	ACE1	ace1	JJ
cord-352796-6einbent	113	21	antibody	antibody	NN
cord-352796-6einbent	113	22	blocked	block	VBD
cord-352796-6einbent	113	23	viral	viral	JJ
cord-352796-6einbent	113	24	replication	replication	NN
cord-352796-6einbent	113	25	in	in	IN
cord-352796-6einbent	113	26	a	a	DT
cord-352796-6einbent	113	27	model	model	NN
cord-352796-6einbent	113	28	system	system	NN
cord-352796-6einbent	113	29	.	.	.
cord-352796-6einbent	114	1	Blocking	block	VBG
cord-352796-6einbent	114	2	of	of	IN
cord-352796-6einbent	114	3	TMPRSS2	TMPRSS2	NNP
cord-352796-6einbent	114	4	protease	protease	NN
cord-352796-6einbent	114	5	and	and	CC
cord-352796-6einbent	114	6	cathepsin	cathepsin	NN
cord-352796-6einbent	114	7	B	B	NNP
cord-352796-6einbent	114	8	/	/	SYM
cord-352796-6einbent	114	9	L	l	NN
cord-352796-6einbent	114	10	activity	activity	NN
cord-352796-6einbent	114	11	could	could	MD
cord-352796-6einbent	114	12	also	also	RB
cord-352796-6einbent	114	13	be	be	VB
cord-352796-6einbent	114	14	considered	consider	VBN
cord-352796-6einbent	114	15	,	,	,
cord-352796-6einbent	114	16	however	however	RB
cord-352796-6einbent	114	17	it	-PRON-	PRP
cord-352796-6einbent	114	18	appears	appear	VBZ
cord-352796-6einbent	114	19	that	that	IN
cord-352796-6einbent	114	20	ACE2	ACE2	NNP
cord-352796-6einbent	114	21	,	,	,
cord-352796-6einbent	114	22	rather	rather	RB
cord-352796-6einbent	114	23	than	than	IN
cord-352796-6einbent	114	24	protease	protease	NN
cord-352796-6einbent	114	25	activity	activity	NN
cord-352796-6einbent	114	26	,	,	,
cord-352796-6einbent	114	27	may	may	MD
cord-352796-6einbent	114	28	be	be	VB
cord-352796-6einbent	114	29	the	the	DT
cord-352796-6einbent	114	30	viral	viral	JJ
cord-352796-6einbent	114	31	entry	entry	NN
cord-352796-6einbent	114	32	rate	rate	NN
cord-352796-6einbent	114	33	limiting	limit	VBG
cord-352796-6einbent	114	34	factor	factor	NN
cord-352796-6einbent	114	35	(	(	-LRB-
cord-352796-6einbent	114	36	45	45	CD
cord-352796-6einbent	114	37	)	)	-RRB-
cord-352796-6einbent	114	38	.	.	.
cord-352796-6einbent	115	1	A	a	DT
cord-352796-6einbent	115	2	search	search	NN
cord-352796-6einbent	115	3	of	of	IN
cord-352796-6einbent	115	4	FDA	FDA	NNP
cord-352796-6einbent	115	5	-	-	HYPH
cord-352796-6einbent	115	6	approved	approve	VBN
cord-352796-6einbent	115	7	drug	drug	NN
cord-352796-6einbent	115	8	libraries	library	NNS
cord-352796-6einbent	115	9	identified	identify	VBD
cord-352796-6einbent	115	10	a	a	DT
cord-352796-6einbent	115	11	number	number	NN
cord-352796-6einbent	115	12	of	of	IN
cord-352796-6einbent	115	13	drugs	drug	NNS
cord-352796-6einbent	115	14	including	include	VBG
cord-352796-6einbent	115	15	chloroquine	chloroquine	NN
cord-352796-6einbent	115	16	as	as	IN
cord-352796-6einbent	115	17	potentially	potentially	RB
cord-352796-6einbent	115	18	having	have	VBG
cord-352796-6einbent	115	19	anti	anti	JJ
cord-352796-6einbent	115	20	-	-	JJ
cord-352796-6einbent	115	21	coronavirus	coronavirus	JJ
cord-352796-6einbent	115	22	actions	action	NNS
cord-352796-6einbent	115	23	(	(	-LRB-
cord-352796-6einbent	115	24	71	71	CD
cord-352796-6einbent	115	25	)	)	-RRB-
cord-352796-6einbent	115	26	and	and	CC
cord-352796-6einbent	115	27	therefore	therefore	RB
cord-352796-6einbent	115	28	potentially	potentially	RB
cord-352796-6einbent	115	29	able	able	JJ
cord-352796-6einbent	115	30	to	to	TO
cord-352796-6einbent	115	31	be	be	VB
cord-352796-6einbent	115	32	repurposed	repurpose	VBN
cord-352796-6einbent	115	33	.	.	.
cord-352796-6einbent	116	1	Table	table	NN
cord-352796-6einbent	116	2	2	2	CD
cord-352796-6einbent	116	3	summarises	summarise	VBZ
cord-352796-6einbent	116	4	the	the	DT
cord-352796-6einbent	116	5	drugs	drug	NNS
cord-352796-6einbent	116	6	that	that	WDT
cord-352796-6einbent	116	7	have	have	VBP
cord-352796-6einbent	116	8	been	be	VBN
cord-352796-6einbent	116	9	identified	identify	VBN
cord-352796-6einbent	116	10	as	as	IN
cord-352796-6einbent	116	11	potential	potential	JJ
cord-352796-6einbent	116	12	treatments	treatment	NNS
cord-352796-6einbent	116	13	for	for	IN
cord-352796-6einbent	116	14	coronavirus	coronavirus	NN
cord-352796-6einbent	116	15	infection	infection	NN
cord-352796-6einbent	116	16	,	,	,
cord-352796-6einbent	116	17	their	-PRON-	PRP$
cord-352796-6einbent	116	18	efficacy	efficacy	NN
cord-352796-6einbent	116	19	(	(	-LRB-
cord-352796-6einbent	116	20	in	in	IN
cord-352796-6einbent	116	21	vitro	vitro	FW
cord-352796-6einbent	116	22	and	and	CC
cord-352796-6einbent	116	23	in	in	IN
cord-352796-6einbent	116	24	vivo	vivo	NNP
cord-352796-6einbent	116	25	)	)	-RRB-
cord-352796-6einbent	116	26	and	and	CC
cord-352796-6einbent	116	27	for	for	IN
cord-352796-6einbent	116	28	which	which	WDT
cord-352796-6einbent	116	29	there	there	EX
cord-352796-6einbent	116	30	is	be	VBZ
cord-352796-6einbent	116	31	data	datum	NNS
cord-352796-6einbent	116	32	(	(	-LRB-
cord-352796-6einbent	116	33	for	for	IN
cord-352796-6einbent	116	34	that	that	DT
cord-352796-6einbent	116	35	agent	agent	NN
cord-352796-6einbent	116	36	or	or	CC
cord-352796-6einbent	116	37	a	a	DT
cord-352796-6einbent	116	38	related	related	JJ
cord-352796-6einbent	116	39	compound	compound	NN
cord-352796-6einbent	116	40	)	)	-RRB-
cord-352796-6einbent	116	41	for	for	IN
cord-352796-6einbent	116	42	previous	previous	JJ
cord-352796-6einbent	116	43	topical	topical	JJ
cord-352796-6einbent	116	44	ocular	ocular	JJ
cord-352796-6einbent	116	45	surface	surface	NN
cord-352796-6einbent	116	46	usage	usage	NN
cord-352796-6einbent	116	47	.	.	.
cord-352796-6einbent	117	1	It	-PRON-	PRP
cord-352796-6einbent	117	2	is	be	VBZ
cord-352796-6einbent	117	3	apparent	apparent	JJ
cord-352796-6einbent	117	4	that	that	IN
cord-352796-6einbent	117	5	while	while	IN
cord-352796-6einbent	117	6	for	for	IN
cord-352796-6einbent	117	7	each	each	DT
cord-352796-6einbent	117	8	of	of	IN
cord-352796-6einbent	117	9	these	these	DT
cord-352796-6einbent	117	10	agents	agent	NNS
cord-352796-6einbent	117	11	,	,	,
cord-352796-6einbent	117	12	there	there	EX
cord-352796-6einbent	117	13	is	be	VBZ
cord-352796-6einbent	117	14	evidence	evidence	NN
cord-352796-6einbent	117	15	of	of	IN
cord-352796-6einbent	117	16	in	in	FW
cord-352796-6einbent	117	17	vitro	vitro	FW
cord-352796-6einbent	117	18	anti	anti	JJ
cord-352796-6einbent	117	19	-	-	JJ
cord-352796-6einbent	117	20	coronavirus	coronavirus	JJ
cord-352796-6einbent	117	21	activity	activity	NN
cord-352796-6einbent	117	22	,	,	,
cord-352796-6einbent	117	23	there	there	EX
cord-352796-6einbent	117	24	is	be	VBZ
cord-352796-6einbent	117	25	a	a	DT
cord-352796-6einbent	117	26	paucity	paucity	NN
cord-352796-6einbent	117	27	of	of	IN
cord-352796-6einbent	117	28	in	in	IN
cord-352796-6einbent	117	29	vivo	vivo	NN
cord-352796-6einbent	117	30	studies	study	NNS
cord-352796-6einbent	117	31	.	.	.
cord-352796-6einbent	118	1	This	this	DT
cord-352796-6einbent	118	2	has	have	VBZ
cord-352796-6einbent	118	3	been	be	VBN
cord-352796-6einbent	118	4	raised	raise	VBN
cord-352796-6einbent	118	5	as	as	IN
cord-352796-6einbent	118	6	a	a	DT
cord-352796-6einbent	118	7	matter	matter	NN
cord-352796-6einbent	118	8	for	for	IN
cord-352796-6einbent	118	9	concern	concern	NN
cord-352796-6einbent	118	10	in	in	IN
cord-352796-6einbent	118	11	that	that	IN
cord-352796-6einbent	118	12	there	there	EX
cord-352796-6einbent	118	13	are	be	VBP
cord-352796-6einbent	118	14	precedents	precedent	NNS
cord-352796-6einbent	118	15	for	for	IN
cord-352796-6einbent	118	16	paradoxical	paradoxical	JJ
cord-352796-6einbent	118	17	untoward	untoward	JJ
cord-352796-6einbent	118	18	drug	drug	NN
cord-352796-6einbent	118	19	systemic	systemic	JJ
cord-352796-6einbent	118	20	effects	effect	NNS
cord-352796-6einbent	118	21	that	that	WDT
cord-352796-6einbent	118	22	result	result	VBP
cord-352796-6einbent	118	23	in	in	IN
cord-352796-6einbent	118	24	increased	increase	VBN
cord-352796-6einbent	118	25	disease	disease	NN
cord-352796-6einbent	118	26	severity	severity	NN
cord-352796-6einbent	118	27	when	when	WRB
cord-352796-6einbent	118	28	in	in	FW
cord-352796-6einbent	118	29	vitro	vitro	FW
cord-352796-6einbent	118	30	testing	testing	NN
cord-352796-6einbent	118	31	alone	alone	RB
cord-352796-6einbent	118	32	might	may	MD
cord-352796-6einbent	118	33	suggest	suggest	VB
cord-352796-6einbent	118	34	efficacy	efficacy	NN
cord-352796-6einbent	118	35	(	(	-LRB-
cord-352796-6einbent	118	36	85	85	CD
cord-352796-6einbent	118	37	)	)	-RRB-
cord-352796-6einbent	118	38	.	.	.
cord-352796-6einbent	119	1	Chloroquine	Chloroquine	NNP
cord-352796-6einbent	119	2	has	have	VBZ
cord-352796-6einbent	119	3	long	long	RB
cord-352796-6einbent	119	4	been	be	VBN
cord-352796-6einbent	119	5	used	use	VBN
cord-352796-6einbent	119	6	in	in	IN
cord-352796-6einbent	119	7	the	the	DT
cord-352796-6einbent	119	8	treatment	treatment	NN
cord-352796-6einbent	119	9	of	of	IN
cord-352796-6einbent	119	10	malaria	malaria	NN
cord-352796-6einbent	119	11	and	and	CC
cord-352796-6einbent	119	12	subsequently	subsequently	RB
cord-352796-6einbent	119	13	,	,	,
cord-352796-6einbent	119	14	autoimmune	autoimmune	JJ
cord-352796-6einbent	119	15	disorders	disorder	NNS
cord-352796-6einbent	119	16	(	(	-LRB-
cord-352796-6einbent	119	17	such	such	JJ
cord-352796-6einbent	119	18	as	as	IN
cord-352796-6einbent	119	19	rheumatoid	rheumatoid	JJ
cord-352796-6einbent	119	20	arthritis	arthritis	NN
cord-352796-6einbent	119	21	)	)	-RRB-
cord-352796-6einbent	119	22	as	as	RB
cord-352796-6einbent	119	23	well	well	RB
cord-352796-6einbent	119	24	as	as	IN
cord-352796-6einbent	119	25	in	in	IN
cord-352796-6einbent	119	26	oncology	oncology	NN
cord-352796-6einbent	119	27	and	and	CC
cord-352796-6einbent	119	28	for	for	IN
cord-352796-6einbent	119	29	pediatric	pediatric	JJ
cord-352796-6einbent	119	30	inflammatory	inflammatory	JJ
cord-352796-6einbent	119	31	disease	disease	NN
cord-352796-6einbent	119	32	.	.	.
cord-352796-6einbent	120	1	However	however	RB
cord-352796-6einbent	120	2	,	,	,
cord-352796-6einbent	120	3	chloroquine	chloroquine	NN
cord-352796-6einbent	120	4	has	have	VBZ
cord-352796-6einbent	120	5	direct	direct	JJ
cord-352796-6einbent	120	6	antiviral	antiviral	JJ
cord-352796-6einbent	120	7	effects	effect	NNS
cord-352796-6einbent	120	8	,	,	,
cord-352796-6einbent	120	9	inhibiting	inhibit	VBG
cord-352796-6einbent	120	10	pH	ph	NN
cord-352796-6einbent	120	11	-	-	HYPH
cord-352796-6einbent	120	12	dependent	dependent	JJ
cord-352796-6einbent	120	13	steps	step	NNS
cord-352796-6einbent	120	14	of	of	IN
cord-352796-6einbent	120	15	the	the	DT
cord-352796-6einbent	120	16	replication	replication	NN
cord-352796-6einbent	120	17	of	of	IN
cord-352796-6einbent	120	18	flaviviruses	flavivirus	NNS
cord-352796-6einbent	120	19	,	,	,
cord-352796-6einbent	120	20	retroviruses	retrovirus	NNS
cord-352796-6einbent	120	21	,	,	,
cord-352796-6einbent	120	22	and	and	CC
cord-352796-6einbent	120	23	coronaviruses	coronaviruse	NNS
cord-352796-6einbent	120	24	(	(	-LRB-
cord-352796-6einbent	120	25	86	86	CD
cord-352796-6einbent	120	26	)	)	-RRB-
cord-352796-6einbent	120	27	,	,	,
cord-352796-6einbent	120	28	exhibiting	exhibit	VBG
cord-352796-6einbent	120	29	strong	strong	JJ
cord-352796-6einbent	120	30	antiviral	antiviral	JJ
cord-352796-6einbent	120	31	effects	effect	NNS
cord-352796-6einbent	120	32	on	on	IN
cord-352796-6einbent	120	33	coronavirus	coronavirus	NN
cord-352796-6einbent	120	34	infection	infection	NN
cord-352796-6einbent	120	35	of	of	IN
cord-352796-6einbent	120	36	primate	primate	JJ
cord-352796-6einbent	120	37	cells	cell	NNS
cord-352796-6einbent	120	38	(	(	-LRB-
cord-352796-6einbent	120	39	72	72	CD
cord-352796-6einbent	120	40	,	,	,
cord-352796-6einbent	120	41	87	87	CD
cord-352796-6einbent	120	42	)	)	-RRB-
cord-352796-6einbent	120	43	.	.	.
cord-352796-6einbent	121	1	The	the	DT
cord-352796-6einbent	121	2	drug	drug	NN
cord-352796-6einbent	121	3	can	can	MD
cord-352796-6einbent	121	4	be	be	VB
cord-352796-6einbent	121	5	effective	effective	JJ
cord-352796-6einbent	121	6	either	either	CC
cord-352796-6einbent	121	7	before	before	IN
cord-352796-6einbent	121	8	or	or	CC
cord-352796-6einbent	121	9	after	after	IN
cord-352796-6einbent	121	10	exposure	exposure	NN
cord-352796-6einbent	121	11	to	to	IN
cord-352796-6einbent	121	12	the	the	DT
cord-352796-6einbent	121	13	virus	virus	NN
cord-352796-6einbent	121	14	,	,	,
cord-352796-6einbent	121	15	so	so	RB
cord-352796-6einbent	121	16	could	could	MD
cord-352796-6einbent	121	17	act	act	VB
cord-352796-6einbent	121	18	both	both	DT
cord-352796-6einbent	121	19	therapeutically	therapeutically	RB
cord-352796-6einbent	121	20	and	and	CC
cord-352796-6einbent	121	21	prophylactically	prophylactically	RB
cord-352796-6einbent	121	22	.	.	.
cord-352796-6einbent	122	1	Several	several	JJ
cord-352796-6einbent	122	2	mechanisms	mechanism	NNS
cord-352796-6einbent	122	3	have	have	VBP
cord-352796-6einbent	122	4	been	be	VBN
cord-352796-6einbent	122	5	proposed	propose	VBN
cord-352796-6einbent	123	1	but	but	CC
cord-352796-6einbent	123	2	of	of	IN
cord-352796-6einbent	123	3	particular	particular	JJ
cord-352796-6einbent	123	4	interest	interest	NN
cord-352796-6einbent	123	5	is	be	VBZ
cord-352796-6einbent	123	6	that	that	IN
cord-352796-6einbent	123	7	the	the	DT
cord-352796-6einbent	123	8	drug	drug	NN
cord-352796-6einbent	123	9	appears	appear	VBZ
cord-352796-6einbent	123	10	to	to	TO
cord-352796-6einbent	123	11	interfere	interfere	VB
cord-352796-6einbent	123	12	with	with	IN
cord-352796-6einbent	123	13	terminal	terminal	JJ
cord-352796-6einbent	123	14	glycosylation	glycosylation	NN
cord-352796-6einbent	123	15	of	of	IN
cord-352796-6einbent	123	16	ACE2	ACE2	NNP
cord-352796-6einbent	123	17	(	(	-LRB-
cord-352796-6einbent	123	18	87	87	CD
cord-352796-6einbent	123	19	)	)	-RRB-
cord-352796-6einbent	123	20	(	(	-LRB-
cord-352796-6einbent	123	21	88	88	CD
cord-352796-6einbent	123	22	)	)	-RRB-
cord-352796-6einbent	123	23	(	(	-LRB-
cord-352796-6einbent	123	24	89	89	CD
cord-352796-6einbent	123	25	)	)	-RRB-
cord-352796-6einbent	123	26	.	.	.
cord-352796-6einbent	124	1	Chloroquine	Chloroquine	NNP
cord-352796-6einbent	124	2	also	also	RB
cord-352796-6einbent	124	3	has	have	VBZ
cord-352796-6einbent	124	4	immunomodulatory	immunomodulatory	JJ
cord-352796-6einbent	124	5	effects	effect	NNS
cord-352796-6einbent	124	6	,	,	,
cord-352796-6einbent	124	7	(	(	-LRB-
cord-352796-6einbent	124	8	86	86	CD
cord-352796-6einbent	124	9	,	,	,
cord-352796-6einbent	124	10	90	90	CD
cord-352796-6einbent	124	11	)	)	-RRB-
cord-352796-6einbent	124	12	suppressing	suppress	VBG
cord-352796-6einbent	124	13	the	the	DT
cord-352796-6einbent	124	14	production	production	NN
cord-352796-6einbent	124	15	/	/	SYM
cord-352796-6einbent	124	16	release	release	NN
cord-352796-6einbent	124	17	of	of	IN
cord-352796-6einbent	124	18	tumour	tumour	NN
cord-352796-6einbent	124	19	necrosis	necrosis	NN
cord-352796-6einbent	124	20	factor	factor	NN
cord-352796-6einbent	124	21	and	and	CC
cord-352796-6einbent	124	22	interleukin	interleukin	NN
cord-352796-6einbent	124	23	6	6	CD
cord-352796-6einbent	124	24	,	,	,
cord-352796-6einbent	124	25	which	which	WDT
cord-352796-6einbent	124	26	may	may	MD
cord-352796-6einbent	124	27	mitigate	mitigate	VB
cord-352796-6einbent	124	28	the	the	DT
cord-352796-6einbent	124	29	severe	severe	JJ
cord-352796-6einbent	124	30	inflammatory	inflammatory	JJ
cord-352796-6einbent	124	31	cascade	cascade	NN
cord-352796-6einbent	124	32	associated	associate	VBN
cord-352796-6einbent	124	33	with	with	IN
cord-352796-6einbent	124	34	severe	severe	JJ
cord-352796-6einbent	124	35	COVID-19	covid-19	JJ
cord-352796-6einbent	124	36	disease	disease	NN
cord-352796-6einbent	124	37	(	(	-LRB-
cord-352796-6einbent	124	38	86	86	CD
cord-352796-6einbent	124	39	)	)	-RRB-
cord-352796-6einbent	124	40	.	.	.
cord-352796-6einbent	125	1	Recently	recently	RB
cord-352796-6einbent	125	2	,	,	,
cord-352796-6einbent	125	3	hydroxychloroquine	hydroxychloroquine	NNP
cord-352796-6einbent	125	4	was	be	VBD
cord-352796-6einbent	125	5	found	find	VBN
cord-352796-6einbent	125	6	to	to	TO
cord-352796-6einbent	125	7	be	be	VB
cord-352796-6einbent	125	8	more	more	RBR
cord-352796-6einbent	125	9	potent	potent	JJ
cord-352796-6einbent	125	10	than	than	IN
cord-352796-6einbent	125	11	chloroquine	chloroquine	NN
cord-352796-6einbent	125	12	at	at	IN
cord-352796-6einbent	125	13	inhibiting	inhibit	VBG
cord-352796-6einbent	125	14	SARS	SARS	NNP
cord-352796-6einbent	125	15	-	-	HYPH
cord-352796-6einbent	125	16	CoV-2	CoV-2	NNP
cord-352796-6einbent	125	17	in	in	IN
cord-352796-6einbent	125	18	vitro	vitro	FW
cord-352796-6einbent	125	19	(	(	-LRB-
cord-352796-6einbent	125	20	91	91	CD
cord-352796-6einbent	125	21	)	)	-RRB-
cord-352796-6einbent	125	22	,	,	,
cord-352796-6einbent	125	23	fortuitous	fortuitous	JJ
cord-352796-6einbent	125	24	,	,	,
cord-352796-6einbent	125	25	since	since	IN
cord-352796-6einbent	125	26	it	-PRON-	PRP
cord-352796-6einbent	125	27	appears	appear	VBZ
cord-352796-6einbent	125	28	that	that	IN
cord-352796-6einbent	125	29	lower	low	JJR
cord-352796-6einbent	125	30	toxicity	toxicity	NN
cord-352796-6einbent	125	31	has	have	VBZ
cord-352796-6einbent	125	32	been	be	VBN
cord-352796-6einbent	125	33	attributed	attribute	VBN
cord-352796-6einbent	125	34	to	to	IN
cord-352796-6einbent	125	35	this	this	DT
cord-352796-6einbent	125	36	derivative	derivative	NN
cord-352796-6einbent	125	37	(	(	-LRB-
cord-352796-6einbent	125	38	92	92	CD
cord-352796-6einbent	125	39	)	)	-RRB-
cord-352796-6einbent	125	40	.	.	.
cord-352796-6einbent	126	1	A	a	DT
cord-352796-6einbent	126	2	recent	recent	JJ
cord-352796-6einbent	126	3	systematic	systematic	JJ
cord-352796-6einbent	126	4	review	review	NN
cord-352796-6einbent	126	5	of	of	IN
cord-352796-6einbent	126	6	clinical	clinical	JJ
cord-352796-6einbent	126	7	trials	trial	NNS
cord-352796-6einbent	126	8	utilising	utilise	VBG
cord-352796-6einbent	126	9	chloroquine	chloroquine	NN
cord-352796-6einbent	126	10	or	or	CC
cord-352796-6einbent	126	11	hydroxychloroquine	hydroxychloroquine	NN
cord-352796-6einbent	126	12	(	(	-LRB-
cord-352796-6einbent	126	13	74	74	CD
cord-352796-6einbent	126	14	)	)	-RRB-
cord-352796-6einbent	126	15	concluded	conclude	VBD
cord-352796-6einbent	126	16	that	that	IN
cord-352796-6einbent	126	17	5/7	5/7	CD
cord-352796-6einbent	126	18	trials	trial	NNS
cord-352796-6einbent	126	19	had	have	VBD
cord-352796-6einbent	126	20	shown	show	VBN
cord-352796-6einbent	126	21	favorable	favorable	JJ
cord-352796-6einbent	126	22	outcomes	outcome	NNS
cord-352796-6einbent	126	23	for	for	IN
cord-352796-6einbent	126	24	patients	patient	NNS
cord-352796-6einbent	126	25	using	use	VBG
cord-352796-6einbent	126	26	these	these	DT
cord-352796-6einbent	126	27	drugs	drug	NNS
cord-352796-6einbent	126	28	and	and	CC
cord-352796-6einbent	126	29	2/7	2/7	CD
cord-352796-6einbent	126	30	demonstrated	demonstrate	VBD
cord-352796-6einbent	126	31	no	no	DT
cord-352796-6einbent	126	32	significant	significant	JJ
cord-352796-6einbent	126	33	change	change	NN
cord-352796-6einbent	126	34	compared	compare	VBN
cord-352796-6einbent	126	35	to	to	IN
cord-352796-6einbent	126	36	control	control	NN
cord-352796-6einbent	126	37	.	.	.
cord-352796-6einbent	127	1	It	-PRON-	PRP
cord-352796-6einbent	127	2	was	be	VBD
cord-352796-6einbent	127	3	noted	note	VBN
cord-352796-6einbent	127	4	that	that	IN
cord-352796-6einbent	127	5	all	all	DT
cord-352796-6einbent	127	6	7	7	CD
cord-352796-6einbent	127	7	trials	trial	NNS
cord-352796-6einbent	127	8	carried	carry	VBD
cord-352796-6einbent	127	9	varying	vary	VBG
cord-352796-6einbent	127	10	degrees	degree	NNS
cord-352796-6einbent	127	11	of	of	IN
cord-352796-6einbent	127	12	poor	poor	JJ
cord-352796-6einbent	127	13	study	study	NN
cord-352796-6einbent	127	14	design	design	NN
cord-352796-6einbent	127	15	and	and	CC
cord-352796-6einbent	127	16	bias	bias	NN
cord-352796-6einbent	127	17	.	.	.
cord-352796-6einbent	128	1	One	one	CD
cord-352796-6einbent	128	2	such	such	JJ
cord-352796-6einbent	128	3	study	study	NN
cord-352796-6einbent	128	4	,	,	,
cord-352796-6einbent	128	5	a	a	DT
cord-352796-6einbent	128	6	pilot	pilot	NN
cord-352796-6einbent	128	7	observational	observational	JJ
cord-352796-6einbent	128	8	study	study	NN
cord-352796-6einbent	128	9	(	(	-LRB-
cord-352796-6einbent	128	10	93	93	CD
cord-352796-6einbent	128	11	)	)	-RRB-
cord-352796-6einbent	128	12	showed	show	VBD
cord-352796-6einbent	128	13	that	that	IN
cord-352796-6einbent	128	14	use	use	NN
cord-352796-6einbent	128	15	of	of	IN
cord-352796-6einbent	128	16	hydroxychloroquine	hydroxychloroquine	NN
cord-352796-6einbent	128	17	and	and	CC
cord-352796-6einbent	128	18	azithromycin	azithromycin	NNP
cord-352796-6einbent	128	19	demonstrated	demonstrate	VBD
cord-352796-6einbent	128	20	apparent	apparent	JJ
cord-352796-6einbent	128	21	improved	improved	JJ
cord-352796-6einbent	128	22	clinical	clinical	JJ
cord-352796-6einbent	128	23	outcomes	outcome	NNS
cord-352796-6einbent	128	24	in	in	IN
cord-352796-6einbent	128	25	65/80	65/80	CD
cord-352796-6einbent	128	26	patients	patient	NNS
cord-352796-6einbent	128	27	,	,	,
cord-352796-6einbent	128	28	expanding	expand	VBG
cord-352796-6einbent	128	29	earlier	early	JJR
cord-352796-6einbent	128	30	work	work	NN
cord-352796-6einbent	128	31	suggesting	suggest	VBG
cord-352796-6einbent	128	32	that	that	IN
cord-352796-6einbent	128	33	combined	combine	VBN
cord-352796-6einbent	128	34	therapy	therapy	NN
cord-352796-6einbent	128	35	resulted	result	VBD
cord-352796-6einbent	128	36	in	in	IN
cord-352796-6einbent	128	37	rapid	rapid	JJ
cord-352796-6einbent	128	38	reduction	reduction	NN
cord-352796-6einbent	128	39	in	in	IN
cord-352796-6einbent	128	40	viral	viral	JJ
cord-352796-6einbent	128	41	load	load	NN
cord-352796-6einbent	128	42	.	.	.
cord-352796-6einbent	129	1	Clearly	clearly	RB
cord-352796-6einbent	129	2	,	,	,
cord-352796-6einbent	129	3	more	more	RBR
cord-352796-6einbent	129	4	robust	robust	JJ
cord-352796-6einbent	129	5	clinical	clinical	JJ
cord-352796-6einbent	129	6	studies	study	NNS
cord-352796-6einbent	129	7	are	be	VBP
cord-352796-6einbent	129	8	needed	need	VBN
cord-352796-6einbent	129	9	and	and	CC
cord-352796-6einbent	129	10	have	have	VBP
cord-352796-6einbent	129	11	been	be	VBN
cord-352796-6einbent	129	12	called	call	VBN
cord-352796-6einbent	129	13	for	for	IN
cord-352796-6einbent	129	14	(	(	-LRB-
cord-352796-6einbent	129	15	74	74	CD
cord-352796-6einbent	129	16	)	)	-RRB-
cord-352796-6einbent	129	17	.	.	.
cord-352796-6einbent	130	1	While	while	IN
cord-352796-6einbent	130	2	systemic	systemic	JJ
cord-352796-6einbent	130	3	chloroquine	chloroquine	NN
cord-352796-6einbent	130	4	and	and	CC
cord-352796-6einbent	130	5	its	-PRON-	PRP$
cord-352796-6einbent	130	6	derivatives	derivative	NNS
cord-352796-6einbent	130	7	appear	appear	VBP
cord-352796-6einbent	130	8	to	to	TO
cord-352796-6einbent	130	9	be	be	VB
cord-352796-6einbent	130	10	associated	associate	VBN
cord-352796-6einbent	130	11	with	with	IN
cord-352796-6einbent	130	12	relatively	relatively	RB
cord-352796-6einbent	130	13	minor	minor	JJ
cord-352796-6einbent	130	14	side	side	NN
cord-352796-6einbent	130	15	effects	effect	NNS
cord-352796-6einbent	130	16	in	in	IN
cord-352796-6einbent	130	17	the	the	DT
cord-352796-6einbent	130	18	shorter	short	JJR
cord-352796-6einbent	130	19	term	term	NN
cord-352796-6einbent	130	20	,	,	,
cord-352796-6einbent	130	21	electrocardiogram	electrocardiogram	VB
cord-352796-6einbent	130	22	QT	qt	NN
cord-352796-6einbent	130	23	interval	interval	NN
cord-352796-6einbent	130	24	prolongation	prolongation	NN
cord-352796-6einbent	130	25	has	have	VBZ
cord-352796-6einbent	130	26	been	be	VBN
cord-352796-6einbent	130	27	reported	report	VBN
cord-352796-6einbent	130	28	(	(	-LRB-
cord-352796-6einbent	130	29	94	94	CD
cord-352796-6einbent	130	30	)	)	-RRB-
cord-352796-6einbent	130	31	and	and	CC
cord-352796-6einbent	130	32	this	this	DT
cord-352796-6einbent	130	33	may	may	MD
cord-352796-6einbent	130	34	be	be	VB
cord-352796-6einbent	130	35	exacerbated	exacerbate	VBN
cord-352796-6einbent	130	36	by	by	IN
cord-352796-6einbent	130	37	combination	combination	NN
cord-352796-6einbent	130	38	treatemtn	treatemtn	NNP
cord-352796-6einbent	130	39	with	with	IN
cord-352796-6einbent	130	40	azithromycin	azithromycin	NNP
cord-352796-6einbent	130	41	(	(	-LRB-
cord-352796-6einbent	130	42	74	74	CD
cord-352796-6einbent	130	43	)	)	-RRB-
cord-352796-6einbent	130	44	.	.	.
cord-352796-6einbent	131	1	The	the	DT
cord-352796-6einbent	131	2	well	well	RB
cord-352796-6einbent	131	3	-	-	HYPH
cord-352796-6einbent	131	4	known	know	VBN
cord-352796-6einbent	131	5	association	association	NN
cord-352796-6einbent	131	6	with	with	IN
cord-352796-6einbent	131	7	irreversible	irreversible	JJ
cord-352796-6einbent	131	8	visual	visual	JJ
cord-352796-6einbent	131	9	loss	loss	NN
cord-352796-6einbent	131	10	due	due	IN
cord-352796-6einbent	131	11	to	to	IN
cord-352796-6einbent	131	12	retinal	retinal	JJ
cord-352796-6einbent	131	13	toxicity	toxicity	NN
cord-352796-6einbent	131	14	is	be	VBZ
cord-352796-6einbent	131	15	considered	consider	VBN
cord-352796-6einbent	131	16	a	a	DT
cord-352796-6einbent	131	17	late	late	JJ
cord-352796-6einbent	131	18	manifestation	manifestation	NN
cord-352796-6einbent	131	19	(	(	-LRB-
cord-352796-6einbent	131	20	95	95	CD
cord-352796-6einbent	131	21	)	)	-RRB-
cord-352796-6einbent	131	22	,	,	.
cord-352796-6einbent	132	1	however	however	RB
cord-352796-6einbent	132	2	early	early	JJ
cord-352796-6einbent	132	3	-	-	HYPH
cord-352796-6einbent	132	4	onset	onset	NN
cord-352796-6einbent	132	5	(	(	-LRB-
cord-352796-6einbent	132	6	~	~	NFP
cord-352796-6einbent	132	7	2	2	CD
cord-352796-6einbent	132	8	months	month	NNS
cord-352796-6einbent	132	9	)	)	-RRB-
cord-352796-6einbent	132	10	has	have	VBZ
cord-352796-6einbent	132	11	been	be	VBN
cord-352796-6einbent	132	12	reported	report	VBN
cord-352796-6einbent	132	13	in	in	IN
cord-352796-6einbent	132	14	a	a	DT
cord-352796-6einbent	132	15	case	case	NN
cord-352796-6einbent	132	16	where	where	WRB
cord-352796-6einbent	132	17	the	the	DT
cord-352796-6einbent	132	18	ideal	ideal	JJ
cord-352796-6einbent	132	19	dosage	dosage	NN
cord-352796-6einbent	132	20	was	be	VBD
cord-352796-6einbent	132	21	exceeded	exceed	VBN
cord-352796-6einbent	132	22	for	for	IN
cord-352796-6einbent	132	23	one	one	CD
cord-352796-6einbent	132	24	month	month	NN
cord-352796-6einbent	132	25	(	(	-LRB-
cord-352796-6einbent	132	26	96	96	CD
cord-352796-6einbent	132	27	)	)	-RRB-
cord-352796-6einbent	132	28	.	.	.
cord-352796-6einbent	133	1	A	a	DT
cord-352796-6einbent	133	2	number	number	NN
cord-352796-6einbent	133	3	of	of	IN
cord-352796-6einbent	133	4	predisposing	predispose	VBG
cord-352796-6einbent	133	5	factors	factor	NNS
cord-352796-6einbent	133	6	to	to	IN
cord-352796-6einbent	133	7	retinal	retinal	JJ
cord-352796-6einbent	133	8	toxicity	toxicity	NN
cord-352796-6einbent	133	9	include	include	VBP
cord-352796-6einbent	133	10	genetic	genetic	JJ
cord-352796-6einbent	133	11	(	(	-LRB-
cord-352796-6einbent	133	12	97	97	CD
cord-352796-6einbent	133	13	)	)	-RRB-
cord-352796-6einbent	134	1	-polymorphisms	-polymorphism	NNS
cord-352796-6einbent	134	2	in	in	IN
cord-352796-6einbent	134	3	the	the	DT
cord-352796-6einbent	134	4	cytochrome	cytochrome	NN
cord-352796-6einbent	134	5	P450	p450	JJ
cord-352796-6einbent	134	6	gene	gene	NN
cord-352796-6einbent	134	7	,	,	,
cord-352796-6einbent	134	8	drug	drug	NN
cord-352796-6einbent	134	9	interactions	interaction	NNS
cord-352796-6einbent	134	10	(	(	-LRB-
cord-352796-6einbent	134	11	98	98	CD
cord-352796-6einbent	134	12	)	)	-RRB-
cord-352796-6einbent	135	1	and	and	CC
cord-352796-6einbent	135	2	racial	racial	JJ
cord-352796-6einbent	135	3	factors	factor	NNS
cord-352796-6einbent	135	4	(	(	-LRB-
cord-352796-6einbent	135	5	99	99	CD
cord-352796-6einbent	135	6	)	)	-RRB-
cord-352796-6einbent	135	7	)	)	-RRB-
cord-352796-6einbent	135	8	,	,	,
cord-352796-6einbent	135	9	may	may	MD
cord-352796-6einbent	135	10	play	play	VB
cord-352796-6einbent	135	11	a	a	DT
cord-352796-6einbent	135	12	role	role	NN
cord-352796-6einbent	135	13	.	.	.
cord-352796-6einbent	136	1	Chloroquine	Chloroquine	NNP
cord-352796-6einbent	136	2	's	's	POS
cord-352796-6einbent	136	3	anticancer	anticancer	JJ
cord-352796-6einbent	136	4	activity	activity	NN
cord-352796-6einbent	136	5	in	in	IN
cord-352796-6einbent	136	6	concert	concert	NN
cord-352796-6einbent	136	7	with	with	IN
cord-352796-6einbent	136	8	zinc	zinc	NN
cord-352796-6einbent	136	9	have	have	VBP
cord-352796-6einbent	136	10	been	be	VBN
cord-352796-6einbent	136	11	explained	explain	VBN
cord-352796-6einbent	136	12	by	by	IN
cord-352796-6einbent	136	13	the	the	DT
cord-352796-6einbent	136	14	fact	fact	NN
cord-352796-6einbent	136	15	that	that	IN
cord-352796-6einbent	136	16	chloroquine	chloroquine	NN
cord-352796-6einbent	136	17	acts	act	VBZ
cord-352796-6einbent	136	18	as	as	IN
cord-352796-6einbent	136	19	a	a	DT
cord-352796-6einbent	136	20	zinc	zinc	NN
cord-352796-6einbent	136	21	ionophore	ionophore	NN
cord-352796-6einbent	136	22	(	(	-LRB-
cord-352796-6einbent	136	23	100	100	CD
cord-352796-6einbent	136	24	)	)	-RRB-
cord-352796-6einbent	136	25	,	,	,
cord-352796-6einbent	136	26	significantly	significantly	RB
cord-352796-6einbent	136	27	,	,	,
cord-352796-6einbent	136	28	inhibiting	inhibit	VBG
cord-352796-6einbent	136	29	cellular	cellular	JJ
cord-352796-6einbent	136	30	autophagy	autophagy	NN
cord-352796-6einbent	136	31	and	and	CC
cord-352796-6einbent	136	32	enhancing	enhance	VBG
cord-352796-6einbent	136	33	apoptotic	apoptotic	JJ
cord-352796-6einbent	136	34	cell	cell	NN
cord-352796-6einbent	136	35	death	death	NN
cord-352796-6einbent	136	36	via	via	IN
cord-352796-6einbent	136	37	inhibition	inhibition	NN
cord-352796-6einbent	136	38	of	of	IN
cord-352796-6einbent	136	39	lysosome	lysosome	NN
cord-352796-6einbent	136	40	function	function	NN
cord-352796-6einbent	136	41	.	.	.
cord-352796-6einbent	137	1	It	-PRON-	PRP
cord-352796-6einbent	137	2	transpires	transpire	VBZ
cord-352796-6einbent	137	3	that	that	IN
cord-352796-6einbent	137	4	zinc	zinc	NN
cord-352796-6einbent	137	5	inhibits	inhibit	VBZ
cord-352796-6einbent	137	6	coronavirus	coronavirus	NN
cord-352796-6einbent	137	7	polymerase	polymerase	NN
cord-352796-6einbent	137	8	activity	activity	NN
cord-352796-6einbent	137	9	(	(	-LRB-
cord-352796-6einbent	137	10	101	101	CD
cord-352796-6einbent	137	11	)	)	-RRB-
cord-352796-6einbent	137	12	,	,	,
cord-352796-6einbent	137	13	blocking	block	VBG
cord-352796-6einbent	137	14	viral	viral	JJ
cord-352796-6einbent	137	15	replication	replication	NN
cord-352796-6einbent	137	16	.	.	.
cord-352796-6einbent	138	1	For	for	IN
cord-352796-6einbent	138	2	this	this	DT
cord-352796-6einbent	138	3	reason	reason	NN
cord-352796-6einbent	138	4	,	,	,
cord-352796-6einbent	138	5	combination	combination	NN
cord-352796-6einbent	138	6	treatment	treatment	NN
cord-352796-6einbent	138	7	for	for	IN
cord-352796-6einbent	138	8	Covid-19	Covid-19	NNP
cord-352796-6einbent	138	9	with	with	IN
cord-352796-6einbent	138	10	chloroquine	chloroquine	NN
cord-352796-6einbent	138	11	and	and	CC
cord-352796-6einbent	138	12	zinc	zinc	NN
cord-352796-6einbent	138	13	has	have	VBZ
cord-352796-6einbent	138	14	been	be	VBN
cord-352796-6einbent	138	15	suggested	suggest	VBN
cord-352796-6einbent	138	16	(	(	-LRB-
cord-352796-6einbent	138	17	102	102	CD
cord-352796-6einbent	138	18	)	)	-RRB-
cord-352796-6einbent	138	19	,	,	,
cord-352796-6einbent	138	20	although	although	IN
cord-352796-6einbent	138	21	this	this	DT
cord-352796-6einbent	138	22	intervention	intervention	NN
cord-352796-6einbent	138	23	has	have	VBZ
cord-352796-6einbent	138	24	yet	yet	RB
cord-352796-6einbent	138	25	to	to	TO
cord-352796-6einbent	138	26	be	be	VB
cord-352796-6einbent	138	27	formally	formally	RB
cord-352796-6einbent	138	28	reported	report	VBN
cord-352796-6einbent	138	29	.	.	.
cord-352796-6einbent	139	1	It	-PRON-	PRP
cord-352796-6einbent	139	2	is	be	VBZ
cord-352796-6einbent	139	3	perhaps	perhaps	RB
cord-352796-6einbent	139	4	unsurprising	unsurprising	JJ
cord-352796-6einbent	139	5	,	,	,
cord-352796-6einbent	139	6	given	give	VBN
cord-352796-6einbent	139	7	the	the	DT
cord-352796-6einbent	139	8	passage	passage	NN
cord-352796-6einbent	139	9	of	of	IN
cord-352796-6einbent	139	10	time	time	NN
cord-352796-6einbent	139	11	,	,	,
cord-352796-6einbent	139	12	that	that	IN
cord-352796-6einbent	139	13	an	an	DT
cord-352796-6einbent	139	14	understanding	understanding	NN
cord-352796-6einbent	139	15	of	of	IN
cord-352796-6einbent	139	16	viral	viral	JJ
cord-352796-6einbent	139	17	oculotropism	oculotropism	NN
cord-352796-6einbent	139	18	from	from	IN
cord-352796-6einbent	139	19	the	the	DT
cord-352796-6einbent	139	20	1918	1918	CD
cord-352796-6einbent	139	21	influenza	influenza	NN
cord-352796-6einbent	139	22	epidemic	epidemic	NN
cord-352796-6einbent	139	23	has	have	VBZ
cord-352796-6einbent	139	24	faded	fade	VBN
cord-352796-6einbent	139	25	.	.	.
cord-352796-6einbent	140	1	Yet	yet	CC
cord-352796-6einbent	140	2	if	if	IN
cord-352796-6einbent	140	3	SARS	SARS	NNP
cord-352796-6einbent	140	4	-	-	HYPH
cord-352796-6einbent	140	5	CoV-2	CoV-2	NNP
cord-352796-6einbent	140	6	oculotropism	oculotropism	NN
cord-352796-6einbent	140	7	is	be	VBZ
cord-352796-6einbent	140	8	confirmed	confirm	VBN
cord-352796-6einbent	140	9	,	,	,
cord-352796-6einbent	140	10	this	this	DT
cord-352796-6einbent	140	11	invasion	invasion	NN
cord-352796-6einbent	140	12	entry	entry	NN
cord-352796-6einbent	140	13	point	point	NN
cord-352796-6einbent	140	14	also	also	RB
cord-352796-6einbent	140	15	represents	represent	VBZ
cord-352796-6einbent	140	16	an	an	DT
cord-352796-6einbent	140	17	opportunity	opportunity	NN
cord-352796-6einbent	140	18	for	for	IN
cord-352796-6einbent	140	19	intervention	intervention	NN
cord-352796-6einbent	140	20	.	.	.
cord-352796-6einbent	141	1	Given	give	VBN
cord-352796-6einbent	141	2	the	the	DT
cord-352796-6einbent	141	3	potential	potential	JJ
cord-352796-6einbent	141	4	toxicity	toxicity	NN
cord-352796-6einbent	141	5	of	of	IN
cord-352796-6einbent	141	6	apparently	apparently	RB
cord-352796-6einbent	141	7	efficacious	efficacious	JJ
cord-352796-6einbent	141	8	drugs	drug	NNS
cord-352796-6einbent	141	9	and	and	CC
cord-352796-6einbent	141	10	issues	issue	NNS
cord-352796-6einbent	141	11	relating	relate	VBG
cord-352796-6einbent	141	12	to	to	IN
cord-352796-6einbent	141	13	drug	drug	NN
cord-352796-6einbent	141	14	bioavailability	bioavailability	NN
cord-352796-6einbent	141	15	,	,	,
cord-352796-6einbent	141	16	initially	initially	RB
cord-352796-6einbent	141	17	in	in	IN
cord-352796-6einbent	141	18	the	the	DT
cord-352796-6einbent	141	19	upper	upper	JJ
cord-352796-6einbent	141	20	airways	airway	NNS
cord-352796-6einbent	141	21	and	and	CC
cord-352796-6einbent	141	22	respiratory	respiratory	JJ
cord-352796-6einbent	141	23	system	system	NN
cord-352796-6einbent	141	24	,	,	,
cord-352796-6einbent	141	25	local	local	JJ
cord-352796-6einbent	141	26	,	,	,
cord-352796-6einbent	141	27	topical	topical	JJ
cord-352796-6einbent	141	28	therapy	therapy	NN
cord-352796-6einbent	141	29	offers	offer	VBZ
cord-352796-6einbent	141	30	potential	potential	JJ
cord-352796-6einbent	141	31	significant	significant	JJ
cord-352796-6einbent	141	32	advantages	advantage	NNS
cord-352796-6einbent	141	33	.	.	.
cord-352796-6einbent	142	1	Many	many	JJ
cord-352796-6einbent	142	2	of	of	IN
cord-352796-6einbent	142	3	the	the	DT
cord-352796-6einbent	142	4	proposed	propose	VBN
cord-352796-6einbent	142	5	systemic	systemic	JJ
cord-352796-6einbent	142	6	therapies	therapy	NNS
cord-352796-6einbent	142	7	such	such	JJ
cord-352796-6einbent	142	8	as	as	IN
cord-352796-6einbent	142	9	chloroquine	chloroquine	NN
cord-352796-6einbent	142	10	,	,	,
cord-352796-6einbent	142	11	zinc	zinc	NN
cord-352796-6einbent	142	12	and	and	CC
cord-352796-6einbent	142	13	ACE	ace	NN
cord-352796-6einbent	142	14	inhibitors	inhibitor	NNS
cord-352796-6einbent	142	15	have	have	VBP
cord-352796-6einbent	142	16	all	all	DT
cord-352796-6einbent	142	17	been	be	VBN
cord-352796-6einbent	142	18	used	use	VBN
cord-352796-6einbent	142	19	topically	topically	RB
cord-352796-6einbent	142	20	in	in	IN
cord-352796-6einbent	142	21	the	the	DT
cord-352796-6einbent	142	22	eye	eye	NN
cord-352796-6einbent	142	23	(	(	-LRB-
cord-352796-6einbent	142	24	Table	Table	NNP
cord-352796-6einbent	142	25	2	2	CD
cord-352796-6einbent	142	26	)	)	-RRB-
cord-352796-6einbent	142	27	.	.	.
cord-352796-6einbent	143	1	Chloroquine	Chloroquine	NNP
cord-352796-6einbent	143	2	as	as	IN
cord-352796-6einbent	143	3	0.03	0.03	CD
cord-352796-6einbent	143	4	%	%	NN
cord-352796-6einbent	143	5	chloroquine	chloroquine	NN
cord-352796-6einbent	143	6	phosphate	phosphate	NN
cord-352796-6einbent	143	7	eye	eye	NN
cord-352796-6einbent	143	8	drops	drop	NNS
cord-352796-6einbent	143	9	have	have	VBP
cord-352796-6einbent	143	10	apparently	apparently	RB
cord-352796-6einbent	143	11	been	be	VBN
cord-352796-6einbent	143	12	efficacious	efficacious	JJ
cord-352796-6einbent	143	13	in	in	IN
cord-352796-6einbent	143	14	the	the	DT
cord-352796-6einbent	143	15	management	management	NN
cord-352796-6einbent	143	16	of	of	IN
cord-352796-6einbent	143	17	dry	dry	JJ
cord-352796-6einbent	143	18	eye	eye	NN
cord-352796-6einbent	143	19	syndrome	syndrome	NN
cord-352796-6einbent	143	20	in	in	IN
cord-352796-6einbent	143	21	humans	human	NNS
cord-352796-6einbent	143	22	(	(	-LRB-
cord-352796-6einbent	143	23	75	75	CD
cord-352796-6einbent	143	24	,	,	,
cord-352796-6einbent	143	25	76	76	CD
cord-352796-6einbent	143	26	)	)	-RRB-
cord-352796-6einbent	143	27	.	.	.
cord-352796-6einbent	144	1	Significant	significant	JJ
cord-352796-6einbent	144	2	side	side	NN
cord-352796-6einbent	144	3	effects	effect	NNS
cord-352796-6einbent	144	4	were	be	VBD
cord-352796-6einbent	144	5	not	not	RB
cord-352796-6einbent	144	6	reported	report	VBN
cord-352796-6einbent	144	7	,	,	,
cord-352796-6einbent	144	8	however	however	WRB
cord-352796-6einbent	144	9	there	there	EX
cord-352796-6einbent	144	10	is	be	VBZ
cord-352796-6einbent	144	11	a	a	DT
cord-352796-6einbent	144	12	report	report	NN
cord-352796-6einbent	144	13	of	of	IN
cord-352796-6einbent	144	14	chloroquine	chloroquine	NNP
cord-352796-6einbent	144	15	keratopathy	keratopathy	NNP
cord-352796-6einbent	144	16	in	in	IN
cord-352796-6einbent	144	17	workers	worker	NNS
cord-352796-6einbent	144	18	chronically	chronically	RB
cord-352796-6einbent	144	19	exposed	expose	VBN
cord-352796-6einbent	144	20	to	to	IN
cord-352796-6einbent	144	21	chloroquine	chloroquine	NN
cord-352796-6einbent	144	22	dust	dust	NN
cord-352796-6einbent	144	23	(	(	-LRB-
cord-352796-6einbent	144	24	103	103	CD
cord-352796-6einbent	144	25	)	)	-RRB-
cord-352796-6einbent	144	26	.	.	.
cord-352796-6einbent	145	1	Chronic	chronic	JJ
cord-352796-6einbent	145	2	usage	usage	NN
cord-352796-6einbent	145	3	is	be	VBZ
cord-352796-6einbent	145	4	unlikely	unlikely	JJ
cord-352796-6einbent	145	5	in	in	IN
cord-352796-6einbent	145	6	the	the	DT
cord-352796-6einbent	145	7	setting	setting	NN
cord-352796-6einbent	145	8	here	here	RB
cord-352796-6einbent	145	9	proposed	propose	VBD
cord-352796-6einbent	145	10	.	.	.
cord-352796-6einbent	146	1	ACE	ACE	NNP
cord-352796-6einbent	146	2	inhibitors	inhibitor	NNS
cord-352796-6einbent	146	3	have	have	VBP
cord-352796-6einbent	146	4	been	be	VBN
cord-352796-6einbent	146	5	used	use	VBN
cord-352796-6einbent	146	6	topically	topically	RB
cord-352796-6einbent	146	7	in	in	IN
cord-352796-6einbent	146	8	animal	animal	NN
cord-352796-6einbent	146	9	models	model	NNS
cord-352796-6einbent	146	10	of	of	IN
cord-352796-6einbent	146	11	glaucoma	glaucoma	NN
cord-352796-6einbent	146	12	(	(	-LRB-
cord-352796-6einbent	146	13	104	104	CD
cord-352796-6einbent	146	14	)	)	-RRB-
cord-352796-6einbent	146	15	.	.	.
cord-352796-6einbent	147	1	In	in	IN
cord-352796-6einbent	147	2	this	this	DT
cord-352796-6einbent	147	3	class	class	NN
cord-352796-6einbent	147	4	of	of	IN
cord-352796-6einbent	147	5	drugs	drug	NNS
cord-352796-6einbent	147	6	,	,	,
cord-352796-6einbent	147	7	agents	agent	NNS
cord-352796-6einbent	147	8	such	such	JJ
cord-352796-6einbent	147	9	as	as	IN
cord-352796-6einbent	147	10	telmisartan	telmisartan	NNP
cord-352796-6einbent	147	11	are	be	VBP
cord-352796-6einbent	147	12	long	long	RB
cord-352796-6einbent	147	13	acting	act	VBG
cord-352796-6einbent	147	14	,	,	,
cord-352796-6einbent	147	15	with	with	IN
cord-352796-6einbent	147	16	a	a	DT
cord-352796-6einbent	147	17	mean	mean	JJ
cord-352796-6einbent	147	18	half	half	JJ
cord-352796-6einbent	147	19	-	-	HYPH
cord-352796-6einbent	147	20	life	life	NN
cord-352796-6einbent	147	21	of	of	IN
cord-352796-6einbent	147	22	24	24	CD
cord-352796-6einbent	147	23	hours	hour	NNS
cord-352796-6einbent	147	24	(	(	-LRB-
cord-352796-6einbent	147	25	105	105	CD
cord-352796-6einbent	147	26	)	)	-RRB-
cord-352796-6einbent	147	27	.	.	.
cord-352796-6einbent	148	1	Zinc	zinc	NN
cord-352796-6einbent	148	2	has	have	VBZ
cord-352796-6einbent	148	3	traditionally	traditionally	RB
cord-352796-6einbent	148	4	been	be	VBN
cord-352796-6einbent	148	5	used	use	VBN
cord-352796-6einbent	148	6	in	in	IN
cord-352796-6einbent	148	7	astringent	astringent	JJ
cord-352796-6einbent	148	8	eye	eye	NN
cord-352796-6einbent	148	9	drops	drop	NNS
cord-352796-6einbent	148	10	or	or	CC
cord-352796-6einbent	148	11	as	as	IN
cord-352796-6einbent	148	12	an	an	DT
cord-352796-6einbent	148	13	excipient	excipient	NN
cord-352796-6einbent	148	14	,	,	,
cord-352796-6einbent	148	15	zinc	zinc	NN
cord-352796-6einbent	148	16	sulphate	sulphate	NN
cord-352796-6einbent	148	17	(	(	-LRB-
cord-352796-6einbent	148	18	0.25	0.25	CD
cord-352796-6einbent	148	19	%	%	NN
cord-352796-6einbent	148	20	)	)	-RRB-
cord-352796-6einbent	148	21	(	(	-LRB-
cord-352796-6einbent	148	22	83	83	CD
cord-352796-6einbent	148	23	)	)	-RRB-
cord-352796-6einbent	148	24	.	.	.
cord-352796-6einbent	149	1	Since	since	IN
cord-352796-6einbent	149	2	chloroquine	chloroquine	NN
cord-352796-6einbent	149	3	and	and	CC
cord-352796-6einbent	149	4	ACE2	ACE2	NNP
cord-352796-6einbent	149	5	inhibitors	inhibitor	NNS
cord-352796-6einbent	149	6	seem	seem	VBP
cord-352796-6einbent	149	7	to	to	TO
cord-352796-6einbent	149	8	act	act	VB
cord-352796-6einbent	149	9	at	at	IN
cord-352796-6einbent	149	10	different	different	JJ
cord-352796-6einbent	149	11	parts	part	NNS
cord-352796-6einbent	149	12	of	of	IN
cord-352796-6einbent	149	13	the	the	DT
cord-352796-6einbent	149	14	receptor	receptor	NN
cord-352796-6einbent	149	15	,	,	,
cord-352796-6einbent	149	16	in	in	IN
cord-352796-6einbent	149	17	combination	combination	NN
cord-352796-6einbent	149	18	,	,	,
cord-352796-6einbent	149	19	synergy	synergy	NN
cord-352796-6einbent	149	20	is	be	VBZ
cord-352796-6einbent	149	21	possible	possible	JJ
cord-352796-6einbent	149	22	or	or	CC
cord-352796-6einbent	149	23	at	at	IN
cord-352796-6einbent	149	24	the	the	DT
cord-352796-6einbent	149	25	very	very	RB
cord-352796-6einbent	149	26	least	least	JJS
cord-352796-6einbent	149	27	an	an	DT
cord-352796-6einbent	149	28	additive	additive	NN
cord-352796-6einbent	149	29	effect	effect	NN
cord-352796-6einbent	149	30	,	,	,
cord-352796-6einbent	149	31	permitting	permit	VBG
cord-352796-6einbent	149	32	a	a	DT
cord-352796-6einbent	149	33	reduction	reduction	NN
cord-352796-6einbent	149	34	in	in	IN
cord-352796-6einbent	149	35	dosage	dosage	NN
cord-352796-6einbent	149	36	and	and	CC
cord-352796-6einbent	149	37	risk	risk	NN
cord-352796-6einbent	149	38	of	of	IN
cord-352796-6einbent	149	39	potential	potential	JJ
cord-352796-6einbent	149	40	side	side	NN
cord-352796-6einbent	149	41	effects	effect	NNS
cord-352796-6einbent	149	42	.	.	.
cord-352796-6einbent	150	1	However	however	RB
cord-352796-6einbent	150	2	,	,	,
cord-352796-6einbent	150	3	another	another	DT
cord-352796-6einbent	150	4	issue	issue	NN
cord-352796-6einbent	150	5	is	be	VBZ
cord-352796-6einbent	150	6	that	that	IN
cord-352796-6einbent	150	7	ACE2	ACE2	NNP
cord-352796-6einbent	150	8	inhibitors	inhibitor	NNS
cord-352796-6einbent	150	9	may	may	MD
cord-352796-6einbent	150	10	upregulate	upregulate	VB
cord-352796-6einbent	150	11	this	this	DT
cord-352796-6einbent	150	12	receptor	receptor	NN
cord-352796-6einbent	150	13	(	(	-LRB-
cord-352796-6einbent	150	14	106	106	CD
cord-352796-6einbent	150	15	)	)	-RRB-
cord-352796-6einbent	150	16	,	,	,
cord-352796-6einbent	150	17	perhaps	perhaps	RB
cord-352796-6einbent	150	18	increasing	increase	VBG
cord-352796-6einbent	150	19	the	the	DT
cord-352796-6einbent	150	20	risk	risk	NN
cord-352796-6einbent	150	21	of	of	IN
cord-352796-6einbent	150	22	coronavirus	coronavirus	NN
cord-352796-6einbent	150	23	infection	infection	NN
cord-352796-6einbent	150	24	.	.	.
cord-352796-6einbent	151	1	Early	early	JJ
cord-352796-6einbent	151	2	reports	report	NNS
cord-352796-6einbent	151	3	have	have	VBP
cord-352796-6einbent	151	4	suggested	suggest	VBN
cord-352796-6einbent	151	5	that	that	IN
cord-352796-6einbent	151	6	hypertension	hypertension	NN
cord-352796-6einbent	151	7	may	may	MD
cord-352796-6einbent	151	8	be	be	VB
cord-352796-6einbent	151	9	a	a	DT
cord-352796-6einbent	151	10	risk	risk	NN
cord-352796-6einbent	151	11	factor	factor	NN
cord-352796-6einbent	151	12	for	for	IN
cord-352796-6einbent	151	13	infection	infection	NN
cord-352796-6einbent	151	14	but	but	CC
cord-352796-6einbent	151	15	these	these	DT
cord-352796-6einbent	151	16	are	be	VBP
cord-352796-6einbent	151	17	unconfirmed	unconfirmed	JJ
cord-352796-6einbent	151	18	(	(	-LRB-
cord-352796-6einbent	151	19	107	107	CD
cord-352796-6einbent	151	20	)	)	-RRB-
cord-352796-6einbent	151	21	.	.	.
cord-352796-6einbent	152	1	Azithromycin	Azithromycin	NNP
cord-352796-6einbent	152	2	has	have	VBZ
cord-352796-6einbent	152	3	also	also	RB
cord-352796-6einbent	152	4	previously	previously	RB
cord-352796-6einbent	152	5	been	be	VBN
cord-352796-6einbent	152	6	safely	safely	RB
cord-352796-6einbent	152	7	used	use	VBN
cord-352796-6einbent	152	8	topically	topically	RB
cord-352796-6einbent	152	9	in	in	IN
cord-352796-6einbent	152	10	the	the	DT
cord-352796-6einbent	152	11	human	human	JJ
cord-352796-6einbent	152	12	eye	eye	NN
cord-352796-6einbent	152	13	as	as	IN
cord-352796-6einbent	152	14	a	a	DT
cord-352796-6einbent	152	15	1	1	CD
cord-352796-6einbent	152	16	-	-	SYM
cord-352796-6einbent	152	17	1.5	1.5	CD
cord-352796-6einbent	152	18	%	%	NN
cord-352796-6einbent	152	19	solution	solution	NN
cord-352796-6einbent	152	20	to	to	TO
cord-352796-6einbent	152	21	treat	treat	VB
cord-352796-6einbent	152	22	ocular	ocular	JJ
cord-352796-6einbent	152	23	infections	infection	NNS
cord-352796-6einbent	152	24	(	(	-LRB-
cord-352796-6einbent	152	25	78	78	CD
cord-352796-6einbent	152	26	,	,	,
cord-352796-6einbent	152	27	79	79	CD
cord-352796-6einbent	152	28	)	)	-RRB-
cord-352796-6einbent	152	29	.	.	.
cord-352796-6einbent	153	1	In	in	IN
cord-352796-6einbent	153	2	the	the	DT
cord-352796-6einbent	153	3	case	case	NN
cord-352796-6einbent	153	4	of	of	IN
cord-352796-6einbent	153	5	hydroxychloroquine	hydroxychloroquine	NNP
cord-352796-6einbent	153	6	,	,	,
cord-352796-6einbent	153	7	preliminary	preliminary	JJ
cord-352796-6einbent	153	8	calculations	calculation	NNS
cord-352796-6einbent	153	9	suggest	suggest	VBP
cord-352796-6einbent	153	10	that	that	IN
cord-352796-6einbent	153	11	with	with	IN
cord-352796-6einbent	153	12	topical	topical	JJ
cord-352796-6einbent	153	13	application	application	NN
cord-352796-6einbent	153	14	,	,	,
cord-352796-6einbent	153	15	a	a	DT
cord-352796-6einbent	153	16	dosage	dosage	NN
cord-352796-6einbent	153	17	one	one	CD
cord-352796-6einbent	153	18	to	to	IN
cord-352796-6einbent	153	19	two	two	CD
cord-352796-6einbent	153	20	orders	order	NNS
cord-352796-6einbent	153	21	of	of	IN
cord-352796-6einbent	153	22	magnitude	magnitude	NN
cord-352796-6einbent	153	23	higher	high	JJR
cord-352796-6einbent	153	24	than	than	IN
cord-352796-6einbent	153	25	plasma	plasma	NN
cord-352796-6einbent	153	26	levels	level	NNS
cord-352796-6einbent	153	27	(	(	-LRB-
cord-352796-6einbent	153	28	reached	reach	VBN
cord-352796-6einbent	153	29	with	with	IN
cord-352796-6einbent	153	30	systemic	systemic	JJ
cord-352796-6einbent	153	31	treatment	treatment	NN
cord-352796-6einbent	153	32	(	(	-LRB-
cord-352796-6einbent	153	33	108	108	CD
cord-352796-6einbent	153	34	)	)	-RRB-
cord-352796-6einbent	153	35	)	)	-RRB-
cord-352796-6einbent	153	36	could	could	MD
cord-352796-6einbent	153	37	be	be	VB
cord-352796-6einbent	153	38	achieved	achieve	VBN
cord-352796-6einbent	153	39	.	.	.
cord-352796-6einbent	154	1	At	at	IN
cord-352796-6einbent	154	2	this	this	DT
cord-352796-6einbent	154	3	point	point	NN
cord-352796-6einbent	154	4	,	,	,
cord-352796-6einbent	154	5	clinical	clinical	JJ
cord-352796-6einbent	154	6	studies	study	NNS
cord-352796-6einbent	154	7	are	be	VBP
cord-352796-6einbent	154	8	needed	need	VBN
cord-352796-6einbent	154	9	expeditiously	expeditiously	RB
cord-352796-6einbent	154	10	to	to	TO
cord-352796-6einbent	154	11	investigate	investigate	VB
cord-352796-6einbent	154	12	the	the	DT
cord-352796-6einbent	154	13	safety	safety	NN
cord-352796-6einbent	154	14	and	and	CC
cord-352796-6einbent	154	15	efficacy	efficacy	NN
cord-352796-6einbent	154	16	of	of	IN
cord-352796-6einbent	154	17	local	local	JJ
cord-352796-6einbent	154	18	prophylactic	prophylactic	JJ
cord-352796-6einbent	154	19	regimens	regimen	NNS
cord-352796-6einbent	154	20	following	follow	VBG
cord-352796-6einbent	154	21	exposure	exposure	NN
cord-352796-6einbent	154	22	to	to	IN
cord-352796-6einbent	154	23	SARS	SARS	NNP
cord-352796-6einbent	154	24	-	-	HYPH
cord-352796-6einbent	154	25	CoV-2	CoV-2	NNP
cord-352796-6einbent	154	26	.	.	.
cord-352796-6einbent	155	1	For	for	IN
cord-352796-6einbent	155	2	instance	instance	NN
cord-352796-6einbent	155	3	,	,	,
cord-352796-6einbent	155	4	investigations	investigation	NNS
cord-352796-6einbent	155	5	can	can	MD
cord-352796-6einbent	155	6	include	include	VB
cord-352796-6einbent	155	7	initial	initial	JJ
cord-352796-6einbent	155	8	local	local	JJ
cord-352796-6einbent	155	9	delivery	delivery	NN
cord-352796-6einbent	155	10	of	of	IN
cord-352796-6einbent	155	11	a	a	DT
cord-352796-6einbent	155	12	combination	combination	NN
cord-352796-6einbent	155	13	of	of	IN
cord-352796-6einbent	155	14	chloroquine	chloroquine	NN
cord-352796-6einbent	155	15	,	,	,
cord-352796-6einbent	155	16	zinc	zinc	NN
cord-352796-6einbent	155	17	and	and	CC
cord-352796-6einbent	155	18	azithromycin	azithromycin	NN
cord-352796-6einbent	155	19	to	to	IN
cord-352796-6einbent	155	20	the	the	DT
cord-352796-6einbent	155	21	eyelids	eyelid	NNS
cord-352796-6einbent	155	22	and	and	CC
cord-352796-6einbent	155	23	ocular	ocular	JJ
cord-352796-6einbent	155	24	surface	surface	NN
cord-352796-6einbent	155	25	with	with	IN
cord-352796-6einbent	155	26	eye	eye	NN
cord-352796-6einbent	155	27	drops	drop	NNS
cord-352796-6einbent	155	28	or	or	CC
cord-352796-6einbent	155	29	a	a	DT
cord-352796-6einbent	155	30	spray	spray	NN
cord-352796-6einbent	155	31	/	/	SYM
cord-352796-6einbent	155	32	aerosol	aerosol	NN
cord-352796-6einbent	155	33	.	.	.
cord-352796-6einbent	156	1	This	this	DT
cord-352796-6einbent	156	2	would	would	MD
cord-352796-6einbent	156	3	potentially	potentially	RB
cord-352796-6einbent	156	4	inhibit	inhibit	VB
cord-352796-6einbent	156	5	binding	bind	VBG
cord-352796-6einbent	156	6	of	of	IN
cord-352796-6einbent	156	7	SARS	SARS	NNP
cord-352796-6einbent	156	8	-	-	HYPH
cord-352796-6einbent	156	9	CoV-2	CoV-2	NNP
cord-352796-6einbent	156	10	to	to	IN
cord-352796-6einbent	156	11	the	the	DT
cord-352796-6einbent	156	12	likely	likely	JJ
cord-352796-6einbent	156	13	major	major	JJ
cord-352796-6einbent	156	14	entry	entry	NN
cord-352796-6einbent	156	15	point	point	NN
cord-352796-6einbent	156	16	into	into	IN
cord-352796-6einbent	156	17	the	the	DT
cord-352796-6einbent	156	18	human	human	JJ
cord-352796-6einbent	156	19	body	body	NN
cord-352796-6einbent	156	20	,	,	,
cord-352796-6einbent	156	21	would	would	MD
cord-352796-6einbent	156	22	reduce	reduce	VB
cord-352796-6einbent	156	23	the	the	DT
cord-352796-6einbent	156	24	risk	risk	NN
cord-352796-6einbent	156	25	of	of	IN
cord-352796-6einbent	156	26	systemic	systemic	JJ
cord-352796-6einbent	156	27	side	side	NN
cord-352796-6einbent	156	28	effects	effect	NNS
cord-352796-6einbent	156	29	and	and	CC
cord-352796-6einbent	156	30	conserve	conserve	VB
cord-352796-6einbent	156	31	drugs	drug	NNS
cord-352796-6einbent	156	32	that	that	WDT
cord-352796-6einbent	156	33	may	may	MD
cord-352796-6einbent	156	34	become	become	VB
cord-352796-6einbent	156	35	scarce	scarce	JJ
cord-352796-6einbent	156	36	,	,	,
cord-352796-6einbent	156	37	since	since	IN
cord-352796-6einbent	156	38	the	the	DT
cord-352796-6einbent	156	39	dosage	dosage	NN
cord-352796-6einbent	156	40	required	require	VBN
cord-352796-6einbent	156	41	would	would	MD
cord-352796-6einbent	156	42	be	be	VB
cord-352796-6einbent	156	43	much	much	RB
cord-352796-6einbent	156	44	less	less	JJR
cord-352796-6einbent	156	45	than	than	IN
cord-352796-6einbent	156	46	for	for	IN
cord-352796-6einbent	156	47	systemic	systemic	JJ
cord-352796-6einbent	156	48	treatment	treatment	NN
cord-352796-6einbent	156	49	.	.	.
cord-352796-6einbent	157	1	A	a	DT
cord-352796-6einbent	157	2	spray	spray	NN
cord-352796-6einbent	157	3	or	or	CC
cord-352796-6einbent	157	4	aerosol	aerosol	NN
cord-352796-6einbent	157	5	preparation	preparation	NN
cord-352796-6einbent	157	6	would	would	MD
cord-352796-6einbent	157	7	also	also	RB
cord-352796-6einbent	157	8	allow	allow	VB
cord-352796-6einbent	157	9	treatment	treatment	NN
cord-352796-6einbent	157	10	of	of	IN
cord-352796-6einbent	157	11	the	the	DT
cord-352796-6einbent	157	12	nasal	nasal	NN
cord-352796-6einbent	157	13	passages	passage	NNS
cord-352796-6einbent	157	14	(	(	-LRB-
cord-352796-6einbent	157	15	45	45	CD
cord-352796-6einbent	157	16	)	)	-RRB-
cord-352796-6einbent	157	17	and	and	CC
cord-352796-6einbent	157	18	mouth	mouth	NN
cord-352796-6einbent	157	19	(	(	-LRB-
cord-352796-6einbent	157	20	109	109	CD
cord-352796-6einbent	157	21	)	)	-RRB-
cord-352796-6einbent	157	22	,	,	,
cord-352796-6einbent	157	23	given	give	VBN
cord-352796-6einbent	157	24	high	high	JJ
cord-352796-6einbent	157	25	ACE2	ACE2	NNP
cord-352796-6einbent	157	26	receptor	receptor	NN
cord-352796-6einbent	157	27	populations	population	NNS
cord-352796-6einbent	157	28	in	in	IN
cord-352796-6einbent	157	29	these	these	DT
cord-352796-6einbent	157	30	locations	location	NNS
cord-352796-6einbent	157	31	.	.	.
cord-352796-6einbent	158	1	However	however	RB
cord-352796-6einbent	158	2	,	,	,
cord-352796-6einbent	158	3	if	if	IN
cord-352796-6einbent	158	4	the	the	DT
cord-352796-6einbent	158	5	virus	virus	NN
cord-352796-6einbent	158	6	is	be	VBZ
cord-352796-6einbent	158	7	truly	truly	RB
cord-352796-6einbent	158	8	oculotropic	oculotropic	JJ
cord-352796-6einbent	158	9	,	,	,
cord-352796-6einbent	158	10	this	this	DT
cord-352796-6einbent	158	11	may	may	MD
cord-352796-6einbent	158	12	be	be	VB
cord-352796-6einbent	158	13	superfluous	superfluous	JJ
cord-352796-6einbent	158	14	.	.	.
cord-352796-6einbent	159	1	If	if	IN
cord-352796-6einbent	159	2	a	a	DT
cord-352796-6einbent	159	3	patient	patient	NN
cord-352796-6einbent	159	4	has	have	VBZ
cord-352796-6einbent	159	5	active	active	JJ
cord-352796-6einbent	159	6	infection	infection	NN
cord-352796-6einbent	159	7	of	of	IN
cord-352796-6einbent	159	8	the	the	DT
cord-352796-6einbent	159	9	respiratory	respiratory	JJ
cord-352796-6einbent	159	10	tree	tree	NN
cord-352796-6einbent	159	11	,	,	,
cord-352796-6einbent	159	12	then	then	RB
cord-352796-6einbent	159	13	this	this	DT
cord-352796-6einbent	159	14	combined	combine	VBN
cord-352796-6einbent	159	15	medication	medication	NN
cord-352796-6einbent	159	16	could	could	MD
cord-352796-6einbent	159	17	also	also	RB
cord-352796-6einbent	159	18	be	be	VB
cord-352796-6einbent	159	19	given	give	VBN
cord-352796-6einbent	159	20	in	in	IN
cord-352796-6einbent	159	21	an	an	DT
cord-352796-6einbent	159	22	inhaled	inhale	VBN
cord-352796-6einbent	159	23	form	form	NN
cord-352796-6einbent	159	24	.	.	.
cord-352796-6einbent	160	1	The	the	DT
cord-352796-6einbent	160	2	advantage	advantage	NN
cord-352796-6einbent	160	3	of	of	IN
cord-352796-6einbent	160	4	this	this	DT
cord-352796-6einbent	160	5	ACE2	ACE2	NNP
cord-352796-6einbent	160	6	targeting	targeting	NN
cord-352796-6einbent	160	7	approach	approach	NN
cord-352796-6einbent	160	8	is	be	VBZ
cord-352796-6einbent	160	9	that	that	IN
cord-352796-6einbent	160	10	ACE2	ACE2	NNP
cord-352796-6einbent	160	11	receptors	receptor	NNS
cord-352796-6einbent	160	12	from	from	IN
cord-352796-6einbent	160	13	the	the	DT
cord-352796-6einbent	160	14	outer	outer	JJ
cord-352796-6einbent	160	15	cornea	cornea	NN
cord-352796-6einbent	160	16	,	,	,
cord-352796-6einbent	160	17	through	through	IN
cord-352796-6einbent	160	18	the	the	DT
cord-352796-6einbent	160	19	lacrimal	lacrimal	JJ
cord-352796-6einbent	160	20	drainage	drainage	NN
cord-352796-6einbent	160	21	system	system	NN
cord-352796-6einbent	160	22	to	to	IN
cord-352796-6einbent	160	23	the	the	DT
cord-352796-6einbent	160	24	respiratory	respiratory	JJ
cord-352796-6einbent	160	25	and	and	CC
cord-352796-6einbent	160	26	gastrointestinal	gastrointestinal	JJ
cord-352796-6einbent	160	27	systems	system	NNS
cord-352796-6einbent	160	28	as	as	RB
cord-352796-6einbent	160	29	well	well	RB
cord-352796-6einbent	160	30	as	as	IN
cord-352796-6einbent	160	31	both	both	DT
cord-352796-6einbent	160	32	nasal	nasal	JJ
cord-352796-6einbent	160	33	and	and	CC
cord-352796-6einbent	160	34	oral	oral	JJ
cord-352796-6einbent	160	35	cavities	cavity	NNS
cord-352796-6einbent	160	36	,	,	,
cord-352796-6einbent	160	37	are	be	VBP
cord-352796-6einbent	160	38	directly	directly	RB
cord-352796-6einbent	160	39	accessible	accessible	JJ
cord-352796-6einbent	160	40	to	to	IN
cord-352796-6einbent	160	41	a	a	DT
cord-352796-6einbent	160	42	high	high	JJ
cord-352796-6einbent	160	43	topical	topical	JJ
cord-352796-6einbent	160	44	drug	drug	NN
cord-352796-6einbent	160	45	dose	dose	NN
cord-352796-6einbent	160	46	.	.	.
cord-352796-6einbent	161	1	Thus	thus	RB
cord-352796-6einbent	161	2	,	,	,
cord-352796-6einbent	161	3	the	the	DT
cord-352796-6einbent	161	4	portals	portal	NNS
cord-352796-6einbent	161	5	that	that	WDT
cord-352796-6einbent	161	6	make	make	VBP
cord-352796-6einbent	161	7	us	-PRON-	PRP
cord-352796-6einbent	161	8	susceptible	susceptible	JJ
cord-352796-6einbent	161	9	to	to	IN
cord-352796-6einbent	161	10	coronavirus	coronavirus	NN
cord-352796-6einbent	161	11	attack	attack	NN
cord-352796-6einbent	161	12	and	and	CC
cord-352796-6einbent	161	13	invasion	invasion	NN
cord-352796-6einbent	161	14	can	can	MD
cord-352796-6einbent	161	15	be	be	VB
cord-352796-6einbent	161	16	used	use	VBN
cord-352796-6einbent	161	17	to	to	TO
cord-352796-6einbent	161	18	provide	provide	VB
cord-352796-6einbent	161	19	protection	protection	NN
cord-352796-6einbent	161	20	that	that	WDT
cord-352796-6einbent	161	21	is	be	VBZ
cord-352796-6einbent	161	22	likely	likely	JJ
cord-352796-6einbent	161	23	to	to	TO
cord-352796-6einbent	161	24	be	be	VB
cord-352796-6einbent	161	25	safe	safe	JJ
cord-352796-6einbent	161	26	,	,	,
cord-352796-6einbent	161	27	extensive	extensive	JJ
cord-352796-6einbent	161	28	,	,	,
cord-352796-6einbent	161	29	convenient	convenient	JJ
cord-352796-6einbent	161	30	and	and	CC
cord-352796-6einbent	161	31	at	at	IN
cord-352796-6einbent	161	32	low	low	JJ
cord-352796-6einbent	161	33	cost	cost	NN
cord-352796-6einbent	161	34	.	.	.
cord-352796-6einbent	162	1	The	the	DT
cord-352796-6einbent	162	2	ocular	ocular	JJ
cord-352796-6einbent	162	3	surface	surface	NN
cord-352796-6einbent	162	4	,	,	,
cord-352796-6einbent	162	5	offering	offer	VBG
cord-352796-6einbent	162	6	all	all	DT
cord-352796-6einbent	162	7	of	of	IN
cord-352796-6einbent	162	8	the	the	DT
cord-352796-6einbent	162	9	benefits	benefit	NNS
cord-352796-6einbent	162	10	of	of	IN
cord-352796-6einbent	162	11	local	local	JJ
cord-352796-6einbent	162	12	treatment	treatment	NN
cord-352796-6einbent	162	13	familiar	familiar	JJ
cord-352796-6einbent	162	14	to	to	IN
cord-352796-6einbent	162	15	ophthalmologists	ophthalmologist	NNS
cord-352796-6einbent	162	16	,	,	,
cord-352796-6einbent	162	17	may	may	MD
cord-352796-6einbent	162	18	thus	thus	RB
cord-352796-6einbent	162	19	provide	provide	VB
cord-352796-6einbent	162	20	a	a	DT
cord-352796-6einbent	162	21	convenient	convenient	JJ
cord-352796-6einbent	162	22	testing	testing	NN
cord-352796-6einbent	162	23	ground	ground	NN
cord-352796-6einbent	162	24	for	for	IN
cord-352796-6einbent	162	25	rapid	rapid	JJ
cord-352796-6einbent	162	26	,	,	,
cord-352796-6einbent	162	27	safe	safe	JJ
cord-352796-6einbent	162	28	and	and	CC
cord-352796-6einbent	162	29	likely	likely	JJ
cord-352796-6einbent	162	30	cost	cost	NN
cord-352796-6einbent	162	31	-	-	HYPH
cord-352796-6einbent	162	32	effective	effective	JJ
cord-352796-6einbent	162	33	trials	trial	NNS
cord-352796-6einbent	162	34	of	of	IN
cord-352796-6einbent	162	35	newer	new	JJR
cord-352796-6einbent	162	36	drugs	drug	NNS
cord-352796-6einbent	162	37	that	that	WDT
cord-352796-6einbent	162	38	may	may	MD
cord-352796-6einbent	162	39	be	be	VB
cord-352796-6einbent	162	40	developed	develop	VBN
cord-352796-6einbent	162	41	to	to	TO
cord-352796-6einbent	162	42	combat	combat	VB
cord-352796-6einbent	162	43	this	this	DT
cord-352796-6einbent	162	44	modern	modern	JJ
cord-352796-6einbent	162	45	plague	plague	NN
cord-352796-6einbent	162	46	.	.	.
cord-352796-6einbent	163	1	Table	table	NN
cord-352796-6einbent	163	2	2	2	CD
cord-352796-6einbent	163	3	.	.	.
cord-352796-6einbent	163	4	 	 	_SP
cord-352796-6einbent	164	1	Another	another	DT
cord-352796-6einbent	164	2	Decade	decade	NN
cord-352796-6einbent	164	3	,	,	,
cord-352796-6einbent	164	4	Another	another	DT
cord-352796-6einbent	164	5	Coronavirus	Coronavirus	NNP
cord-352796-6einbent	164	6	Jia	Jia	NNP
cord-352796-6einbent	164	7	Zhi	Zhi	NNP
cord-352796-6einbent	164	8	-	-	HYPH
cord-352796-6einbent	164	9	fang	fang	NNP
cord-352796-6einbent	164	10	.	.	.
cord-352796-6einbent	165	1	2019-nCoV	2019-ncov	CD
cord-352796-6einbent	165	2	transmission	transmission	NN
cord-352796-6einbent	165	3	through	through	IN
cord-352796-6einbent	165	4	the	the	DT
cord-352796-6einbent	165	5	ocular	ocular	JJ
cord-352796-6einbent	165	6	surface	surface	NN
cord-352796-6einbent	165	7	must	must	MD
cord-352796-6einbent	165	8	not	not	RB
cord-352796-6einbent	165	9	be	be	VB
cord-352796-6einbent	165	10	ignored	ignore	VBN
cord-352796-6einbent	165	11	.	.	.
cord-352796-6einbent	166	1	The	the	DT
cord-352796-6einbent	166	2	Lancet	Lancet	NNP
cord-352796-6einbent	167	1	The	the	DT
cord-352796-6einbent	167	2	transmission	transmission	NN
cord-352796-6einbent	167	3	of	of	IN
cord-352796-6einbent	167	4	infection	infection	NN
cord-352796-6einbent	167	5	through	through	IN
cord-352796-6einbent	167	6	the	the	DT
cord-352796-6einbent	167	7	eye	eye	NN
cord-352796-6einbent	167	8	Ocular	ocular	JJ
cord-352796-6einbent	167	9	tropism	tropism	NN
cord-352796-6einbent	167	10	of	of	IN
cord-352796-6einbent	167	11	respiratory	respiratory	JJ
cord-352796-6einbent	167	12	viruses	virus	NNS
cord-352796-6einbent	168	1	The	the	DT
cord-352796-6einbent	168	2	eyes	eye	NNS
cord-352796-6einbent	168	3	have	have	VBP
cord-352796-6einbent	168	4	it	-PRON-	PRP
cord-352796-6einbent	168	5	:	:	:
cord-352796-6einbent	168	6	influenza	influenza	NN
cord-352796-6einbent	168	7	virus	virus	NN
cord-352796-6einbent	168	8	infection	infection	NN
cord-352796-6einbent	168	9	beyond	beyond	IN
cord-352796-6einbent	168	10	the	the	DT
cord-352796-6einbent	168	11	respiratory	respiratory	JJ
cord-352796-6einbent	168	12	tract	tract	NN
cord-352796-6einbent	168	13	Pathogenesis	pathogenesis	NN
cord-352796-6einbent	168	14	,	,	,
cord-352796-6einbent	168	15	transmissibility	transmissibility	NN
cord-352796-6einbent	168	16	,	,	,
cord-352796-6einbent	168	17	and	and	CC
cord-352796-6einbent	168	18	ocular	ocular	JJ
cord-352796-6einbent	168	19	tropism	tropism	NN
cord-352796-6einbent	168	20	of	of	IN
cord-352796-6einbent	168	21	a	a	DT
cord-352796-6einbent	168	22	highly	highly	RB
cord-352796-6einbent	168	23	pathogenic	pathogenic	JJ
cord-352796-6einbent	168	24	avian	avian	JJ
cord-352796-6einbent	168	25	influenza	influenza	NN
cord-352796-6einbent	168	26	A	a	NN
cord-352796-6einbent	168	27	(	(	-LRB-
cord-352796-6einbent	168	28	H7N3	H7N3	NNP
cord-352796-6einbent	168	29	)	)	-RRB-
cord-352796-6einbent	168	30	virus	virus	NN
cord-352796-6einbent	168	31	associated	associate	VBN
cord-352796-6einbent	168	32	with	with	IN
cord-352796-6einbent	168	33	human	human	JJ
cord-352796-6einbent	168	34	conjunctivitis	conjunctivitis	NN
cord-352796-6einbent	168	35	Sialic	Sialic	NNP
cord-352796-6einbent	168	36	Acid	Acid	NNP
cord-352796-6einbent	168	37	-	-	HYPH
cord-352796-6einbent	168	38	Containing	contain	VBG
cord-352796-6einbent	168	39	Glycans	Glycans	NNPS
cord-352796-6einbent	168	40	as	as	IN
cord-352796-6einbent	168	41	Cellular	Cellular	NNP
cord-352796-6einbent	168	42	Receptors	Receptors	NNPS
cord-352796-6einbent	168	43	for	for	IN
cord-352796-6einbent	168	44	Ocular	Ocular	NNP
cord-352796-6einbent	168	45	Human	Human	NNP
cord-352796-6einbent	168	46	Adenoviruses	Adenoviruses	NNPS
cord-352796-6einbent	168	47	:	:	:
cord-352796-6einbent	168	48	Implications	implication	NNS
cord-352796-6einbent	168	49	for	for	IN
cord-352796-6einbent	168	50	Tropism	tropism	NN
cord-352796-6einbent	168	51	and	and	CC
cord-352796-6einbent	168	52	Treatment	Treatment	NNP
cord-352796-6einbent	168	53	Eye	Eye	NNP
cord-352796-6einbent	168	54	hospital	hospital	NN
cord-352796-6einbent	168	55	eye	eye	NN
cord-352796-6einbent	168	56	Initial	initial	JJ
cord-352796-6einbent	168	57	viral	viral	JJ
cord-352796-6einbent	168	58	load	load	NN
cord-352796-6einbent	168	59	and	and	CC
cord-352796-6einbent	168	60	the	the	DT
cord-352796-6einbent	168	61	outcomes	outcome	NNS
cord-352796-6einbent	168	62	of	of	IN
cord-352796-6einbent	168	63	SARS	SARS	NNP
cord-352796-6einbent	169	1	The	the	DT
cord-352796-6einbent	169	2	history	history	NN
cord-352796-6einbent	169	3	of	of	IN
cord-352796-6einbent	169	4	optical	optical	JJ
cord-352796-6einbent	169	5	instruments	instrument	NNS
cord-352796-6einbent	169	6	for	for	IN
cord-352796-6einbent	169	7	the	the	DT
cord-352796-6einbent	169	8	examination	examination	NN
cord-352796-6einbent	169	9	of	of	IN
cord-352796-6einbent	169	10	the	the	DT
cord-352796-6einbent	169	11	eye	eye	NN
cord-352796-6einbent	169	12	Dispersal	Dispersal	NNP
cord-352796-6einbent	169	13	of	of	IN
cord-352796-6einbent	169	14	exhaled	exhale	VBN
cord-352796-6einbent	169	15	air	air	NN
cord-352796-6einbent	169	16	and	and	CC
cord-352796-6einbent	169	17	personal	personal	JJ
cord-352796-6einbent	169	18	exposure	exposure	NN
cord-352796-6einbent	169	19	in	in	IN
cord-352796-6einbent	169	20	displacement	displacement	NN
cord-352796-6einbent	169	21	ventilated	ventilate	VBN
cord-352796-6einbent	169	22	rooms	room	NNS
cord-352796-6einbent	169	23	Slit	slit	JJ
cord-352796-6einbent	169	24	lamps	lamp	NNS
cord-352796-6einbent	169	25	and	and	CC
cord-352796-6einbent	169	26	lenses	lense	NNS
cord-352796-6einbent	169	27	:	:	:
cord-352796-6einbent	169	28	a	a	DT
cord-352796-6einbent	169	29	potential	potential	JJ
cord-352796-6einbent	169	30	source	source	NN
cord-352796-6einbent	169	31	of	of	IN
cord-352796-6einbent	169	32	nosocomial	nosocomial	JJ
cord-352796-6einbent	169	33	infections	infection	NNS
cord-352796-6einbent	169	34	?	?	.
cord-352796-6einbent	170	1	Eye	eye	JJ
cord-352796-6einbent	170	2	Outbreak	outbreak	NN
cord-352796-6einbent	170	3	of	of	IN
cord-352796-6einbent	170	4	Epidemic	Epidemic	NNP
cord-352796-6einbent	170	5	Keratoconjunctivitis	Keratoconjunctivitis	NNP
cord-352796-6einbent	170	6	Caused	cause	VBN
cord-352796-6einbent	170	7	by	by	IN
cord-352796-6einbent	170	8	Human	Human	NNP
cord-352796-6einbent	170	9	Adenovirus	Adenovirus	NNP
cord-352796-6einbent	170	10	Type	Type	NNP
cord-352796-6einbent	170	11	D53	D53	NNP
cord-352796-6einbent	170	12	in	in	IN
cord-352796-6einbent	170	13	an	an	DT
cord-352796-6einbent	170	14	Eye	Eye	NNP
cord-352796-6einbent	170	15	Care	Care	NNP
cord-352796-6einbent	170	16	Clinic	Clinic	NNP
cord-352796-6einbent	170	17	-Los	-los	XX
cord-352796-6einbent	170	18	Angeles	Angeles	NNP
cord-352796-6einbent	170	19	County	County	NNP
cord-352796-6einbent	170	20	Frequency	Frequency	NNP
cord-352796-6einbent	170	21	and	and	CC
cord-352796-6einbent	170	22	assortment	assortment	NN
cord-352796-6einbent	170	23	of	of	IN
cord-352796-6einbent	170	24	self	self	NN
cord-352796-6einbent	170	25	-	-	HYPH
cord-352796-6einbent	170	26	report	report	NN
cord-352796-6einbent	170	27	occupational	occupational	JJ
cord-352796-6einbent	170	28	complaints	complaint	NNS
cord-352796-6einbent	170	29	among	among	IN
cord-352796-6einbent	170	30	Iranian	iranian	JJ
cord-352796-6einbent	170	31	ophthalmologists	ophthalmologist	NNS
cord-352796-6einbent	170	32	:	:	:
cord-352796-6einbent	170	33	a	a	DT
cord-352796-6einbent	170	34	preliminary	preliminary	JJ
cord-352796-6einbent	170	35	survey	survey	NN
cord-352796-6einbent	171	1	The	the	DT
cord-352796-6einbent	171	2	prevalence	prevalence	NN
cord-352796-6einbent	171	3	of	of	IN
cord-352796-6einbent	171	4	adenoviral	adenoviral	JJ
cord-352796-6einbent	171	5	conjunctivitis	conjunctivitis	NN
cord-352796-6einbent	171	6	in	in	IN
cord-352796-6einbent	171	7	Tikrit	Tikrit	NNP
cord-352796-6einbent	171	8	district	district	NN
cord-352796-6einbent	171	9	and	and	CC
cord-352796-6einbent	171	10	the	the	DT
cord-352796-6einbent	171	11	role	role	NN
cord-352796-6einbent	171	12	of	of	IN
cord-352796-6einbent	171	13	traditional	traditional	JJ
cord-352796-6einbent	171	14	medicine	medicine	NN
cord-352796-6einbent	171	15	"	"	''
cord-352796-6einbent	171	16	OM	OM	NNP
cord-352796-6einbent	171	17	AL	AL	NNP
cord-352796-6einbent	171	18	KAASH	KAASH	NNP
cord-352796-6einbent	171	19	"	"	''
cord-352796-6einbent	171	20	in	in	IN
cord-352796-6einbent	171	21	transmission	transmission	NN
cord-352796-6einbent	171	22	of	of	IN
cord-352796-6einbent	171	23	the	the	DT
cord-352796-6einbent	171	24	disease	disease	NN
cord-352796-6einbent	171	25	and	and	CC
cord-352796-6einbent	171	26	in	in	IN
cord-352796-6einbent	171	27	the	the	DT
cord-352796-6einbent	171	28	severity	severity	NN
cord-352796-6einbent	171	29	of	of	IN
cord-352796-6einbent	171	30	complications	complication	NNS
cord-352796-6einbent	171	31	Precautions	precaution	NNS
cord-352796-6einbent	171	32	in	in	IN
cord-352796-6einbent	171	33	ophthalmic	ophthalmic	JJ
cord-352796-6einbent	171	34	practice	practice	NN
cord-352796-6einbent	171	35	in	in	IN
cord-352796-6einbent	171	36	a	a	DT
cord-352796-6einbent	171	37	hospital	hospital	NN
cord-352796-6einbent	171	38	with	with	IN
cord-352796-6einbent	171	39	a	a	DT
cord-352796-6einbent	171	40	major	major	JJ
cord-352796-6einbent	171	41	acute	acute	JJ
cord-352796-6einbent	171	42	SARS	SARS	NNP
cord-352796-6einbent	171	43	outbreak	outbreak	NN
cord-352796-6einbent	171	44	:	:	:
cord-352796-6einbent	171	45	an	an	DT
cord-352796-6einbent	171	46	experience	experience	NN
cord-352796-6einbent	171	47	from	from	IN
cord-352796-6einbent	171	48	Hong	Hong	NNP
cord-352796-6einbent	171	49	Kong	Kong	NNP
cord-352796-6einbent	171	50	Novel	Novel	NNP
cord-352796-6einbent	171	51	Coronavirus	Coronavirus	NNP
cord-352796-6einbent	171	52	disease	disease	NN
cord-352796-6einbent	171	53	2019	2019	CD
cord-352796-6einbent	171	54	(	(	-LRB-
cord-352796-6einbent	171	55	COVID-19	COVID-19	NNP
cord-352796-6einbent	171	56	)	)	-RRB-
cord-352796-6einbent	171	57	:	:	:
cord-352796-6einbent	171	58	The	the	DT
cord-352796-6einbent	171	59	importance	importance	NN
cord-352796-6einbent	171	60	of	of	IN
cord-352796-6einbent	171	61	recognising	recognise	VBG
cord-352796-6einbent	171	62	possible	possible	JJ
cord-352796-6einbent	171	63	early	early	JJ
cord-352796-6einbent	171	64	ocular	ocular	JJ
cord-352796-6einbent	171	65	manifestation	manifestation	NN
cord-352796-6einbent	171	66	and	and	CC
cord-352796-6einbent	171	67	using	use	VBG
cord-352796-6einbent	171	68	protective	protective	JJ
cord-352796-6einbent	171	69	eyewear	eyewear	NN
cord-352796-6einbent	171	70	Early	Early	NNP
cord-352796-6einbent	171	71	Transmission	Transmission	NNP
cord-352796-6einbent	171	72	Dynamics	Dynamics	NNPS
cord-352796-6einbent	171	73	in	in	IN
cord-352796-6einbent	171	74	Wuhan	Wuhan	NNP
cord-352796-6einbent	171	75	,	,	,
cord-352796-6einbent	171	76	China	China	NNP
cord-352796-6einbent	171	77	,	,	,
cord-352796-6einbent	171	78	of	of	IN
cord-352796-6einbent	171	79	Novel	Novel	NNP
cord-352796-6einbent	171	80	Coronavirus	Coronavirus	NNP
cord-352796-6einbent	171	81	-	-	HYPH
cord-352796-6einbent	171	82	Infected	Infected	NNP
cord-352796-6einbent	171	83	Pneumonia	Pneumonia	NNP
cord-352796-6einbent	171	84	Transmission	Transmission	NNP
cord-352796-6einbent	171	85	routes	route	NNS
cord-352796-6einbent	171	86	of	of	IN
cord-352796-6einbent	171	87	2019-nCoV	2019-ncov	CD
cord-352796-6einbent	171	88	and	and	CC
cord-352796-6einbent	171	89	controls	control	NNS
cord-352796-6einbent	171	90	in	in	IN
cord-352796-6einbent	171	91	dental	dental	JJ
cord-352796-6einbent	171	92	practice	practice	NN
cord-352796-6einbent	171	93	WHO	who	WP
cord-352796-6einbent	171	94	|	|	VBZ
cord-352796-6einbent	171	95	Update	update	NN
cord-352796-6einbent	171	96	27	27	CD
cord-352796-6einbent	171	97	-One	-one	NN
cord-352796-6einbent	171	98	month	month	NN
cord-352796-6einbent	171	99	into	into	IN
cord-352796-6einbent	171	100	the	the	DT
cord-352796-6einbent	171	101	global	global	JJ
cord-352796-6einbent	171	102	SARS	SARS	NNP
cord-352796-6einbent	171	103	outbreak	outbreak	NN
cord-352796-6einbent	171	104	:	:	:
cord-352796-6einbent	171	105	Status	status	NN
cord-352796-6einbent	171	106	of	of	IN
cord-352796-6einbent	171	107	the	the	DT
cord-352796-6einbent	171	108	outbreak	outbreak	NN
cord-352796-6einbent	171	109	and	and	CC
cord-352796-6einbent	171	110	lessons	lesson	NNS
cord-352796-6einbent	171	111	for	for	IN
cord-352796-6einbent	171	112	the	the	DT
cord-352796-6einbent	171	113	immediate	immediate	JJ
cord-352796-6einbent	171	114	future	future	NN
cord-352796-6einbent	171	115	Accessed	Accessed	NNP
cord-352796-6einbent	171	116	Recognition	Recognition	NNP
cord-352796-6einbent	171	117	of	of	IN
cord-352796-6einbent	171	118	aerosol	aerosol	NN
cord-352796-6einbent	171	119	transmission	transmission	NN
cord-352796-6einbent	171	120	of	of	IN
cord-352796-6einbent	171	121	infectious	infectious	JJ
cord-352796-6einbent	171	122	agents	agent	NNS
cord-352796-6einbent	171	123	:	:	:
cord-352796-6einbent	171	124	a	a	DT
cord-352796-6einbent	171	125	commentary	commentary	NN
cord-352796-6einbent	171	126	The	the	DT
cord-352796-6einbent	171	127	exposed	expose	VBN
cord-352796-6einbent	171	128	ocular	ocular	JJ
cord-352796-6einbent	171	129	surface	surface	NN
cord-352796-6einbent	171	130	and	and	CC
cord-352796-6einbent	171	131	its	-PRON-	PRP$
cord-352796-6einbent	171	132	relationship	relationship	NN
cord-352796-6einbent	171	133	to	to	IN
cord-352796-6einbent	171	134	spontaneous	spontaneous	JJ
cord-352796-6einbent	171	135	eyeblink	eyeblink	NN
cord-352796-6einbent	171	136	rate	rate	NN
cord-352796-6einbent	171	137	in	in	IN
cord-352796-6einbent	171	138	elderly	elderly	JJ
cord-352796-6einbent	171	139	caucasians	caucasian	NNS
cord-352796-6einbent	171	140	Ocular	ocular	JJ
cord-352796-6einbent	171	141	surface	surface	NN
cord-352796-6einbent	171	142	area	area	NN
cord-352796-6einbent	171	143	as	as	IN
cord-352796-6einbent	171	144	an	an	DT
cord-352796-6einbent	171	145	informative	informative	JJ
cord-352796-6einbent	171	146	index	index	NN
cord-352796-6einbent	171	147	of	of	IN
cord-352796-6einbent	171	148	visual	visual	JJ
cord-352796-6einbent	171	149	ergonomics	ergonomic	NNS
cord-352796-6einbent	171	150	On	on	IN
cord-352796-6einbent	171	151	the	the	DT
cord-352796-6einbent	171	152	size	size	NN
cord-352796-6einbent	171	153	of	of	IN
cord-352796-6einbent	171	154	the	the	DT
cord-352796-6einbent	171	155	conjunctival	conjunctival	NN
cord-352796-6einbent	171	156	sac	sac	NN
cord-352796-6einbent	171	157	Comparison	comparison	NN
cord-352796-6einbent	171	158	of	of	IN
cord-352796-6einbent	171	159	conjunctival	conjunctival	NN
cord-352796-6einbent	171	160	and	and	CC
cord-352796-6einbent	171	161	corneal	corneal	JJ
cord-352796-6einbent	171	162	surface	surface	NN
cord-352796-6einbent	171	163	areas	area	NNS
cord-352796-6einbent	171	164	in	in	IN
cord-352796-6einbent	171	165	rabbit	rabbit	NN
cord-352796-6einbent	171	166	and	and	CC
cord-352796-6einbent	171	167	human	human	JJ
cord-352796-6einbent	171	168	Migration	migration	NN
cord-352796-6einbent	171	169	of	of	IN
cord-352796-6einbent	171	170	Cosmetic	cosmetic	JJ
cord-352796-6einbent	171	171	Products	product	NNS
cord-352796-6einbent	171	172	into	into	IN
cord-352796-6einbent	171	173	the	the	DT
cord-352796-6einbent	171	174	Tear	Tear	NNP
cord-352796-6einbent	171	175	Film	Film	NNP
cord-352796-6einbent	171	176	Supracutaneous	Supracutaneous	NNP
cord-352796-6einbent	171	177	treatment	treatment	NN
cord-352796-6einbent	171	178	of	of	IN
cord-352796-6einbent	171	179	dry	dry	JJ
cord-352796-6einbent	171	180	eye	eye	NN
cord-352796-6einbent	171	181	patients	patient	NNS
cord-352796-6einbent	171	182	with	with	IN
cord-352796-6einbent	171	183	calcium	calcium	NN
cord-352796-6einbent	171	184	carbonate	carbonate	NN
cord-352796-6einbent	171	185	New	new	JJ
cord-352796-6einbent	171	186	treatment	treatment	NN
cord-352796-6einbent	171	187	of	of	IN
cord-352796-6einbent	171	188	dry	dry	JJ
cord-352796-6einbent	171	189	eye	eye	NN
cord-352796-6einbent	171	190	:	:	:
cord-352796-6einbent	171	191	the	the	DT
cord-352796-6einbent	171	192	effect	effect	NN
cord-352796-6einbent	171	193	of	of	IN
cord-352796-6einbent	171	194	calcium	calcium	NN
cord-352796-6einbent	171	195	ointment	ointment	NN
cord-352796-6einbent	171	196	through	through	IN
cord-352796-6einbent	171	197	eyelid	eyelid	NN
cord-352796-6einbent	171	198	skin	skin	NN
cord-352796-6einbent	171	199	delivery	delivery	NN
cord-352796-6einbent	171	200	Evaluation	Evaluation	NNP
cord-352796-6einbent	171	201	of	of	IN
cord-352796-6einbent	171	202	Eyeball	Eyeball	NNP
cord-352796-6einbent	171	203	and	and	CC
cord-352796-6einbent	171	204	Orbit	Orbit	NNP
cord-352796-6einbent	171	205	in	in	IN
cord-352796-6einbent	171	206	Relation	Relation	NNP
cord-352796-6einbent	171	207	to	to	IN
cord-352796-6einbent	171	208	Gender	Gender	NNP
cord-352796-6einbent	171	209	and	and	CC
cord-352796-6einbent	171	210	Age	Age	NNP
cord-352796-6einbent	171	211	Morphometric	Morphometric	NNP
cord-352796-6einbent	171	212	Analysis	Analysis	NNP
cord-352796-6einbent	171	213	of	of	IN
cord-352796-6einbent	171	214	the	the	DT
cord-352796-6einbent	171	215	Orbital	orbital	JJ
cord-352796-6einbent	171	216	Aperture	Aperture	NNP
cord-352796-6einbent	171	217	in	in	IN
cord-352796-6einbent	171	218	North	North	NNP
cord-352796-6einbent	171	219	Indian	Indian	NNP
cord-352796-6einbent	171	220	Population	Population	NNP
cord-352796-6einbent	171	221	:	:	:
cord-352796-6einbent	172	1	A	a	DT
cord-352796-6einbent	172	2	Retrospective	Retrospective	NNP
cord-352796-6einbent	172	3	Digital	Digital	NNP
cord-352796-6einbent	172	4	Forensic	Forensic	NNP
cord-352796-6einbent	172	5	Study	Study	NNP
cord-352796-6einbent	172	6	Eyelashes	eyelash	NNS
cord-352796-6einbent	172	7	divert	divert	VBP
cord-352796-6einbent	172	8	airflow	airflow	NN
cord-352796-6einbent	172	9	to	to	TO
cord-352796-6einbent	172	10	protect	protect	VB
cord-352796-6einbent	172	11	the	the	DT
cord-352796-6einbent	172	12	eye	eye	NN
cord-352796-6einbent	172	13	Ethnic	ethnic	JJ
cord-352796-6einbent	172	14	characteristics	characteristic	NNS
cord-352796-6einbent	172	15	of	of	IN
cord-352796-6einbent	172	16	eyelashes	eyelash	NNS
cord-352796-6einbent	172	17	:	:	:
cord-352796-6einbent	172	18	a	a	DT
cord-352796-6einbent	172	19	comparative	comparative	JJ
cord-352796-6einbent	172	20	analysis	analysis	NN
cord-352796-6einbent	172	21	in	in	IN
cord-352796-6einbent	172	22	Asian	asian	JJ
cord-352796-6einbent	172	23	and	and	CC
cord-352796-6einbent	172	24	Caucasian	caucasian	JJ
cord-352796-6einbent	172	25	females	female	NNS
cord-352796-6einbent	172	26	Identification	Identification	NNP
cord-352796-6einbent	172	27	of	of	IN
cord-352796-6einbent	172	28	nucleolin	nucleolin	NNP
cord-352796-6einbent	172	29	as	as	IN
cord-352796-6einbent	172	30	a	a	DT
cord-352796-6einbent	172	31	cellular	cellular	JJ
cord-352796-6einbent	172	32	receptor	receptor	NN
cord-352796-6einbent	172	33	for	for	IN
cord-352796-6einbent	172	34	human	human	JJ
cord-352796-6einbent	172	35	respiratory	respiratory	JJ
cord-352796-6einbent	172	36	syncytial	syncytial	JJ
cord-352796-6einbent	172	37	virus	virus	NN
cord-352796-6einbent	172	38	Evolution	evolution	NN
cord-352796-6einbent	172	39	of	of	IN
cord-352796-6einbent	172	40	the	the	DT
cord-352796-6einbent	172	41	novel	novel	JJ
cord-352796-6einbent	172	42	coronavirus	coronavirus	NN
cord-352796-6einbent	172	43	from	from	IN
cord-352796-6einbent	172	44	the	the	DT
cord-352796-6einbent	172	45	ongoing	ongoing	JJ
cord-352796-6einbent	172	46	Wuhan	Wuhan	NNP
cord-352796-6einbent	172	47	outbreak	outbreak	NN
cord-352796-6einbent	172	48	and	and	CC
cord-352796-6einbent	172	49	modeling	modeling	NN
cord-352796-6einbent	172	50	of	of	IN
cord-352796-6einbent	172	51	its	-PRON-	PRP$
cord-352796-6einbent	172	52	spike	spike	NN
cord-352796-6einbent	172	53	protein	protein	NN
cord-352796-6einbent	172	54	for	for	IN
cord-352796-6einbent	172	55	risk	risk	NN
cord-352796-6einbent	172	56	of	of	IN
cord-352796-6einbent	172	57	human	human	JJ
cord-352796-6einbent	172	58	transmission	transmission	NN
cord-352796-6einbent	172	59	Single	single	JJ
cord-352796-6einbent	172	60	-	-	HYPH
cord-352796-6einbent	172	61	cell	cell	NN
cord-352796-6einbent	172	62	RNA	rna	NN
cord-352796-6einbent	172	63	expression	expression	NN
cord-352796-6einbent	172	64	profiling	profiling	NN
cord-352796-6einbent	172	65	of	of	IN
cord-352796-6einbent	172	66	ACE2	ACE2	NNP
cord-352796-6einbent	172	67	,	,	,
cord-352796-6einbent	172	68	the	the	DT
cord-352796-6einbent	172	69	putative	putative	JJ
cord-352796-6einbent	172	70	receptor	receptor	NN
cord-352796-6einbent	172	71	of	of	IN
cord-352796-6einbent	172	72	Wuhan	Wuhan	NNP
cord-352796-6einbent	172	73	Crystal	Crystal	NNP
cord-352796-6einbent	172	74	structure	structure	NN
cord-352796-6einbent	172	75	of	of	IN
cord-352796-6einbent	172	76	NL63	NL63	NNP
cord-352796-6einbent	172	77	respiratory	respiratory	JJ
cord-352796-6einbent	172	78	coronavirus	coronavirus	NN
cord-352796-6einbent	172	79	receptor	receptor	NN
cord-352796-6einbent	172	80	-	-	HYPH
cord-352796-6einbent	172	81	binding	bind	VBG
cord-352796-6einbent	172	82	domain	domain	NN
cord-352796-6einbent	172	83	complexed	complexe	VBN
cord-352796-6einbent	172	84	with	with	IN
cord-352796-6einbent	172	85	its	-PRON-	PRP$
cord-352796-6einbent	172	86	human	human	JJ
cord-352796-6einbent	172	87	receptor	receptor	NN
cord-352796-6einbent	173	1	The	the	DT
cord-352796-6einbent	173	2	S	S	NNP
cord-352796-6einbent	173	3	proteins	protein	NNS
cord-352796-6einbent	173	4	of	of	IN
cord-352796-6einbent	173	5	human	human	JJ
cord-352796-6einbent	173	6	coronavirus	coronavirus	NN
cord-352796-6einbent	173	7	NL63	NL63	NNP
cord-352796-6einbent	173	8	and	and	CC
cord-352796-6einbent	173	9	severe	severe	JJ
cord-352796-6einbent	173	10	acute	acute	JJ
cord-352796-6einbent	173	11	respiratory	respiratory	JJ
cord-352796-6einbent	173	12	syndrome	syndrome	NN
cord-352796-6einbent	173	13	coronavirus	coronavirus	NN
cord-352796-6einbent	173	14	bind	bind	VBP
cord-352796-6einbent	173	15	overlapping	overlap	VBG
cord-352796-6einbent	173	16	regions	region	NNS
cord-352796-6einbent	173	17	of	of	IN
cord-352796-6einbent	174	1	ACE2	ACE2	NNP
cord-352796-6einbent	174	2	A	a	DT
cord-352796-6einbent	174	3	pneumonia	pneumonia	NN
cord-352796-6einbent	174	4	outbreak	outbreak	NN
cord-352796-6einbent	174	5	associated	associate	VBN
cord-352796-6einbent	174	6	with	with	IN
cord-352796-6einbent	174	7	a	a	DT
cord-352796-6einbent	174	8	new	new	JJ
cord-352796-6einbent	174	9	coronavirus	coronavirus	NN
cord-352796-6einbent	174	10	of	of	IN
cord-352796-6einbent	174	11	probable	probable	JJ
cord-352796-6einbent	174	12	bat	bat	NN
cord-352796-6einbent	174	13	origin	origin	NN
cord-352796-6einbent	174	14	Tissue	tissue	NN
cord-352796-6einbent	174	15	distribution	distribution	NN
cord-352796-6einbent	174	16	of	of	IN
cord-352796-6einbent	174	17	ACE2	ACE2	NNP
cord-352796-6einbent	174	18	protein	protein	NN
cord-352796-6einbent	174	19	,	,	,
cord-352796-6einbent	174	20	the	the	DT
cord-352796-6einbent	174	21	functional	functional	JJ
cord-352796-6einbent	174	22	receptor	receptor	NN
cord-352796-6einbent	174	23	for	for	IN
cord-352796-6einbent	174	24	SARS	SARS	NNP
cord-352796-6einbent	174	25	coronavirus	coronavirus	NN
cord-352796-6einbent	174	26	.	.	.
cord-352796-6einbent	175	1	A	a	DT
cord-352796-6einbent	175	2	first	first	JJ
cord-352796-6einbent	175	3	step	step	NN
cord-352796-6einbent	175	4	in	in	IN
cord-352796-6einbent	175	5	understanding	understand	VBG
cord-352796-6einbent	175	6	SARS	SARS	NNP
cord-352796-6einbent	175	7	pathogenesis	pathogenesis	NN
cord-352796-6einbent	175	8	ACE2	ACE2	NNP
cord-352796-6einbent	175	9	receptor	receptor	NN
cord-352796-6einbent	175	10	expression	expression	NN
cord-352796-6einbent	175	11	and	and	CC
cord-352796-6einbent	175	12	severe	severe	JJ
cord-352796-6einbent	175	13	acute	acute	JJ
cord-352796-6einbent	175	14	respiratory	respiratory	JJ
cord-352796-6einbent	175	15	syndrome	syndrome	NN
cord-352796-6einbent	175	16	coronavirus	coronavirus	NN
cord-352796-6einbent	175	17	infection	infection	NN
cord-352796-6einbent	175	18	depend	depend	VBP
cord-352796-6einbent	175	19	on	on	IN
cord-352796-6einbent	175	20	differentiation	differentiation	NN
cord-352796-6einbent	175	21	of	of	IN
cord-352796-6einbent	175	22	human	human	JJ
cord-352796-6einbent	175	23	airway	airway	NN
cord-352796-6einbent	175	24	epithelia	epithelium	NNS
cord-352796-6einbent	175	25	Immunohistochemical	Immunohistochemical	NNP
cord-352796-6einbent	175	26	localization	localization	NN
cord-352796-6einbent	175	27	of	of	IN
cord-352796-6einbent	175	28	angiotensin	angiotensin	NN
cord-352796-6einbent	175	29	-	-	HYPH
cord-352796-6einbent	175	30	converting	convert	VBG
cord-352796-6einbent	175	31	enzyme	enzyme	NN
cord-352796-6einbent	175	32	,	,	,
cord-352796-6einbent	175	33	angiotensin	angiotensin	NN
cord-352796-6einbent	175	34	II	II	NNP
cord-352796-6einbent	175	35	and	and	CC
cord-352796-6einbent	175	36	AT1	AT1	NNP
cord-352796-6einbent	175	37	receptor	receptor	NN
cord-352796-6einbent	175	38	in	in	IN
cord-352796-6einbent	175	39	human	human	JJ
cord-352796-6einbent	175	40	ocular	ocular	JJ
cord-352796-6einbent	175	41	tissues	tissue	NNS
cord-352796-6einbent	176	1	SARS	SARS	NNP
cord-352796-6einbent	176	2	-	-	HYPH
cord-352796-6einbent	176	3	CoV-2	CoV-2	NNP
cord-352796-6einbent	176	4	entry	entry	NN
cord-352796-6einbent	176	5	factors	factor	NNS
cord-352796-6einbent	176	6	are	be	VBP
cord-352796-6einbent	176	7	highly	highly	RB
cord-352796-6einbent	176	8	expressed	express	VBN
cord-352796-6einbent	176	9	in	in	IN
cord-352796-6einbent	176	10	nasal	nasal	JJ
cord-352796-6einbent	176	11	epithelial	epithelial	JJ
cord-352796-6einbent	176	12	cells	cell	NNS
cord-352796-6einbent	176	13	together	together	RB
cord-352796-6einbent	176	14	with	with	IN
cord-352796-6einbent	176	15	innate	innate	JJ
cord-352796-6einbent	176	16	immune	immune	JJ
cord-352796-6einbent	176	17	genes	gene	NNS
cord-352796-6einbent	176	18	Tropism	tropism	NN
cord-352796-6einbent	176	19	,	,	,
cord-352796-6einbent	176	20	replication	replication	NN
cord-352796-6einbent	176	21	competence	competence	NN
cord-352796-6einbent	176	22	,	,	,
cord-352796-6einbent	176	23	and	and	CC
cord-352796-6einbent	176	24	innate	innate	JJ
cord-352796-6einbent	176	25	immune	immune	JJ
cord-352796-6einbent	176	26	responses	response	NNS
cord-352796-6einbent	176	27	of	of	IN
cord-352796-6einbent	176	28	the	the	DT
cord-352796-6einbent	176	29	coronavirus	coronavirus	NN
cord-352796-6einbent	176	30	SARS	SARS	NNP
cord-352796-6einbent	176	31	-	-	HYPH
cord-352796-6einbent	176	32	CoV-2	CoV-2	NNP
cord-352796-6einbent	176	33	in	in	IN
cord-352796-6einbent	176	34	human	human	JJ
cord-352796-6einbent	176	35	respiratory	respiratory	JJ
cord-352796-6einbent	176	36	tract	tract	NN
cord-352796-6einbent	176	37	and	and	CC
cord-352796-6einbent	176	38	conjunctiva	conjunctiva	NN
cord-352796-6einbent	176	39	:	:	:
cord-352796-6einbent	176	40	an	an	DT
cord-352796-6einbent	176	41	analysis	analysis	NN
cord-352796-6einbent	176	42	in	in	IN
cord-352796-6einbent	176	43	ex	ex	JJ
cord-352796-6einbent	176	44	-	-	NN
cord-352796-6einbent	176	45	vivo	vivo	JJ
cord-352796-6einbent	176	46	and	and	CC
cord-352796-6einbent	176	47	in	in	IN
cord-352796-6einbent	176	48	-	-	HYPH
cord-352796-6einbent	176	49	vitro	vitro	FW
cord-352796-6einbent	176	50	cultures	culture	NNS
cord-352796-6einbent	176	51	Identification	identification	NN
cord-352796-6einbent	176	52	of	of	IN
cord-352796-6einbent	176	53	a	a	DT
cord-352796-6einbent	176	54	new	new	JJ
cord-352796-6einbent	176	55	human	human	JJ
cord-352796-6einbent	176	56	coronavirus	coronavirus	NN
cord-352796-6einbent	176	57	Human	human	JJ
cord-352796-6einbent	176	58	coronavirus	coronavirus	NN
cord-352796-6einbent	177	1	NL63	NL63	NNP
cord-352796-6einbent	177	2	,	,	,
cord-352796-6einbent	177	3	France	France	NNP
cord-352796-6einbent	177	4	Dry	Dry	NNP
cord-352796-6einbent	177	5	Eye	Eye	NNP
cord-352796-6einbent	177	6	Epidermal	epidermal	JJ
cord-352796-6einbent	177	7	surface	surface	NN
cord-352796-6einbent	177	8	lipids	lipid	NNS
cord-352796-6einbent	177	9	Lipids	lipid	NNS
cord-352796-6einbent	177	10	,	,	,
cord-352796-6einbent	177	11	proteins	protein	NNS
cord-352796-6einbent	177	12	and	and	CC
cord-352796-6einbent	177	13	corneocyte	corneocyte	NNP
cord-352796-6einbent	177	14	adhesion	adhesion	NN
cord-352796-6einbent	177	15	Tear	Tear	NNP
cord-352796-6einbent	177	16	film	film	NN
cord-352796-6einbent	177	17	lipids	lipid	NNS
cord-352796-6einbent	178	1	Common	common	JJ
cord-352796-6einbent	178	2	Features	feature	NNS
cord-352796-6einbent	178	3	of	of	IN
cord-352796-6einbent	178	4	Enveloped	Enveloped	NNP
cord-352796-6einbent	178	5	Viruses	Viruses	NNPS
cord-352796-6einbent	178	6	and	and	CC
cord-352796-6einbent	178	7	Implications	implication	NNS
cord-352796-6einbent	178	8	for	for	IN
cord-352796-6einbent	178	9	Immunogen	Immunogen	NNP
cord-352796-6einbent	178	10	Design	Design	NNP
cord-352796-6einbent	178	11	for	for	IN
cord-352796-6einbent	178	12	Next	Next	NNP
cord-352796-6einbent	178	13	-	-	HYPH
cord-352796-6einbent	178	14	Generation	generation	NN
cord-352796-6einbent	178	15	Vaccines	Vaccines	NNPS
cord-352796-6einbent	178	16	Murine	Murine	NNP
cord-352796-6einbent	178	17	coronavirus	coronavirus	NN
cord-352796-6einbent	178	18	requires	require	VBZ
cord-352796-6einbent	178	19	lipid	lipid	NN
cord-352796-6einbent	178	20	rafts	raft	NNS
cord-352796-6einbent	178	21	for	for	IN
cord-352796-6einbent	178	22	virus	virus	NN
cord-352796-6einbent	178	23	entry	entry	NN
cord-352796-6einbent	178	24	and	and	CC
cord-352796-6einbent	178	25	cell	cell	NN
cord-352796-6einbent	178	26	-	-	HYPH
cord-352796-6einbent	178	27	cell	cell	NN
cord-352796-6einbent	178	28	fusion	fusion	NN
cord-352796-6einbent	178	29	but	but	CC
cord-352796-6einbent	178	30	not	not	RB
cord-352796-6einbent	178	31	for	for	IN
cord-352796-6einbent	178	32	virus	virus	NN
cord-352796-6einbent	178	33	release	release	NN
cord-352796-6einbent	178	34	Importance	importance	NN
cord-352796-6einbent	178	35	of	of	IN
cord-352796-6einbent	178	36	cholesterol	cholesterol	NN
cord-352796-6einbent	178	37	-	-	HYPH
cord-352796-6einbent	178	38	rich	rich	JJ
cord-352796-6einbent	178	39	membrane	membrane	NN
cord-352796-6einbent	178	40	microdomains	microdomain	NNS
cord-352796-6einbent	178	41	in	in	IN
cord-352796-6einbent	178	42	the	the	DT
cord-352796-6einbent	178	43	interaction	interaction	NN
cord-352796-6einbent	178	44	of	of	IN
cord-352796-6einbent	178	45	the	the	DT
cord-352796-6einbent	178	46	S	S	NNP
cord-352796-6einbent	178	47	protein	protein	NN
cord-352796-6einbent	178	48	of	of	IN
cord-352796-6einbent	178	49	SARS	SARS	NNP
cord-352796-6einbent	178	50	-	-	HYPH
cord-352796-6einbent	178	51	coronavirus	coronavirus	NN
cord-352796-6einbent	178	52	with	with	IN
cord-352796-6einbent	178	53	the	the	DT
cord-352796-6einbent	178	54	cellular	cellular	JJ
cord-352796-6einbent	178	55	receptor	receptor	NN
cord-352796-6einbent	178	56	angiotensin	angiotensin	NN
cord-352796-6einbent	178	57	-	-	HYPH
cord-352796-6einbent	178	58	converting	convert	VBG
cord-352796-6einbent	178	59	enzyme	enzyme	NN
cord-352796-6einbent	178	60	2	2	CD
cord-352796-6einbent	178	61	Complexity	complexity	NN
cord-352796-6einbent	178	62	of	of	IN
cord-352796-6einbent	178	63	the	the	DT
cord-352796-6einbent	178	64	tear	tear	JJ
cord-352796-6einbent	178	65	film	film	NN
cord-352796-6einbent	178	66	:	:	:
cord-352796-6einbent	178	67	importance	importance	NN
cord-352796-6einbent	178	68	in	in	IN
cord-352796-6einbent	178	69	homeostasis	homeostasis	NN
cord-352796-6einbent	178	70	and	and	CC
cord-352796-6einbent	178	71	dysfunction	dysfunction	NN
cord-352796-6einbent	178	72	during	during	IN
cord-352796-6einbent	178	73	disease	disease	NNP
cord-352796-6einbent	178	74	Evaluation	Evaluation	NNP
cord-352796-6einbent	178	75	of	of	IN
cord-352796-6einbent	178	76	coronavirus	coronavirus	NN
cord-352796-6einbent	178	77	in	in	IN
cord-352796-6einbent	178	78	tears	tear	NNS
cord-352796-6einbent	178	79	and	and	CC
cord-352796-6einbent	178	80	conjunctival	conjunctival	JJ
cord-352796-6einbent	178	81	secretions	secretion	NNS
cord-352796-6einbent	178	82	of	of	IN
cord-352796-6einbent	178	83	patients	patient	NNS
cord-352796-6einbent	178	84	with	with	IN
cord-352796-6einbent	178	85	SARS	SARS	NNP
cord-352796-6einbent	178	86	-	-	HYPH
cord-352796-6einbent	178	87	CoV-2	CoV-2	NNP
cord-352796-6einbent	178	88	infection	infection	NN
cord-352796-6einbent	178	89	SARS	SARS	NNP
cord-352796-6einbent	178	90	-	-	HYPH
cord-352796-6einbent	178	91	CoV-2	CoV-2	NNP
cord-352796-6einbent	178	92	Isolation	isolation	NN
cord-352796-6einbent	178	93	From	from	IN
cord-352796-6einbent	178	94	Ocular	ocular	JJ
cord-352796-6einbent	178	95	Secretions	secretion	NNS
cord-352796-6einbent	178	96	of	of	IN
cord-352796-6einbent	178	97	a	a	DT
cord-352796-6einbent	178	98	Patient	Patient	NNP
cord-352796-6einbent	178	99	With	with	IN
cord-352796-6einbent	178	100	COVID-19	COVID-19	NNP
cord-352796-6einbent	178	101	in	in	IN
cord-352796-6einbent	178	102	Italy	Italy	NNP
cord-352796-6einbent	178	103	With	with	IN
cord-352796-6einbent	178	104	Prolonged	prolonged	JJ
cord-352796-6einbent	178	105	Viral	Viral	NNP
cord-352796-6einbent	178	106	RNA	RNA	NNP
cord-352796-6einbent	178	107	Detection	Detection	NNP
cord-352796-6einbent	178	108	Ocular	ocular	JJ
cord-352796-6einbent	178	109	manifestations	manifestation	NNS
cord-352796-6einbent	178	110	of	of	IN
cord-352796-6einbent	178	111	a	a	DT
cord-352796-6einbent	178	112	hospitalised	hospitalise	VBN
cord-352796-6einbent	178	113	patient	patient	NN
cord-352796-6einbent	178	114	with	with	IN
cord-352796-6einbent	178	115	confirmed	confirm	VBN
cord-352796-6einbent	178	116	2019	2019	CD
cord-352796-6einbent	178	117	novel	novel	NN
cord-352796-6einbent	178	118	coronavirus	coronavirus	NN
cord-352796-6einbent	178	119	disease	disease	NN
cord-352796-6einbent	178	120	Functional	functional	JJ
cord-352796-6einbent	178	121	anatomy	anatomy	NN
cord-352796-6einbent	178	122	and	and	CC
cord-352796-6einbent	178	123	immunological	immunological	JJ
cord-352796-6einbent	178	124	interactions	interaction	NNS
cord-352796-6einbent	178	125	of	of	IN
cord-352796-6einbent	178	126	ocular	ocular	JJ
cord-352796-6einbent	178	127	surface	surface	NN
cord-352796-6einbent	178	128	and	and	CC
cord-352796-6einbent	179	1	adnexa	adnexa	NNP
cord-352796-6einbent	179	2	Nasolacrimal	Nasolacrimal	NNP
cord-352796-6einbent	179	3	duct	duct	NN
cord-352796-6einbent	179	4	closure	closure	NN
cord-352796-6einbent	179	5	modulates	modulate	VBZ
cord-352796-6einbent	179	6	ocular	ocular	JJ
cord-352796-6einbent	179	7	mucosal	mucosal	JJ
cord-352796-6einbent	179	8	and	and	CC
cord-352796-6einbent	179	9	systemic	systemic	JJ
cord-352796-6einbent	179	10	CD4(+	CD4(+	NNS
cord-352796-6einbent	179	11	)	)	-RRB-
cord-352796-6einbent	180	1	T	t	NN
cord-352796-6einbent	180	2	-	-	HYPH
cord-352796-6einbent	180	3	cell	cell	NN
cord-352796-6einbent	180	4	responses	response	NNS
cord-352796-6einbent	180	5	induced	induce	VBN
cord-352796-6einbent	180	6	following	follow	VBG
cord-352796-6einbent	180	7	topical	topical	JJ
cord-352796-6einbent	180	8	ocular	ocular	JJ
cord-352796-6einbent	180	9	or	or	CC
cord-352796-6einbent	180	10	intranasal	intranasal	JJ
cord-352796-6einbent	180	11	immunization	immunization	NN
cord-352796-6einbent	180	12	Tears	tear	NNS
cord-352796-6einbent	180	13	and	and	CC
cord-352796-6einbent	180	14	conjunctival	conjunctival	NN
cord-352796-6einbent	180	15	scrapings	scraping	NNS
cord-352796-6einbent	180	16	for	for	IN
cord-352796-6einbent	180	17	coronavirus	coronavirus	NN
cord-352796-6einbent	180	18	in	in	IN
cord-352796-6einbent	180	19	patients	patient	NNS
cord-352796-6einbent	180	20	with	with	IN
cord-352796-6einbent	180	21	SARS	SARS	NNP
cord-352796-6einbent	180	22	Angiotensin	Angiotensin	NNP
cord-352796-6einbent	180	23	receptor	receptor	NN
cord-352796-6einbent	180	24	blockers	blocker	NNS
cord-352796-6einbent	180	25	as	as	IN
cord-352796-6einbent	180	26	tentative	tentative	JJ
cord-352796-6einbent	180	27	SARS	SARS	NNP
cord-352796-6einbent	180	28	-	-	HYPH
cord-352796-6einbent	180	29	CoV-2	CoV-2	NNP
cord-352796-6einbent	180	30	therapeutics	therapeutic	NNS
cord-352796-6einbent	180	31	Coronaviruses	Coronaviruses	NNP
cord-352796-6einbent	180	32	-drug	-drug	NNP
cord-352796-6einbent	180	33	discovery	discovery	NN
cord-352796-6einbent	180	34	and	and	CC
cord-352796-6einbent	180	35	therapeutic	therapeutic	JJ
cord-352796-6einbent	180	36	options	option	NNS
cord-352796-6einbent	181	1	Angiotensin	angiotensin	NN
cord-352796-6einbent	181	2	-	-	HYPH
cord-352796-6einbent	181	3	converting	convert	VBG
cord-352796-6einbent	181	4	enzyme	enzyme	NN
cord-352796-6einbent	181	5	2	2	CD
cord-352796-6einbent	181	6	is	be	VBZ
cord-352796-6einbent	181	7	a	a	DT
cord-352796-6einbent	181	8	functional	functional	JJ
cord-352796-6einbent	181	9	receptor	receptor	NN
cord-352796-6einbent	181	10	for	for	IN
cord-352796-6einbent	181	11	the	the	DT
cord-352796-6einbent	181	12	SARS	SARS	NNP
cord-352796-6einbent	181	13	coronavirus	coronavirus	NN
cord-352796-6einbent	182	1	The	the	DT
cord-352796-6einbent	182	2	comparative	comparative	JJ
cord-352796-6einbent	182	3	efficacy	efficacy	NN
cord-352796-6einbent	182	4	and	and	CC
cord-352796-6einbent	182	5	safety	safety	NN
cord-352796-6einbent	182	6	of	of	IN
cord-352796-6einbent	182	7	the	the	DT
cord-352796-6einbent	182	8	angiotensin	angiotensin	NN
cord-352796-6einbent	182	9	receptor	receptor	NN
cord-352796-6einbent	182	10	blockers	blocker	NNS
cord-352796-6einbent	182	11	in	in	IN
cord-352796-6einbent	182	12	the	the	DT
cord-352796-6einbent	182	13	management	management	NN
cord-352796-6einbent	182	14	of	of	IN
cord-352796-6einbent	182	15	hypertension	hypertension	NN
cord-352796-6einbent	182	16	and	and	CC
cord-352796-6einbent	182	17	other	other	JJ
cord-352796-6einbent	182	18	cardiovascular	cardiovascular	JJ
cord-352796-6einbent	182	19	diseases	disease	NNS
cord-352796-6einbent	182	20	Crystal	Crystal	NNP
cord-352796-6einbent	182	21	structure	structure	NN
cord-352796-6einbent	182	22	of	of	IN
cord-352796-6einbent	182	23	the	the	DT
cord-352796-6einbent	182	24	human	human	JJ
cord-352796-6einbent	182	25	angiotensin	angiotensin	NN
cord-352796-6einbent	182	26	-	-	HYPH
cord-352796-6einbent	182	27	converting	convert	VBG
cord-352796-6einbent	182	28	enzyme	enzyme	NN
cord-352796-6einbent	182	29	-	-	HYPH
cord-352796-6einbent	182	30	lisinopril	lisinopril	NN
cord-352796-6einbent	182	31	complex	complex	NN
cord-352796-6einbent	182	32	A	a	DT
cord-352796-6einbent	182	33	virus	virus	NN
cord-352796-6einbent	182	34	-	-	HYPH
cord-352796-6einbent	182	35	binding	bind	VBG
cord-352796-6einbent	182	36	hot	hot	JJ
cord-352796-6einbent	182	37	spot	spot	NN
cord-352796-6einbent	182	38	on	on	IN
cord-352796-6einbent	182	39	human	human	JJ
cord-352796-6einbent	182	40	angiotensin	angiotensin	NN
cord-352796-6einbent	182	41	-	-	HYPH
cord-352796-6einbent	182	42	converting	convert	VBG
cord-352796-6einbent	182	43	enzyme	enzyme	NN
cord-352796-6einbent	182	44	2	2	CD
cord-352796-6einbent	182	45	is	be	VBZ
cord-352796-6einbent	182	46	critical	critical	JJ
cord-352796-6einbent	182	47	for	for	IN
cord-352796-6einbent	182	48	binding	bind	VBG
cord-352796-6einbent	182	49	of	of	IN
cord-352796-6einbent	182	50	two	two	CD
cord-352796-6einbent	182	51	different	different	JJ
cord-352796-6einbent	182	52	coronaviruses	coronaviruse	NNS
cord-352796-6einbent	182	53	ACE2	ACE2	NNP
cord-352796-6einbent	182	54	X	x	NN
cord-352796-6einbent	182	55	-	-	NN
cord-352796-6einbent	182	56	ray	ray	NN
cord-352796-6einbent	182	57	structures	structure	NNS
cord-352796-6einbent	182	58	reveal	reveal	VBP
cord-352796-6einbent	182	59	a	a	DT
cord-352796-6einbent	182	60	large	large	JJ
cord-352796-6einbent	182	61	hingebending	hingebending	NN
cord-352796-6einbent	182	62	motion	motion	NN
cord-352796-6einbent	182	63	important	important	JJ
cord-352796-6einbent	182	64	for	for	IN
cord-352796-6einbent	182	65	inhibitor	inhibitor	NN
cord-352796-6einbent	182	66	binding	binding	NN
cord-352796-6einbent	182	67	and	and	CC
cord-352796-6einbent	182	68	catalysis	catalysis	NN
cord-352796-6einbent	182	69	Screening	screening	NN
cord-352796-6einbent	182	70	of	of	IN
cord-352796-6einbent	182	71	an	an	DT
cord-352796-6einbent	182	72	FDA	FDA	NNP
cord-352796-6einbent	182	73	-	-	HYPH
cord-352796-6einbent	182	74	approved	approve	VBN
cord-352796-6einbent	182	75	compound	compound	NN
cord-352796-6einbent	182	76	library	library	NN
cord-352796-6einbent	182	77	identifies	identify	VBZ
cord-352796-6einbent	182	78	four	four	CD
cord-352796-6einbent	182	79	small	small	JJ
cord-352796-6einbent	182	80	-	-	HYPH
cord-352796-6einbent	182	81	molecule	molecule	NN
cord-352796-6einbent	182	82	inhibitors	inhibitor	NNS
cord-352796-6einbent	182	83	of	of	IN
cord-352796-6einbent	182	84	Middle	Middle	NNP
cord-352796-6einbent	182	85	East	East	NNP
cord-352796-6einbent	182	86	respiratory	respiratory	JJ
cord-352796-6einbent	182	87	syndrome	syndrome	NN
cord-352796-6einbent	182	88	coronavirus	coronavirus	NN
cord-352796-6einbent	182	89	replication	replication	NN
cord-352796-6einbent	182	90	in	in	IN
cord-352796-6einbent	182	91	cell	cell	NN
cord-352796-6einbent	182	92	culture	culture	NN
cord-352796-6einbent	182	93	Remdesivir	Remdesivir	NNP
cord-352796-6einbent	182	94	and	and	CC
cord-352796-6einbent	182	95	chloroquine	chloroquine	NNP
cord-352796-6einbent	183	1	effectively	effectively	RB
cord-352796-6einbent	183	2	inhibit	inhibit	VB
cord-352796-6einbent	183	3	the	the	DT
cord-352796-6einbent	183	4	recently	recently	RB
cord-352796-6einbent	183	5	emerged	emerge	VBN
cord-352796-6einbent	183	6	novel	novel	JJ
cord-352796-6einbent	183	7	coronavirus	coronavirus	NN
cord-352796-6einbent	183	8	(	(	-LRB-
cord-352796-6einbent	183	9	2019-nCoV	2019-ncov	CD
cord-352796-6einbent	183	10	)	)	-RRB-
cord-352796-6einbent	183	11	in	in	IN
cord-352796-6einbent	183	12	vitro	vitro	FW
cord-352796-6einbent	183	13	Evaluation	Evaluation	NNP
cord-352796-6einbent	183	14	of	of	IN
cord-352796-6einbent	183	15	immunomodulators	immunomodulator	NNS
cord-352796-6einbent	183	16	,	,	,
cord-352796-6einbent	183	17	interferons	interferon	NNS
cord-352796-6einbent	183	18	and	and	CC
cord-352796-6einbent	183	19	known	know	VBN
cord-352796-6einbent	183	20	in	in	IN
cord-352796-6einbent	183	21	vitro	vitro	FW
cord-352796-6einbent	183	22	SARS	SARS	NNP
cord-352796-6einbent	183	23	-	-	HYPH
cord-352796-6einbent	183	24	coV	coV	NNP
cord-352796-6einbent	183	25	inhibitors	inhibitor	NNS
cord-352796-6einbent	183	26	for	for	IN
cord-352796-6einbent	183	27	inhibition	inhibition	NN
cord-352796-6einbent	183	28	of	of	IN
cord-352796-6einbent	183	29	SARS	SARS	NNP
cord-352796-6einbent	183	30	-	-	HYPH
cord-352796-6einbent	183	31	coV	coV	VBG
cord-352796-6einbent	183	32	replication	replication	NN
cord-352796-6einbent	183	33	in	in	IN
cord-352796-6einbent	183	34	BALB	BALB	NNP
cord-352796-6einbent	183	35	/	/	SYM
cord-352796-6einbent	183	36	c	c	NN
cord-352796-6einbent	183	37	mice	mouse	NNS
cord-352796-6einbent	184	1	A	a	DT
cord-352796-6einbent	184	2	Rapid	Rapid	NNP
cord-352796-6einbent	184	3	Systematic	Systematic	NNP
cord-352796-6einbent	184	4	Review	Review	NNP
cord-352796-6einbent	184	5	of	of	IN
cord-352796-6einbent	184	6	Clinical	Clinical	NNP
cord-352796-6einbent	184	7	Trials	trial	NNS
cord-352796-6einbent	184	8	Utilizing	utilize	VBG
cord-352796-6einbent	184	9	Chloroquine	Chloroquine	NNP
cord-352796-6einbent	184	10	and	and	CC
cord-352796-6einbent	184	11	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-352796-6einbent	184	12	as	as	IN
cord-352796-6einbent	184	13	a	a	DT
cord-352796-6einbent	184	14	Treatment	Treatment	NNP
cord-352796-6einbent	184	15	for	for	IN
cord-352796-6einbent	184	16	COVID-19	COVID-19	NNP
cord-352796-6einbent	184	17	Evaluation	Evaluation	NNP
cord-352796-6einbent	184	18	of	of	IN
cord-352796-6einbent	184	19	the	the	DT
cord-352796-6einbent	184	20	effects	effect	NNS
cord-352796-6einbent	184	21	of	of	IN
cord-352796-6einbent	184	22	chloroquine	chloroquine	NN
cord-352796-6einbent	184	23	phosphate	phosphate	NN
cord-352796-6einbent	184	24	eye	eye	NN
cord-352796-6einbent	184	25	drops	drop	NNS
cord-352796-6einbent	184	26	in	in	IN
cord-352796-6einbent	184	27	patients	patient	NNS
cord-352796-6einbent	184	28	with	with	IN
cord-352796-6einbent	184	29	dry	dry	JJ
cord-352796-6einbent	184	30	eye	eye	NN
cord-352796-6einbent	184	31	syndrome	syndrome	NN
cord-352796-6einbent	184	32	Efficacy	Efficacy	NNP
cord-352796-6einbent	184	33	and	and	CC
cord-352796-6einbent	184	34	Safety	Safety	NNP
cord-352796-6einbent	184	35	of	of	IN
cord-352796-6einbent	184	36	Topical	Topical	NNP
cord-352796-6einbent	184	37	Chloroquine	Chloroquine	NNP
cord-352796-6einbent	184	38	in	in	IN
cord-352796-6einbent	184	39	Mild	mild	JJ
cord-352796-6einbent	184	40	to	to	IN
cord-352796-6einbent	184	41	Moderate	Moderate	NNP
cord-352796-6einbent	184	42	Dry	Dry	NNP
cord-352796-6einbent	184	43	Eye	Eye	NNP
cord-352796-6einbent	184	44	Disease	Disease	NNP
cord-352796-6einbent	184	45	Clinical	Clinical	NNP
cord-352796-6einbent	184	46	Pharmacology	Pharmacology	NNP
cord-352796-6einbent	184	47	Perspectives	Perspectives	NNPS
cord-352796-6einbent	184	48	on	on	IN
cord-352796-6einbent	184	49	the	the	DT
cord-352796-6einbent	184	50	Antiviral	Antiviral	NNP
cord-352796-6einbent	184	51	Activity	Activity	NNP
cord-352796-6einbent	184	52	of	of	IN
cord-352796-6einbent	184	53	Azithromycin	Azithromycin	NNP
cord-352796-6einbent	184	54	and	and	CC
cord-352796-6einbent	184	55	Use	Use	NNP
cord-352796-6einbent	184	56	in	in	IN
cord-352796-6einbent	184	57	COVID-19	COVID-19	NNP
cord-352796-6einbent	184	58	Review	Review	NNP
cord-352796-6einbent	184	59	of	of	IN
cord-352796-6einbent	184	60	Azithromycin	Azithromycin	NNP
cord-352796-6einbent	184	61	Ophthalmic	Ophthalmic	NNP
cord-352796-6einbent	184	62	1	1	CD
cord-352796-6einbent	184	63	%	%	NN
cord-352796-6einbent	184	64	Solution	solution	NN
cord-352796-6einbent	184	65	(	(	-LRB-
cord-352796-6einbent	184	66	AzaSite	AzaSite	NNP
cord-352796-6einbent	184	67	(	(	-LRB-
cord-352796-6einbent	184	68	®	®	NN
cord-352796-6einbent	184	69	)	)	-RRB-
cord-352796-6einbent	184	70	)	)	-RRB-
cord-352796-6einbent	184	71	for	for	IN
cord-352796-6einbent	184	72	the	the	DT
cord-352796-6einbent	184	73	Treatment	Treatment	NNP
cord-352796-6einbent	184	74	of	of	IN
cord-352796-6einbent	184	75	Ocular	Ocular	NNP
cord-352796-6einbent	184	76	Infections	Infections	NNPS
cord-352796-6einbent	184	77	Elimination	Elimination	NNP
cord-352796-6einbent	184	78	of	of	IN
cord-352796-6einbent	184	79	active	active	JJ
cord-352796-6einbent	184	80	trachoma	trachoma	NN
cord-352796-6einbent	184	81	after	after	IN
cord-352796-6einbent	184	82	two	two	CD
cord-352796-6einbent	184	83	topical	topical	JJ
cord-352796-6einbent	184	84	mass	mass	NN
cord-352796-6einbent	184	85	treatments	treatment	NNS
cord-352796-6einbent	184	86	with	with	IN
cord-352796-6einbent	184	87	azithromycin	azithromycin	NNP
cord-352796-6einbent	184	88	1.5	1.5	CD
cord-352796-6einbent	184	89	%	%	NN
cord-352796-6einbent	184	90	eye	eye	NN
cord-352796-6einbent	184	91	drops	drop	VBZ
cord-352796-6einbent	184	92	Corneal	corneal	JJ
cord-352796-6einbent	184	93	pharmacokinetics	pharmacokinetic	NNS
cord-352796-6einbent	184	94	of	of	IN
cord-352796-6einbent	184	95	topically	topically	RB
cord-352796-6einbent	184	96	applied	apply	VBN
cord-352796-6einbent	184	97	azithromycin	azithromycin	NNP
cord-352796-6einbent	184	98	and	and	CC
cord-352796-6einbent	184	99	clarithromycin	clarithromycin	NNS
cord-352796-6einbent	184	100	Effects	effect	NNS
cord-352796-6einbent	184	101	of	of	IN
cord-352796-6einbent	184	102	dehydration	dehydration	NN
cord-352796-6einbent	184	103	on	on	IN
cord-352796-6einbent	184	104	corneal	corneal	JJ
cord-352796-6einbent	184	105	tissue	tissue	NN
cord-352796-6einbent	184	106	absorption	absorption	NN
cord-352796-6einbent	184	107	of	of	IN
cord-352796-6einbent	184	108	topical	topical	JJ
cord-352796-6einbent	184	109	azithromycin	azithromycin	NNS
cord-352796-6einbent	184	110	in	in	IN
cord-352796-6einbent	184	111	rabbits	rabbit	NNS
cord-352796-6einbent	184	112	Zn(2	Zn(2	NNP
cord-352796-6einbent	184	113	+	+	SYM
cord-352796-6einbent	184	114	)	)	-RRB-
cord-352796-6einbent	184	115	inhibits	inhibit	VBZ
cord-352796-6einbent	184	116	coronavirus	coronavirus	NN
cord-352796-6einbent	184	117	and	and	CC
cord-352796-6einbent	184	118	arterivirus	arterivirus	NNP
cord-352796-6einbent	184	119	RNA	RNA	NNP
cord-352796-6einbent	184	120	polymerase	polymerase	NN
cord-352796-6einbent	184	121	activity	activity	NN
cord-352796-6einbent	184	122	in	in	IN
cord-352796-6einbent	184	123	vitro	vitro	FW
cord-352796-6einbent	184	124	and	and	CC
cord-352796-6einbent	184	125	zinc	zinc	NN
cord-352796-6einbent	184	126	ionophores	ionophores	NNP
cord-352796-6einbent	184	127	block	block	VBP
cord-352796-6einbent	184	128	the	the	DT
cord-352796-6einbent	184	129	replication	replication	NN
cord-352796-6einbent	184	130	of	of	IN
cord-352796-6einbent	184	131	these	these	DT
cord-352796-6einbent	184	132	viruses	virus	NNS
cord-352796-6einbent	184	133	in	in	IN
cord-352796-6einbent	184	134	cell	cell	NN
cord-352796-6einbent	184	135	culture	culture	NN
cord-352796-6einbent	184	136	Influence	influence	NN
cord-352796-6einbent	184	137	of	of	IN
cord-352796-6einbent	184	138	topical	topical	JJ
cord-352796-6einbent	184	139	and	and	CC
cord-352796-6einbent	184	140	oral	oral	JJ
cord-352796-6einbent	184	141	zinc	zinc	NN
cord-352796-6einbent	184	142	upon	upon	IN
cord-352796-6einbent	184	143	corneal	corneal	JJ
cord-352796-6einbent	184	144	wound	wound	NN
cord-352796-6einbent	184	145	healing	heal	VBG
cord-352796-6einbent	184	146	Influence	influence	NN
cord-352796-6einbent	184	147	of	of	IN
cord-352796-6einbent	184	148	local	local	JJ
cord-352796-6einbent	184	149	antiseptics	antiseptic	NNS
cord-352796-6einbent	184	150	on	on	IN
cord-352796-6einbent	184	151	regeneration	regeneration	NN
cord-352796-6einbent	184	152	of	of	IN
cord-352796-6einbent	184	153	corneal	corneal	JJ
cord-352796-6einbent	184	154	epithelium	epithelium	NN
cord-352796-6einbent	184	155	of	of	IN
cord-352796-6einbent	184	156	rabbits	rabbit	NNS
cord-352796-6einbent	185	1	Chloroquine	chloroquine	NN
cord-352796-6einbent	185	2	paradox	paradox	NN
cord-352796-6einbent	185	3	may	may	MD
cord-352796-6einbent	185	4	cause	cause	VB
cord-352796-6einbent	185	5	more	more	JJR
cord-352796-6einbent	185	6	damage	damage	NN
cord-352796-6einbent	185	7	than	than	IN
cord-352796-6einbent	185	8	help	help	NN
cord-352796-6einbent	185	9	fight	fight	VB
cord-352796-6einbent	185	10	COVID-19	COVID-19	NNP
cord-352796-6einbent	185	11	Effects	effect	NNS
cord-352796-6einbent	185	12	of	of	IN
cord-352796-6einbent	185	13	chloroquine	chloroquine	NN
cord-352796-6einbent	185	14	on	on	IN
cord-352796-6einbent	185	15	viral	viral	JJ
cord-352796-6einbent	185	16	infections	infection	NNS
cord-352796-6einbent	185	17	:	:	:
cord-352796-6einbent	185	18	an	an	DT
cord-352796-6einbent	185	19	old	old	JJ
cord-352796-6einbent	185	20	drug	drug	NN
cord-352796-6einbent	185	21	against	against	IN
cord-352796-6einbent	185	22	today	today	NN
cord-352796-6einbent	185	23	's	's	POS
cord-352796-6einbent	185	24	diseases	disease	NNS
cord-352796-6einbent	185	25	?	?	.
cord-352796-6einbent	186	1	Chloroquine	Chloroquine	NNP
cord-352796-6einbent	186	2	is	be	VBZ
cord-352796-6einbent	186	3	a	a	DT
cord-352796-6einbent	186	4	potent	potent	JJ
cord-352796-6einbent	186	5	inhibitor	inhibitor	NN
cord-352796-6einbent	186	6	of	of	IN
cord-352796-6einbent	186	7	SARS	SARS	NNP
cord-352796-6einbent	186	8	coronavirus	coronavirus	NN
cord-352796-6einbent	186	9	infection	infection	NN
cord-352796-6einbent	186	10	and	and	CC
cord-352796-6einbent	186	11	spread	spread	VBN
cord-352796-6einbent	186	12	In	in	FW
cord-352796-6einbent	186	13	vitro	vitro	FW
cord-352796-6einbent	186	14	inhibition	inhibition	NN
cord-352796-6einbent	186	15	of	of	IN
cord-352796-6einbent	186	16	severe	severe	JJ
cord-352796-6einbent	186	17	acute	acute	JJ
cord-352796-6einbent	186	18	respiratory	respiratory	JJ
cord-352796-6einbent	186	19	syndrome	syndrome	NN
cord-352796-6einbent	186	20	coronavirus	coronavirus	NN
cord-352796-6einbent	186	21	by	by	IN
cord-352796-6einbent	186	22	chloroquine	chloroquine	JJ
cord-352796-6einbent	186	23	New	new	JJ
cord-352796-6einbent	186	24	insights	insight	NNS
cord-352796-6einbent	186	25	into	into	IN
cord-352796-6einbent	186	26	the	the	DT
cord-352796-6einbent	186	27	antiviral	antiviral	JJ
cord-352796-6einbent	186	28	effects	effect	NNS
cord-352796-6einbent	186	29	of	of	IN
cord-352796-6einbent	186	30	chloroquine	chloroquine	NN
cord-352796-6einbent	186	31	The	the	DT
cord-352796-6einbent	186	32	anti	anti	JJ
cord-352796-6einbent	186	33	-	-	JJ
cord-352796-6einbent	186	34	viral	viral	JJ
cord-352796-6einbent	186	35	facet	facet	NN
cord-352796-6einbent	186	36	of	of	IN
cord-352796-6einbent	186	37	anti	anti	JJ
cord-352796-6einbent	186	38	-	-	JJ
cord-352796-6einbent	186	39	rheumatic	rheumatic	JJ
cord-352796-6einbent	186	40	drugs	drug	NNS
cord-352796-6einbent	186	41	:	:	:
cord-352796-6einbent	186	42	Lessons	lesson	NNS
cord-352796-6einbent	186	43	from	from	IN
cord-352796-6einbent	186	44	COVID-19	COVID-19	NNP
cord-352796-6einbent	186	45	In	in	IN
cord-352796-6einbent	186	46	Vitro	Vitro	NNP
cord-352796-6einbent	186	47	Antiviral	Antiviral	NNP
cord-352796-6einbent	186	48	Activity	Activity	NNP
cord-352796-6einbent	186	49	and	and	CC
cord-352796-6einbent	186	50	Projection	Projection	NNP
cord-352796-6einbent	186	51	of	of	IN
cord-352796-6einbent	186	52	Optimized	Optimized	NNP
cord-352796-6einbent	186	53	Dosing	Dosing	NNP
cord-352796-6einbent	186	54	Design	Design	NNP
cord-352796-6einbent	186	55	of	of	IN
cord-352796-6einbent	186	56	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-352796-6einbent	186	57	for	for	IN
cord-352796-6einbent	186	58	the	the	DT
cord-352796-6einbent	186	59	Treatment	Treatment	NNP
cord-352796-6einbent	186	60	of	of	IN
cord-352796-6einbent	186	61	Severe	severe	JJ
cord-352796-6einbent	186	62	Acute	acute	JJ
cord-352796-6einbent	186	63	Respiratory	Respiratory	NNP
cord-352796-6einbent	186	64	Syndrome	Syndrome	NNP
cord-352796-6einbent	186	65	Coronavirus	Coronavirus	NNP
cord-352796-6einbent	186	66	2	2	CD
cord-352796-6einbent	187	1	(	(	-LRB-
cord-352796-6einbent	187	2	SARS	SARS	NNP
cord-352796-6einbent	187	3	-	-	HYPH
cord-352796-6einbent	187	4	CoV-2	CoV-2	NNP
cord-352796-6einbent	187	5	)	)	-RRB-
cord-352796-6einbent	187	6	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-352796-6einbent	187	7	,	,	,
cord-352796-6einbent	187	8	a	a	DT
cord-352796-6einbent	187	9	less	less	RBR
cord-352796-6einbent	187	10	toxic	toxic	JJ
cord-352796-6einbent	187	11	derivative	derivative	NN
cord-352796-6einbent	187	12	of	of	IN
cord-352796-6einbent	187	13	chloroquine	chloroquine	NN
cord-352796-6einbent	187	14	,	,	,
cord-352796-6einbent	187	15	is	be	VBZ
cord-352796-6einbent	187	16	effective	effective	JJ
cord-352796-6einbent	187	17	in	in	IN
cord-352796-6einbent	187	18	inhibiting	inhibit	VBG
cord-352796-6einbent	187	19	SARS	SARS	NNP
cord-352796-6einbent	187	20	-	-	HYPH
cord-352796-6einbent	187	21	CoV-2	CoV-2	NNP
cord-352796-6einbent	187	22	infection	infection	NN
cord-352796-6einbent	187	23	in	in	IN
cord-352796-6einbent	187	24	vitro	vitro	FW
cord-352796-6einbent	187	25	Clinical	clinical	JJ
cord-352796-6einbent	187	26	and	and	CC
cord-352796-6einbent	187	27	microbiological	microbiological	JJ
cord-352796-6einbent	187	28	effect	effect	NN
cord-352796-6einbent	187	29	of	of	IN
cord-352796-6einbent	187	30	a	a	DT
cord-352796-6einbent	187	31	combination	combination	NN
cord-352796-6einbent	187	32	of	of	IN
cord-352796-6einbent	187	33	hydroxychloroquine	hydroxychloroquine	NN
cord-352796-6einbent	187	34	and	and	CC
cord-352796-6einbent	187	35	azithromycin	azithromycin	NNP
cord-352796-6einbent	187	36	in	in	IN
cord-352796-6einbent	187	37	80	80	CD
cord-352796-6einbent	188	1	COVID-19	covid-19	JJ
cord-352796-6einbent	188	2	patients	patient	NNS
cord-352796-6einbent	188	3	with	with	IN
cord-352796-6einbent	188	4	at	at	RB
cord-352796-6einbent	188	5	least	least	JJS
cord-352796-6einbent	188	6	a	a	DT
cord-352796-6einbent	188	7	six	six	CD
cord-352796-6einbent	188	8	-	-	HYPH
cord-352796-6einbent	188	9	day	day	NN
cord-352796-6einbent	188	10	follow	follow	VB
cord-352796-6einbent	188	11	up	up	RP
cord-352796-6einbent	188	12	:	:	:
cord-352796-6einbent	188	13	A	a	DT
cord-352796-6einbent	188	14	pilot	pilot	NN
cord-352796-6einbent	188	15	observational	observational	JJ
cord-352796-6einbent	188	16	study	study	NN
cord-352796-6einbent	189	1	The	the	DT
cord-352796-6einbent	189	2	Effect	Effect	NNP
cord-352796-6einbent	189	3	of	of	IN
cord-352796-6einbent	189	4	Chloroquine	Chloroquine	NNP
cord-352796-6einbent	189	5	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-352796-6einbent	189	6	retinopathy	retinopathy	NN
cord-352796-6einbent	189	7	Macular	Macular	NNP
cord-352796-6einbent	189	8	toxicity	toxicity	NN
cord-352796-6einbent	189	9	after	after	IN
cord-352796-6einbent	189	10	short	short	JJ
cord-352796-6einbent	189	11	-	-	HYPH
cord-352796-6einbent	189	12	term	term	NN
cord-352796-6einbent	189	13	hydroxychloroquine	hydroxychloroquine	NN
cord-352796-6einbent	189	14	therapy	therapy	NNP
cord-352796-6einbent	189	15	Analysis	Analysis	NNP
cord-352796-6einbent	189	16	of	of	IN
cord-352796-6einbent	189	17	the	the	DT
cord-352796-6einbent	189	18	ABCR	ABCR	NNP
cord-352796-6einbent	189	19	(	(	-LRB-
cord-352796-6einbent	189	20	ABCA4	ABCA4	NNS
cord-352796-6einbent	189	21	)	)	-RRB-
cord-352796-6einbent	189	22	gene	gene	NN
cord-352796-6einbent	189	23	in	in	IN
cord-352796-6einbent	189	24	4-aminoquinoline	4-aminoquinoline	CD
cord-352796-6einbent	189	25	retinopathy	retinopathy	NN
cord-352796-6einbent	189	26	:	:	:
cord-352796-6einbent	189	27	Is	be	VBZ
cord-352796-6einbent	189	28	retinal	retinal	JJ
cord-352796-6einbent	189	29	toxicity	toxicity	NN
cord-352796-6einbent	189	30	by	by	IN
cord-352796-6einbent	189	31	chloroquine	chloroquine	NN
cord-352796-6einbent	189	32	and	and	CC
cord-352796-6einbent	189	33	hydroxychloroquine	hydroxychloroquine	NN
cord-352796-6einbent	189	34	related	relate	VBN
cord-352796-6einbent	189	35	to	to	IN
cord-352796-6einbent	189	36	Stargardt	Stargardt	NNP
cord-352796-6einbent	189	37	disease	disease	NN
cord-352796-6einbent	189	38	?	?	.
cord-352796-6einbent	190	1	Therapeutic	therapeutic	JJ
cord-352796-6einbent	190	2	use	use	NN
cord-352796-6einbent	190	3	and	and	CC
cord-352796-6einbent	190	4	safety	safety	NN
cord-352796-6einbent	190	5	profile	profile	NN
cord-352796-6einbent	190	6	in	in	IN
cord-352796-6einbent	190	7	the	the	DT
cord-352796-6einbent	190	8	management	management	NN
cord-352796-6einbent	190	9	of	of	IN
cord-352796-6einbent	190	10	osteoarthritis	osteoarthritis	NN
cord-352796-6einbent	190	11	and	and	CC
cord-352796-6einbent	190	12	rheumatoid	rheumatoid	NN
cord-352796-6einbent	190	13	arthritis	arthritis	NN
cord-352796-6einbent	191	1	Audo	Audo	NNP
cord-352796-6einbent	191	2	I	-PRON-	PRP
cord-352796-6einbent	191	3	;	;	:
cord-352796-6einbent	191	4	DHU	DHU	NNP
cord-352796-6einbent	191	5	Vision	Vision	NNP
cord-352796-6einbent	191	6	Handicaps	Handicaps	NNP
cord-352796-6einbent	191	7	task	task	NN
cord-352796-6einbent	191	8	force	force	NN
cord-352796-6einbent	191	9	rétine	rétine	NN
cord-352796-6einbent	191	10	.	.	.
cord-352796-6einbent	192	1	Différences	Différences	NNP
cord-352796-6einbent	192	2	ethniques	ethniques	NNP
cord-352796-6einbent	192	3	parmi	parmi	NNP
cord-352796-6einbent	193	1	les	les	NNP
cord-352796-6einbent	193	2	patients	patient	NNS
cord-352796-6einbent	193	3	souffrant	souffrant	NNP
cord-352796-6einbent	193	4	de	de	NNP
cord-352796-6einbent	193	5	toxicité	toxicité	NNP
cord-352796-6einbent	193	6	maculaire	maculaire	NNP
cord-352796-6einbent	193	7	aux	aux	NNP
cord-352796-6einbent	193	8	antipaludéens	antipaludéens	NNP
cord-352796-6einbent	193	9	de	de	NNP
cord-352796-6einbent	193	10	synthèse	synthèse	NNP
cord-352796-6einbent	193	11	Chloroquine	Chloroquine	NNP
cord-352796-6einbent	194	1	is	be	VBZ
cord-352796-6einbent	194	2	a	a	DT
cord-352796-6einbent	194	3	zinc	zinc	NN
cord-352796-6einbent	194	4	ionophore	ionophore	IN
cord-352796-6einbent	194	5	Zinc	Zinc	NNP
cord-352796-6einbent	194	6	Salts	salt	NNS
cord-352796-6einbent	195	1	Block	Block	NNP
cord-352796-6einbent	195	2	Hepatitis	Hepatitis	NNP
cord-352796-6einbent	195	3	E	e	NN
cord-352796-6einbent	195	4	Virus	virus	NN
cord-352796-6einbent	195	5	Replication	replication	NN
cord-352796-6einbent	195	6	by	by	IN
cord-352796-6einbent	195	7	Inhibiting	inhibit	VBG
cord-352796-6einbent	195	8	the	the	DT
cord-352796-6einbent	195	9	Activity	Activity	NNP
cord-352796-6einbent	195	10	of	of	IN
cord-352796-6einbent	195	11	Viral	Viral	NNP
cord-352796-6einbent	195	12	RNA	RNA	NNP
cord-352796-6einbent	195	13	-	-	HYPH
cord-352796-6einbent	195	14	Dependent	Dependent	NNP
cord-352796-6einbent	195	15	RNA	RNA	NNP
cord-352796-6einbent	195	16	Polymerase	Polymerase	NNP
cord-352796-6einbent	195	17	Improving	improve	VBG
cord-352796-6einbent	195	18	the	the	DT
cord-352796-6einbent	195	19	efficacy	efficacy	NN
cord-352796-6einbent	195	20	of	of	IN
cord-352796-6einbent	195	21	Chloroquine	Chloroquine	NNP
cord-352796-6einbent	195	22	and	and	CC
cord-352796-6einbent	195	23	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-352796-6einbent	195	24	against	against	IN
cord-352796-6einbent	195	25	SARS	SARS	NNP
cord-352796-6einbent	195	26	-	-	HYPH
cord-352796-6einbent	195	27	CoV-2	CoV-2	NNP
cord-352796-6einbent	195	28	may	may	MD
cord-352796-6einbent	195	29	require	require	VB
cord-352796-6einbent	195	30	Zinc	Zinc	NNP
cord-352796-6einbent	195	31	additives	additive	NNS
cord-352796-6einbent	196	1	-A	-A	.
cord-352796-6einbent	197	1	better	well	JJR
cord-352796-6einbent	197	2	synergy	synergy	NN
cord-352796-6einbent	197	3	for	for	IN
cord-352796-6einbent	197	4	future	future	NN
cord-352796-6einbent	198	1	COVID-19	covid-19	VB
cord-352796-6einbent	198	2	clinical	clinical	JJ
cord-352796-6einbent	198	3	trials	trial	NNS
cord-352796-6einbent	199	1	Chloroquine	Chloroquine	NNP
cord-352796-6einbent	199	2	keratopathy	keratopathy	NNP
cord-352796-6einbent	199	3	in	in	IN
cord-352796-6einbent	199	4	chloroquine	chloroquine	NN
cord-352796-6einbent	199	5	workers	worker	NNS
cord-352796-6einbent	199	6	after	after	IN
cord-352796-6einbent	199	7	topical	topical	JJ
cord-352796-6einbent	199	8	dust	dust	NN
cord-352796-6einbent	199	9	exponation	exponation	NN
cord-352796-6einbent	199	10	.	.	.
cord-352796-6einbent	200	1	A	a	DT
cord-352796-6einbent	200	2	case	case	NN
cord-352796-6einbent	200	3	report	report	NN
cord-352796-6einbent	200	4	Topical	topical	JJ
cord-352796-6einbent	200	5	ocular	ocular	JJ
cord-352796-6einbent	200	6	hypotensive	hypotensive	JJ
cord-352796-6einbent	200	7	effects	effect	NNS
cord-352796-6einbent	200	8	of	of	IN
cord-352796-6einbent	200	9	the	the	DT
cord-352796-6einbent	200	10	novel	novel	JJ
cord-352796-6einbent	200	11	angiotensin	angiotensin	NN
cord-352796-6einbent	200	12	converting	convert	VBG
cord-352796-6einbent	200	13	enzyme	enzyme	NN
cord-352796-6einbent	200	14	inhibitor	inhibitor	NN
cord-352796-6einbent	200	15	SCH	SCH	NNP
cord-352796-6einbent	200	16	33861	33861	CD
cord-352796-6einbent	200	17	in	in	IN
cord-352796-6einbent	200	18	conscious	conscious	JJ
cord-352796-6einbent	200	19	rabbits	rabbit	NNS
cord-352796-6einbent	201	1	The	the	DT
cord-352796-6einbent	201	2	comparative	comparative	JJ
cord-352796-6einbent	201	3	pharmacology	pharmacology	NN
cord-352796-6einbent	201	4	of	of	IN
cord-352796-6einbent	201	5	angiotensin	angiotensin	NN
cord-352796-6einbent	201	6	II	II	NNP
cord-352796-6einbent	201	7	receptor	receptor	NN
cord-352796-6einbent	201	8	antagonists	antagonist	NNS
cord-352796-6einbent	201	9	Upregulation	Upregulation	NNP
cord-352796-6einbent	201	10	of	of	IN
cord-352796-6einbent	201	11	angiotensin	angiotensin	NN
cord-352796-6einbent	201	12	-	-	HYPH
cord-352796-6einbent	201	13	converting	convert	VBG
cord-352796-6einbent	201	14	enzyme	enzyme	NN
cord-352796-6einbent	201	15	2	2	CD
cord-352796-6einbent	201	16	after	after	IN
cord-352796-6einbent	201	17	myocardial	myocardial	JJ
cord-352796-6einbent	201	18	infarction	infarction	NN
cord-352796-6einbent	201	19	by	by	IN
cord-352796-6einbent	201	20	blockade	blockade	NN
cord-352796-6einbent	201	21	of	of	IN
cord-352796-6einbent	201	22	angiotensin	angiotensin	NN
cord-352796-6einbent	201	23	II	II	NNP
cord-352796-6einbent	201	24	receptors	receptor	NNS
cord-352796-6einbent	201	25	Clinical	clinical	JJ
cord-352796-6einbent	201	26	features	feature	NNS
cord-352796-6einbent	201	27	of	of	IN
cord-352796-6einbent	201	28	deaths	death	NNS
cord-352796-6einbent	201	29	in	in	IN
cord-352796-6einbent	201	30	the	the	DT
cord-352796-6einbent	201	31	novel	novel	JJ
cord-352796-6einbent	201	32	coronavirus	coronavirus	NN
cord-352796-6einbent	201	33	epidemic	epidemic	NN
cord-352796-6einbent	201	34	in	in	IN
cord-352796-6einbent	201	35	Epub	Epub	NNP
cord-352796-6einbent	201	36	ahead	ahead	RB
cord-352796-6einbent	201	37	of	of	IN
cord-352796-6einbent	201	38	print	print	NN
cord-352796-6einbent	201	39	Bioavailability	Bioavailability	NNP
cord-352796-6einbent	201	40	of	of	IN
cord-352796-6einbent	201	41	hydroxychloroquine	hydroxychloroquine	NN
cord-352796-6einbent	201	42	tablets	tablet	NNS
cord-352796-6einbent	201	43	in	in	IN
cord-352796-6einbent	201	44	healthy	healthy	JJ
cord-352796-6einbent	201	45	volunteers	volunteer	NNS
cord-352796-6einbent	201	46	High	high	JJ
cord-352796-6einbent	201	47	expression	expression	NN
cord-352796-6einbent	201	48	of	of	IN
cord-352796-6einbent	201	49	ACE2	ACE2	NNP
cord-352796-6einbent	201	50	receptor	receptor	NN
cord-352796-6einbent	201	51	of	of	IN
cord-352796-6einbent	201	52	2019-nCoV	2019-ncov	CD
cord-352796-6einbent	201	53	on	on	IN
cord-352796-6einbent	201	54	the	the	DT
cord-352796-6einbent	201	55	epithelial	epithelial	JJ
cord-352796-6einbent	201	56	cells	cell	NNS
cord-352796-6einbent	201	57	of	of	IN
cord-352796-6einbent	201	58	oral	oral	JJ
cord-352796-6einbent	201	59	mucosa	mucosa	NN